Financial-condition grades for SEC filers
Seven checks run on every eligible filer, 3,545 today. A warning is a measured value past a stated threshold. Warnings never enter the letter; fortress and thin data are informational.
Eligible filers triggering each check, with the share of the universe.
Dilution; Short runway; Late filer; Distress; Degenerate inputs; Fortress balance sheet; Thin data.
Rule: split-adjusted shares outstanding up 25% or more in one year. 381 triggered; among the 153 with a letter: A 5, B 12, C 23, D 28, E 85. The largest 150 by market equity are listed.
| Company | Measured | Letter | Percentile | Market equity |
|---|---|---|---|---|
| Akari Therapeutics plc (AKTX) Akari Therapeutics plc (AKTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.3T; last close $8.57 Warnings: dilution, late filer, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 58.5% | none | n/a | $1.3T |
| Lumentum Holdings Inc. (LITE) Lumentum Holdings Inc. (LITE) Cmiddle fifth; percentile 56.5 Nasdaq · Communications Equipment, NEC market equity $94.1B; last close $1,048.15 Warnings: dilution; 10 of 14 inputs | split-adjusted year-over-year share growth is 28.3% | C | 56.5 | $94.1B |
| Coherent Corp. (COHR) Coherent Corp. (COHR) Dfourth fifth; percentile 76.2 NYSE · Optical Instruments & Lenses market equity $59.2B; last close $302.31 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 25.7% | D | 76.2 | $59.2B |
| Waters Corp. (WAT) Waters Corp. (WAT) Bsecond fifth; percentile 30.4 NYSE · Laboratory Analytical Instruments market equity $42.2B; last close $429.94 Warnings: dilution; 12 of 14 inputs | split-adjusted year-over-year share growth is 65.1% | B | 30.4 | $42.2B |
| Omnicom Group Inc. (OMC) Omnicom Group Inc. (OMC) D/Eon the D/E boundary; percentile 82.1 NYSE · Services-Advertising Agencies market equity $21.8B; last close $76.44 Warnings: dilution; 10 of 14 inputs | split-adjusted year-over-year share growth is 57.9% | D/E | 82.1 | $21.8B |
| Bunge Global SA (BG) Bunge Global SA (BG) noneno letter; percentile n/a NYSE · Fats & Oils market equity $20.9B; last close $107.82 Warnings: dilution, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 44.4% | none | n/a | $20.9B |
| Packaging Corp. OF America (PKG) Packaging Corp. OF America (PKG) Cmiddle fifth; percentile 44.9 NYSE · Paperboard Containers & Boxes market equity $20.5B; last close $229.73 Warnings: dilution; 11 of 14 inputs | split-adjusted year-over-year share growth is 99245.4% | C | 44.9 | $20.5B |
| IonQ, Inc. (IONQ) IonQ, Inc. (IONQ) Bsecond fifth; percentile 27.2 NYSE · Services-Computer Integrated Systems Design market equity $15.0B; last close $39.46 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 64.5% | B | 27.2 | $15.0B |
| Kymera Therapeutics, Inc. (KYMR) Kymera Therapeutics, Inc. (KYMR) Cmiddle fifth; percentile 47.8 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $9.1B; last close $109.34 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 25.7% | C | 47.8 | $9.1B |
| Applied Optoelectronics, Inc. (AAOI) Applied Optoelectronics, Inc. (AAOI) Dfourth fifth; percentile 65.1 Nasdaq · Semiconductors & Related Devices market equity $9.0B; last close $106.67 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 51.5% | D | 65.1 | $9.0B |
| SM Energy Co. (SM) SM Energy Co. (SM) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $8.8B; last close $37.08 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 108.2% | none | n/a | $8.8B |
| Praxis Precision Medicines, Inc. (PRAX) Praxis Precision Medicines, Inc. (PRAX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $7.4B; last close $263.40 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | split-adjusted year-over-year share growth is 38.1% | none | n/a | $7.4B |
| Spyre Therapeutics, Inc. (SYRE) Spyre Therapeutics, Inc. (SYRE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $7.0B; last close $80.00 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | split-adjusted year-over-year share growth is 30.3% | none | n/a | $7.0B |
| Transocean Ltd. (RIG) Transocean Ltd. (RIG) B/Con the B/C boundary; percentile 42.2 NYSE · Drilling Oil & Gas Wells market equity $6.2B; last close $5.53 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 25.5% | B/C | 42.2 | $6.2B |
| Iovance Biotherapeutics, Inc. (IOVA) Iovance Biotherapeutics, Inc. (IOVA) Dfourth fifth; percentile 69.5 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $6.0B; last close $13.33 Warnings: dilution, short runway; 7 of 14 inputs | split-adjusted year-over-year share growth is 25.6% | D | 69.5 | $6.0B |
| Terex Corp. (TEX) Terex Corp. (TEX) Cmiddle fifth; percentile 44.5 NYSE · Industrial Trucks, Tractors, Trailors & Stackers market equity $6.0B; last close $52.32 Warnings: dilution; 13 of 14 inputs | split-adjusted year-over-year share growth is 71.2% | C | 44.5 | $6.0B |
| D-Wave Quantum Inc. (QBTS) D-Wave Quantum Inc. (QBTS) Astrongest fifth; percentile 12.3 Nasdaq · Services-Computer Processing & Data Preparation market equity $5.4B; last close $14.60 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 27.4% | A | 12.3 | $5.4B |
| Cogent Biosciences, Inc. (COGT) Cogent Biosciences, Inc. (COGT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.2B; last close $30.09 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 42.6% | none | n/a | $5.2B |
| Oruka Therapeutics, Inc. (ORKA) Oruka Therapeutics, Inc. (ORKA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.1B; last close $77.25 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | split-adjusted year-over-year share growth is 32.3% | none | n/a | $5.1B |
| Dianthus Therapeutics, Inc. (DNTH) Dianthus Therapeutics, Inc. (DNTH) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $4.6B; last close $82.36 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 38.4% | none | n/a | $4.6B |
| Definium Therapeutics, Inc. (DFTX) Definium Therapeutics, Inc. (DFTX) Astrongest fifth; percentile 16.5 Nasdaq · Medicinal Chemicals & Botanical Products market equity $4.6B; last close $34.17 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 32.3% | A | 16.5 | $4.6B |
| Ondas Inc. (ONDS) Ondas Inc. (ONDS) Cmiddle fifth; percentile 45.6 Nasdaq · Radio & Tv Broadcasting & Communications Equipment market equity $3.9B; last close $6.85 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 341.8% | C | 45.6 | $3.9B |
| Tango Therapeutics, Inc. (TNGX) Tango Therapeutics, Inc. (TNGX) Cmiddle fifth; percentile 57.3 Nasdaq · Pharmaceutical Preparations market equity $3.8B; last close $22.56 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 32.0% | C | 57.3 | $3.8B |
| HNI Corp. (HNI) HNI Corp. (HNI) Cmiddle fifth; percentile 52.0 NYSE · Office Furniture (No Wood) market equity $3.4B; last close $47.02 Warnings: dilution; 13 of 14 inputs | split-adjusted year-over-year share growth is 51.6% | C | 52.0 | $3.4B |
| Celcuity Inc. (CELC) Celcuity Inc. (CELC) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories market equity $3.3B; last close $67.86 Warnings: dilution, thin data, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 27.7% | none | n/a | $3.3B |
| Dyne Therapeutics, Inc. (DYN) Dyne Therapeutics, Inc. (DYN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.1B; last close $16.38 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 38.0% | none | n/a | $3.1B |
| Dnow Inc. (DNOW) Dnow Inc. (DNOW) Cmiddle fifth; percentile 46.5 NYSE · Oil & Gas Field Machinery & Equipment market equity $2.8B; last close $15.65 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 76.3% | C | 46.5 | $2.8B |
| MBX Biosciences, Inc. (MBX) MBX Biosciences, Inc. (MBX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.6B; last close $53.26 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 42.1% | none | n/a | $2.6B |
| Perpetua Resources Corp. (PPTA) Perpetua Resources Corp. (PPTA) noneno letter; percentile n/a Nasdaq · Gold and Silver Ores market equity $2.5B; last close $20.10 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 75.4% | none | n/a | $2.5B |
| Redwire Corp. (RDW) Redwire Corp. (RDW) D/Eon the D/E boundary; percentile 79.9 NYSE · Guided Missiles & Space Vehicles & Parts market equity $2.4B; last close $9.76 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 154.0% | D/E | 79.9 | $2.4B |
| Nurix Therapeutics, Inc. (NRIX) Nurix Therapeutics, Inc. (NRIX) Cmiddle fifth; percentile 50.0 Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $22.20 Warnings: dilution, short runway; 7 of 14 inputs | split-adjusted year-over-year share growth is 35.5% | C | 50.0 | $2.3B |
| Sellas Life Sciences Group, Inc. (SLS) Sellas Life Sciences Group, Inc. (SLS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $11.26 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | split-adjusted year-over-year share growth is 97.7% | none | n/a | $2.3B |
| Immunome Inc. (IMNM) Immunome Inc. (IMNM) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.2B; last close $19.32 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 30.1% | none | n/a | $2.2B |
| Recursion Pharmaceuticals, Inc. (RXRX) Recursion Pharmaceuticals, Inc. (RXRX) Cmiddle fifth; percentile 51.6 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $2.1B; last close $3.94 Warnings: dilution, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 33.1% | C | 51.6 | $2.1B |
| Viridian Therapeutics, Inc.\DE (VRDN) Viridian Therapeutics, Inc.\DE (VRDN) Astrongest fifth; percentile 9.2 Nasdaq · Pharmaceutical Preparations market equity $2.1B; last close $18.34 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 25.4% | A | 9.2 | $2.1B |
| Mineralys Therapeutics, Inc. (MLYS) Mineralys Therapeutics, Inc. (MLYS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.0B; last close $22.38 Warnings: dilution, thin data; 3 of 14 inputs | split-adjusted year-over-year share growth is 65.3% | none | n/a | $2.0B |
| Palvella Therapeutics, Inc. (PVLA) Palvella Therapeutics, Inc. (PVLA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.9B; last close $131.18 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 29.9% | none | n/a | $1.9B |
| Trevi Therapeutics, Inc. (TRVI) Trevi Therapeutics, Inc. (TRVI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.8B; last close $12.82 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 32.8% | none | n/a | $1.8B |
| Biohaven Ltd. (BHVN) Biohaven Ltd. (BHVN) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $1.8B; last close $11.94 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 47.4% | none | n/a | $1.8B |
| Mach Natural Resources L.P. (MNR) Mach Natural Resources L.P. (MNR) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $1.8B; last close $10.69 Warnings: dilution, thin data; 3 of 14 inputs | split-adjusted year-over-year share growth is 42.2% | none | n/a | $1.8B |
| Sonida Senior Living, Inc. (SNDA) Sonida Senior Living, Inc. (SNDA) noneno letter; percentile n/a NYSE · Services-Nursing & Personal Care Facilities market equity $1.7B; last close $35.95 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 150.5% | none | n/a | $1.7B |
| Zenas BioPharma, Inc. (ZBIO) Zenas BioPharma, Inc. (ZBIO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.7B; last close $26.26 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 37.2% | none | n/a | $1.7B |
| Quantum Computing Inc. (QUBT) Quantum Computing Inc. (QUBT) Bsecond fifth; percentile 26.8 Nasdaq · Services-Prepackaged Software market equity $1.7B; last close $7.45 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 63.6% | B | 26.8 | $1.7B |
| Ocular Therapeutix, Inc. (OCUL) Ocular Therapeutix, Inc. (OCUL) A/Bon the A/B boundary; percentile 20.0 Nasdaq · Pharmaceutical Preparations market equity $1.6B; last close $7.51 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 36.9% | A/B | 20.0 | $1.6B |
| Compass Pathways plc (CMPS) Compass Pathways plc (CMPS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.6B; last close $11.47 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 39.1% | none | n/a | $1.6B |
| Taysha Gene Therapies, Inc. (TSHA) Taysha Gene Therapies, Inc. (TSHA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $1.4B; last close $4.42 Warnings: dilution, thin data, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 40.1% | none | n/a | $1.4B |
| Rapport Therapeutics, Inc. (RAPP) Rapport Therapeutics, Inc. (RAPP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.4B; last close $29.82 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 31.0% | none | n/a | $1.4B |
| Nektar Therapeutics (NKTR) Nektar Therapeutics (NKTR) Eweakest fifth; percentile 97.6 Nasdaq · Pharmaceutical Preparations market equity $1.4B; last close $40.77 Warnings: dilution, short runway; 8 of 14 inputs | split-adjusted year-over-year share growth is 131.2% | E | 97.6 | $1.4B |
| Dauch Corp. (DCH) Dauch Corp. (DCH) Dfourth fifth; percentile 69.5 NYSE · Motor Vehicle Parts & Accessories market equity $1.4B; last close $5.68 Warnings: dilution; 11 of 14 inputs | split-adjusted year-over-year share growth is 100.7% | D | 69.5 | $1.4B |
| Ryerson Holding Corp. (RYZ) Ryerson Holding Corp. (RYZ) D/Eon the D/E boundary; percentile 79.0 NYSE · Wholesale-Metals Service Centers & of fices market equity $1.3B; last close $25.93 Warnings: dilution; 10 of 14 inputs | split-adjusted year-over-year share growth is 61.6% | D/E | 79.0 | $1.3B |
| Nabors Industries Ltd. (NBR) Nabors Industries Ltd. (NBR) Cmiddle fifth; percentile 47.6 NYSE · Drilling Oil & Gas Wells market equity $1.3B; last close $81.20 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 47.1% | C | 47.6 | $1.3B |
| Damora Therapeutics, Inc. (DMRA) Damora Therapeutics, Inc. (DMRA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.3B; last close $20.58 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 4460.3% | none | n/a | $1.3B |
| Oric Pharmaceuticals, Inc. (ORIC) Oric Pharmaceuticals, Inc. (ORIC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.2B; last close $12.02 Warnings: dilution, short runway, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 41.3% | none | n/a | $1.2B |
| Quantum Corp. (QMCO) Quantum Corp. (QMCO) Eweakest fifth; percentile 92.5 Nasdaq · Computer Storage Devices market equity $1.1B; last close $29.15 Warnings: dilution, late filer; 7 of 14 inputs | split-adjusted year-over-year share growth is 195.6% | E | 92.5 | $1.1B |
| Vor Biopharma Inc. (VOR) Vor Biopharma Inc. (VOR) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $1.1B; last close $19.14 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 682.3% | none | n/a | $1.1B |
| Unusual Machines, Inc. (UMAC) Unusual Machines, Inc. (UMAC) noneno letter; percentile n/a NYSE · Radio & Tv Broadcasting & Communications Equipment market equity $1.1B; last close $21.37 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 131.1% | none | n/a | $1.1B |
| Red Cat Holdings, Inc. (RCAT) Red Cat Holdings, Inc. (RCAT) noneno letter; percentile n/a Nasdaq · Services-Prepackaged Software market equity $902.5M; last close $5.91 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 41.4% | none | n/a | $902.5M |
| Jade Biosciences, Inc. (JBIO) Jade Biosciences, Inc. (JBIO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $899.9M; last close $14.14 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 5855.0% | none | n/a | $899.9M |
| Monte Rosa Therapeutics, Inc. (GLUE) Monte Rosa Therapeutics, Inc. (GLUE) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $880.4M; last close $10.32 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 30.1% | none | n/a | $880.4M |
| ArriVent BioPharma, Inc. (AVBP) ArriVent BioPharma, Inc. (AVBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $823.9M; last close $16.73 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 29.9% | none | n/a | $823.9M |
| Nano Nuclear Energy Inc. (NNE) Nano Nuclear Energy Inc. (NNE) noneno letter; percentile n/a Nasdaq · Electric Services market equity $819.4M; last close $15.26 Warnings: dilution, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 37.9% | none | n/a | $819.4M |
| TXO Partners, L.P. (TXO) TXO Partners, L.P. (TXO) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $795.1M; last close $14.35 Warnings: dilution, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 34.2% | none | n/a | $795.1M |
| Dakota Gold Corp. (DC) Dakota Gold Corp. (DC) noneno letter; percentile n/a NYSE · Metal Mining market equity $793.0M; last close $5.92 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 34.2% | none | n/a | $793.0M |
| Sable Offshore Corp. (SOC) Sable Offshore Corp. (SOC) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $740.6M; last close $3.89 Warnings: dilution, short runway, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 64.7% | none | n/a | $740.6M |
| Candel Therapeutics, Inc. (CADL) Candel Therapeutics, Inc. (CADL) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $739.2M; last close $9.66 Warnings: dilution, thin data, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 55.1% | none | n/a | $739.2M |
| Verastem, Inc. (VSTM) Verastem, Inc. (VSTM) Bsecond fifth; percentile 31.4 Nasdaq · Pharmaceutical Preparations market equity $734.5M; last close $8.11 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 70.6% | B | 31.4 | $734.5M |
| Solid Biosciences Inc. (SLDB) Solid Biosciences Inc. (SLDB) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $731.3M; last close $6.81 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 27.0% | none | n/a | $731.3M |
| Avalo Therapeutics, Inc. (AVTX) Avalo Therapeutics, Inc. (AVTX) Bsecond fifth; percentile 23.8 Nasdaq · Pharmaceutical Preparations market equity $720.3M; last close $13.43 Warnings: dilution, degenerate inputs; 7 of 14 inputs | split-adjusted year-over-year share growth is 113.5% | B | 23.8 | $720.3M |
| 4D Molecular Therapeutics, Inc. (FDMT) 4D Molecular Therapeutics, Inc. (FDMT) A/Bon the A/B boundary; percentile 22.2 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $701.2M; last close $12.71 Warnings: dilution, short runway; 7 of 14 inputs | split-adjusted year-over-year share growth is 49.8% | A/B | 22.2 | $701.2M |
| Olema Pharmaceuticals, Inc. (OLMA) Olema Pharmaceuticals, Inc. (OLMA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $684.2M; last close $7.82 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 27.5% | none | n/a | $684.2M |
| Lightpath Technologies Inc. (LPTH) Lightpath Technologies Inc. (LPTH) Bsecond fifth; percentile 29.2 Nasdaq · Semiconductors & Related Devices market equity $682.2M; last close $9.75 Warnings: dilution, late filer, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 56.8% | B | 29.2 | $682.2M |
| Aura Biosciences, Inc. (AURA) Aura Biosciences, Inc. (AURA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $674.6M; last close $6.50 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 27.7% | none | n/a | $674.6M |
| Fractyl Health, Inc. (GUTS) Fractyl Health, Inc. (GUTS) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $673.3M; last close $4.24 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | split-adjusted year-over-year share growth is 224.3% | none | n/a | $673.3M |
| Immix Biopharma, Inc. (IMMX) Immix Biopharma, Inc. (IMMX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $664.6M; last close $9.30 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 91.1% | none | n/a | $664.6M |
| Prime Medicine, Inc. (PRME) Prime Medicine, Inc. (PRME) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $649.3M; last close $3.58 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 37.7% | none | n/a | $649.3M |
| Anteris Technologies Global Corp. (AVR) Anteris Technologies Global Corp. (AVR) noneno letter; percentile n/a Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies market equity $646.1M; last close $6.63 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 169.6% | none | n/a | $646.1M |
| XMax Inc. (XMAX) XMax Inc. (XMAX) Cmiddle fifth; percentile 42.7 Nasdaq · Household Furniture market equity $569.1M; last close $8.83 Warnings: dilution, late filer; 8 of 14 inputs | split-adjusted year-over-year share growth is 257.4% | C | 42.7 | $569.1M |
| Shattuck Labs, Inc. (STTK) Shattuck Labs, Inc. (STTK) B/Con the B/C boundary; percentile 40.5 Nasdaq · Pharmaceutical Preparations market equity $568.1M; last close $5.66 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 49.4% | B/C | 40.5 | $568.1M |
| United States Antimony Corp. (UAMY) United States Antimony Corp. (UAMY) B/Con the B/C boundary; percentile 38.6 NYSE · Primary Smelting & Refining of Nonferrous Metals market equity $556.8M; last close $3.71 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 25.1% | B/C | 38.6 | $556.8M |
| Contango Silver & Gold Inc. (CTGO) Contango Silver & Gold Inc. (CTGO) noneno letter; percentile n/a NYSE · Gold and Silver Ores market equity $544.4M; last close $16.28 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 37.3% | none | n/a | $544.4M |
| CytomX Therapeutics, Inc. (CTMX) CytomX Therapeutics, Inc. (CTMX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $538.2M; last close $2.46 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 112.5% | none | n/a | $538.2M |
| Crescent Biopharma, Inc. (CBIO) Crescent Biopharma, Inc. (CBIO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $524.5M; last close $14.10 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 4171.4% | none | n/a | $524.5M |
| Altimmune, Inc. (ALT) Altimmune, Inc. (ALT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $505.7M; last close $2.60 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 68.9% | none | n/a | $505.7M |
| Senseonics Holdings, Inc. (SENS) Senseonics Holdings, Inc. (SENS) Eweakest fifth; percentile 89.9 Nasdaq · Industrial Instruments For Measurement, Display, and Control market equity $476.9M; last close $9.02 Warnings: dilution, short runway, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 28.2% | E | 89.9 | $476.9M |
| MasterCraft Boat Holdings, Inc. (MCFT) MasterCraft Boat Holdings, Inc. (MCFT) Eweakest fifth; percentile 85.4 Nasdaq · Ship & Boat Building & Repairing market equity $474.6M; last close $19.52 Warnings: dilution; 11 of 14 inputs | split-adjusted year-over-year share growth is 49.3% | E | 85.4 | $474.6M |
| Capricor Therapeutics, Inc. (CAPR) Capricor Therapeutics, Inc. (CAPR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $465.7M; last close $8.01 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | split-adjusted year-over-year share growth is 25.9% | none | n/a | $465.7M |
| Assembly Biosciences, Inc. (ASMB) Assembly Biosciences, Inc. (ASMB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $464.6M; last close $22.80 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 111.4% | none | n/a | $464.6M |
| Ovid Therapeutics Inc. (OVID) Ovid Therapeutics Inc. (OVID) Dfourth fifth; percentile 70.5 Nasdaq · Pharmaceutical Preparations market equity $457.0M; last close $2.33 Warnings: dilution, short runway; 7 of 14 inputs | split-adjusted year-over-year share growth is 85.5% | D | 70.5 | $457.0M |
| International Tower Hill Mines Ltd. (THM) International Tower Hill Mines Ltd. (THM) noneno letter; percentile n/a NYSE · Metal Mining market equity $456.4M; last close $2.33 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | split-adjusted year-over-year share growth is 25.6% | none | n/a | $456.4M |
| Virgin Galactic Holdings, Inc. (SPCE) Virgin Galactic Holdings, Inc. (SPCE) Eweakest fifth; percentile 99.4 NYSE · Transportation Services market equity $445.7M; last close $2.94 Warnings: dilution; 9 of 14 inputs | split-adjusted year-over-year share growth is 129.1% | E | 99.4 | $445.7M |
| Impact Biomedical Inc. (IBO) Impact Biomedical Inc. (IBO) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $443.1M; last close $4.23 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | split-adjusted year-over-year share growth is 792.2% | none | n/a | $443.1M |
| ASP Isotopes Inc. (ASPI) ASP Isotopes Inc. (ASPI) Cmiddle fifth; percentile 44.5 Nasdaq · Miscellaneous Chemical Products market equity $433.9M; last close $2.82 Warnings: dilution, late filer, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 74.7% | C | 44.5 | $433.9M |
| DiaMedica Therapeutics Inc. (DMAC) DiaMedica Therapeutics Inc. (DMAC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $431.9M; last close $8.00 Warnings: dilution, short runway, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 25.7% | none | n/a | $431.9M |
| Zura Bio Ltd. (ZURA) Zura Bio Ltd. (ZURA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $395.8M; last close $4.12 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 38.8% | none | n/a | $395.8M |
| Serve Robotics Inc. (SERV) Serve Robotics Inc. (SERV) Cmiddle fifth; percentile 45.7 Nasdaq · General Industrial Machinery & Equipment, NEC market equity $385.8M; last close $4.45 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 33.0% | C | 45.7 | $385.8M |
| Kyverna Therapeutics, Inc. (KYTX) Kyverna Therapeutics, Inc. (KYTX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $382.2M; last close $6.17 Warnings: dilution, short runway, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 39.9% | none | n/a | $382.2M |
| Opus Genetics, Inc. (IRD) Opus Genetics, Inc. (IRD) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $371.1M; last close $4.45 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 56.4% | none | n/a | $371.1M |
| Canopy Growth Corp. (CGC) Canopy Growth Corp. (CGC) Eweakest fifth; percentile 90.3 Nasdaq · Medicinal Chemicals & Botanical Products market equity $358.2M; last close $0.85 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 128.0% | E | 90.3 | $358.2M |
| Enanta Pharmaceuticals Inc. (ENTA) Enanta Pharmaceuticals Inc. (ENTA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $352.4M; last close $12.09 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 36.2% | none | n/a | $352.4M |
| C4 Therapeutics, Inc. (CCCC) C4 Therapeutics, Inc. (CCCC) D/Eon the D/E boundary; percentile 79.2 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $350.6M; last close $2.85 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 37.5% | D/E | 79.2 | $350.6M |
| Orchestra BioMed Holdings, Inc. (OBIO) Orchestra BioMed Holdings, Inc. (OBIO) Dfourth fifth; percentile 68.4 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $344.4M; last close $5.72 Warnings: dilution, short runway, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 52.7% | D | 68.4 | $344.4M |
| Agenus Inc. (AGEN) Agenus Inc. (AGEN) Eweakest fifth; percentile 97.3 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $339.5M; last close $7.53 Warnings: dilution, short runway; 7 of 14 inputs | split-adjusted year-over-year share growth is 51.7% | E | 97.3 | $339.5M |
| Relmada Therapeutics, Inc. (RLMD) Relmada Therapeutics, Inc. (RLMD) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $338.1M; last close $3.15 Warnings: dilution, short runway, thin data, degenerate inputs; 6 of 14 inputs | split-adjusted year-over-year share growth is 216.0% | none | n/a | $338.1M |
| Cabaletta Bio, Inc. (CABA) Cabaletta Bio, Inc. (CABA) Cmiddle fifth; percentile 55.9 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $330.6M; last close $1.95 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 119.4% | C | 55.9 | $330.6M |
| Surrozen, Inc./DE (SRZN) Surrozen, Inc./DE (SRZN) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $328.7M; last close $27.96 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 250.1% | none | n/a | $328.7M |
| GameSquare Holdings, Inc. (GAME) GameSquare Holdings, Inc. (GAME) noneno letter; percentile n/a Nasdaq · Services-Amusement & Recreation Services market equity $326.0M; last close $3.07 Warnings: dilution, late filer, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 146.1% | none | n/a | $326.0M |
| Quoin Pharmaceuticals Ltd. (QNRX) Quoin Pharmaceuticals Ltd. (QNRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $319.8M; last close $4.59 Warnings: dilution, short runway, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 20407.9% | none | n/a | $319.8M |
| Indaptus Therapeutics, Inc. (INDP) Indaptus Therapeutics, Inc. (INDP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $315.8M; last close $2.36 Warnings: dilution, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 335.1% | none | n/a | $315.8M |
| Perspective Therapeutics, Inc. (CATX) Perspective Therapeutics, Inc. (CATX) C/Don the C/D boundary; percentile 60.3 NYSE · Pharmaceutical Preparations market equity $309.4M; last close $2.71 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 53.9% | C/D | 60.3 | $309.4M |
| Benitec Biopharma Inc. (BNTC) Benitec Biopharma Inc. (BNTC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $305.2M; last close $8.76 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | split-adjusted year-over-year share growth is 32.9% | none | n/a | $305.2M |
| Cypherpunk Technologies Inc. (CYPH) Cypherpunk Technologies Inc. (CYPH) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $302.8M; last close $2.81 Warnings: dilution, short runway, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 118.1% | none | n/a | $302.8M |
| Larimar Therapeutics, Inc. (LRMR) Larimar Therapeutics, Inc. (LRMR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $280.5M; last close $2.69 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | split-adjusted year-over-year share growth is 62.2% | none | n/a | $280.5M |
| X4 Pharmaceuticals, Inc. (XFOR) X4 Pharmaceuticals, Inc. (XFOR) D/Eon the D/E boundary; percentile 78.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $276.6M; last close $2.79 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 1470.6% | D/E | 78.4 | $276.6M |
| Biodesix Inc. (BDSX) Biodesix Inc. (BDSX) Cmiddle fifth; percentile 49.2 Nasdaq · Services-Medical Laboratories market equity $270.4M; last close $25.36 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 35.1% | C | 49.2 | $270.4M |
| GT Biopharma, Inc. (GTBP) GT Biopharma, Inc. (GTBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $268.9M; last close $6.22 Warnings: dilution, short runway, thin data, degenerate inputs; 2 of 14 inputs | split-adjusted year-over-year share growth is 1312.2% | none | n/a | $268.9M |
| Inhibikase Therapeutics, Inc. (IKT) Inhibikase Therapeutics, Inc. (IKT) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $266.5M; last close $1.91 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | split-adjusted year-over-year share growth is 77.6% | none | n/a | $266.5M |
| Century Therapeutics, Inc. (IPSC) Century Therapeutics, Inc. (IPSC) Eweakest fifth; percentile 91.6 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $264.4M; last close $1.46 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 108.9% | E | 91.6 | $264.4M |
| Lexeo Therapeutics, Inc. (LXEO) Lexeo Therapeutics, Inc. (LXEO) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $263.4M; last close $3.19 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 123.2% | none | n/a | $263.4M |
| Sutro Biopharma, Inc. (STRO) Sutro Biopharma, Inc. (STRO) Eweakest fifth; percentile 93.0 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $254.0M; last close $15.34 Warnings: dilution, short runway, distress, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 97.8% | E | 93.0 | $254.0M |
| Palisade BIO, Inc. (PALI) Palisade BIO, Inc. (PALI) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $252.7M; last close $1.46 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 4 of 14 inputs | split-adjusted year-over-year share growth is 3673.0% | none | n/a | $252.7M |
| Duos Technologies Group, Inc. (DUOT) Duos Technologies Group, Inc. (DUOT) Dfourth fifth; percentile 77.4 Nasdaq · Services-Prepackaged Software market equity $245.5M; last close $7.82 Warnings: dilution, late filer, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 156.3% | D | 77.4 | $245.5M |
| Camp4 Therapeutics Corp. (CAMP) Camp4 Therapeutics Corp. (CAMP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $232.2M; last close $3.72 Warnings: dilution, thin data; 4 of 14 inputs | split-adjusted year-over-year share growth is 157.5% | none | n/a | $232.2M |
| Lightbridge Corp. (LTBR) Lightbridge Corp. (LTBR) noneno letter; percentile n/a Nasdaq · Industrial Inorganic Chemicals market equity $225.1M; last close $6.01 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | split-adjusted year-over-year share growth is 67.8% | none | n/a | $225.1M |
| Lyell Immunopharma, Inc. (LYEL) Lyell Immunopharma, Inc. (LYEL) Dfourth fifth; percentile 69.2 Nasdaq · Pharmaceutical Preparations market equity $215.4M; last close $8.76 Warnings: dilution, degenerate inputs; 7 of 14 inputs | split-adjusted year-over-year share growth is 57.9% | D | 69.2 | $215.4M |
| Invivyd, Inc. (IVVD) Invivyd, Inc. (IVVD) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $206.4M; last close $0.70 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 135.6% | none | n/a | $206.4M |
| ADC Therapeutics SA (ADCT) ADC Therapeutics SA (ADCT) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $203.0M; last close $1.58 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 28.2% | none | n/a | $203.0M |
| Exagen Inc. (XGN) Exagen Inc. (XGN) Dfourth fifth; percentile 66.8 Nasdaq · Services-Medical Laboratories market equity $197.9M; last close $8.15 Warnings: dilution, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 34.4% | D | 66.8 | $197.9M |
| Alpha Cognition Inc. (ACOG) Alpha Cognition Inc. (ACOG) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $196.9M; last close $9.02 Warnings: dilution, thin data; 5 of 14 inputs | split-adjusted year-over-year share growth is 35.9% | none | n/a | $196.9M |
| GSI Technology Inc. (GSIT) GSI Technology Inc. (GSIT) Cmiddle fifth; percentile 56.2 Nasdaq · Semiconductors & Related Devices market equity $189.3M; last close $4.92 Warnings: dilution; 8 of 14 inputs | split-adjusted year-over-year share growth is 37.2% | C | 56.2 | $189.3M |
| Epsilon Energy Ltd. (EPSN) Epsilon Energy Ltd. (EPSN) noneno letter; percentile n/a Nasdaq · Crude Petroleum & Natural Gas market equity $183.8M; last close $6.08 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 37.4% | none | n/a | $183.8M |
| Precision Biosciences Inc. (DTIL) Precision Biosciences Inc. (DTIL) Eweakest fifth; percentile 92.2 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $177.5M; last close $6.43 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 135.9% | E | 92.2 | $177.5M |
| Compass Therapeutics, Inc. (CMPX) Compass Therapeutics, Inc. (CMPX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $177.1M; last close $0.99 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | split-adjusted year-over-year share growth is 30.2% | none | n/a | $177.1M |
| Pedevco Corp. (PED) Pedevco Corp. (PED) C/Don the C/D boundary; percentile 56.5 NYSE · Crude Petroleum & Natural Gas market equity $171.2M; last close $13.44 Warnings: dilution, fortress balance sheet; 7 of 14 inputs | split-adjusted year-over-year share growth is 191.2% | C/D | 56.5 | $171.2M |
| Comstock Inc. (LODE) Comstock Inc. (LODE) Dfourth fifth; percentile 73.0 NYSE · Industrial Organic Chemicals market equity $167.9M; last close $2.22 Warnings: dilution, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 205.7% | D | 73.0 | $167.9M |
| Coherus Oncology, Inc. (CHRS) Coherus Oncology, Inc. (CHRS) Eweakest fifth; percentile 98.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $165.3M; last close $1.06 Warnings: dilution, short runway; 10 of 14 inputs | split-adjusted year-over-year share growth is 29.3% | E | 98.4 | $165.3M |
| PepGen Inc. (PEPG) PepGen Inc. (PEPG) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $164.8M; last close $2.38 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 111.4% | none | n/a | $164.8M |
| ALX Oncology Holdings Inc. (ALXO) ALX Oncology Holdings Inc. (ALXO) Eweakest fifth; percentile 95.4 Nasdaq · Pharmaceutical Preparations market equity $163.2M; last close $1.18 Warnings: dilution, short runway, degenerate inputs, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 146.5% | E | 95.4 | $163.2M |
| Cue Biopharma, Inc. (CUE) Cue Biopharma, Inc. (CUE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $162.2M; last close $22.16 Warnings: dilution, short runway, thin data, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 58.0% | none | n/a | $162.2M |
| Atomera Inc. (ATOM) Atomera Inc. (ATOM) Eweakest fifth; percentile 92.1 Nasdaq · Semiconductors & Related Devices market equity $161.2M; last close $4.13 Warnings: dilution, degenerate inputs; 8 of 14 inputs | split-adjusted year-over-year share growth is 26.0% | E | 92.1 | $161.2M |
| Protara Therapeutics, Inc. (TARA) Protara Therapeutics, Inc. (TARA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $156.6M; last close $2.65 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 47.1% | none | n/a | $156.6M |
| Korro Bio, Inc. (KRRO) Korro Bio, Inc. (KRRO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $155.8M; last close $10.59 Warnings: dilution, short runway, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 53.6% | none | n/a | $155.8M |
| Minerva Neurosciences, Inc. (NERV) Minerva Neurosciences, Inc. (NERV) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $153.7M; last close $3.23 Warnings: dilution, thin data, degenerate inputs, distress; 6 of 14 inputs | split-adjusted year-over-year share growth is 518.8% | none | n/a | $153.7M |
| Skyx Platforms Corp. (SKYX) Skyx Platforms Corp. (SKYX) noneno letter; percentile n/a Nasdaq · Electric Lighting & Wiring Equipment market equity $150.3M; last close $1.12 Warnings: dilution, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 27.6% | none | n/a | $150.3M |
| Outlook Therapeutics, Inc. (OTLK) Outlook Therapeutics, Inc. (OTLK) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $137.3M; last close $0.56 Warnings: dilution, short runway, late filer, thin data, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 100.5% | none | n/a | $137.3M |
| Datavault AI Inc. (DVLT) Datavault AI Inc. (DVLT) Bsecond fifth; percentile 33.1 Nasdaq · Services-Business Services, NEC market equity $137.0M; last close $0.14 Warnings: dilution, short runway, late filer, fortress balance sheet; 9 of 14 inputs | split-adjusted year-over-year share growth is 856.8% | B | 33.1 | $137.0M |
| Owlet, Inc. (OWLT) Owlet, Inc. (OWLT) Cmiddle fifth; percentile 53.4 NYSE · Measuring & Controlling Devices, NEC market equity $136.2M; last close $4.66 Warnings: dilution, fortress balance sheet; 8 of 14 inputs | split-adjusted year-over-year share growth is 70.0% | C | 53.4 | $136.2M |
| Beyond Meat, Inc. (BYND) Beyond Meat, Inc. (BYND) Eweakest fifth; percentile 91.9 Nasdaq · Food and Kindred Products market equity $132.9M; last close $7.73 Warnings: dilution, late filer; 8 of 14 inputs | split-adjusted year-over-year share growth is 508.9% | E | 91.9 | $132.9M |
| Lucid Diagnostics Inc. (LUCD) Lucid Diagnostics Inc. (LUCD) D/Eon the D/E boundary; percentile 80.5 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $132.1M; last close $0.65 Warnings: dilution; 7 of 14 inputs | split-adjusted year-over-year share growth is 95.0% | D/E | 80.5 | $132.1M |
| NRX Pharmaceuticals, Inc. (NRXP) NRX Pharmaceuticals, Inc. (NRXP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $125.1M; last close $2.88 Warnings: dilution, late filer, thin data; 6 of 14 inputs | split-adjusted year-over-year share growth is 92.0% | none | n/a | $125.1M |
| Tonix Pharmaceuticals Holding Corp. (TNXP) Tonix Pharmaceuticals Holding Corp. (TNXP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $124.9M; last close $7.25 Warnings: dilution, thin data, fortress balance sheet; 6 of 14 inputs | split-adjusted year-over-year share growth is 108.3% | none | n/a | $124.9M |
Rule: cash and equivalents divided by trailing four-quarter operating cash burn under 6 months; only when burning cash. 365 triggered; among the 122 with a letter: A 1, B 7, C 16, D 23, E 75. The largest 150 by market equity are listed.
| Company | Measured | Letter | Percentile | Market equity |
|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) ImmunityBio, Inc. (IBRX) B/Con the B/C boundary; percentile 40.3 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $10.5B; last close $9.91 Warnings: short runway; 9 of 14 inputs | cash runway is 3.2 months | B/C | 40.3 | $10.5B |
| Vaxcyte, Inc. (PCVX) Vaxcyte, Inc. (PCVX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $9.7B; last close $64.99 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 2.5 months | none | n/a | $9.7B |
| Cytokinetics Inc. (CYTK) Cytokinetics Inc. (CYTK) Bsecond fifth; percentile 29.5 Nasdaq · Pharmaceutical Preparations market equity $8.6B; last close $62.00 Warnings: short runway; 8 of 14 inputs | cash runway is 5.5 months | B | 29.5 | $8.6B |
| Cleveland-Cliffs Inc. (CLF) Cleveland-Cliffs Inc. (CLF) Eweakest fifth; percentile 92.2 NYSE · Metal Mining market equity $7.0B; last close $12.21 Warnings: short runway; 9 of 14 inputs | cash runway is 3.3 months | E | 92.2 | $7.0B |
| Iovance Biotherapeutics, Inc. (IOVA) Iovance Biotherapeutics, Inc. (IOVA) Dfourth fifth; percentile 69.5 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $6.0B; last close $13.33 Warnings: dilution, short runway; 7 of 14 inputs | cash runway is 5.0 months | D | 69.5 | $6.0B |
| Grail, Inc. (GRAL) Grail, Inc. (GRAL) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories market equity $5.9B; last close $132.61 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 2.3 months | none | n/a | $5.9B |
| CG Oncology, Inc. (CGON) CG Oncology, Inc. (CGON) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $5.6B; last close $63.10 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 1.3 months | none | n/a | $5.6B |
| Erasca, Inc. (ERAS) Erasca, Inc. (ERAS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.4B; last close $15.44 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 5.2 months | none | n/a | $5.4B |
| Gossamer Bio, Inc. (GOSS) Gossamer Bio, Inc. (GOSS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $4.8B; last close $9.72 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 3.0 months | none | n/a | $4.8B |
| Edgewise Therapeutics, Inc. (EWTX) Edgewise Therapeutics, Inc. (EWTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $4.3B; last close $39.24 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 5.5 months | none | n/a | $4.3B |
| Xenon Pharmaceuticals Inc. (XENE) Xenon Pharmaceuticals Inc. (XENE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.5B; last close $36.15 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 4.2 months | none | n/a | $3.5B |
| Viking Therapeutics, Inc. (VKTX) Viking Therapeutics, Inc. (VKTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.2B; last close $27.74 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 3.6 months | none | n/a | $3.2B |
| Arcus Biosciences, Inc. (RCUS) Arcus Biosciences, Inc. (RCUS) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $3.0B; last close $23.82 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 3.8 months | none | n/a | $3.0B |
| Amylyx Pharmaceuticals, Inc. (AMLX) Amylyx Pharmaceuticals, Inc. (AMLX) Dfourth fifth; percentile 67.6 Nasdaq · Pharmaceutical Preparations market equity $3.0B; last close $27.22 Warnings: short runway, degenerate inputs; 7 of 14 inputs | cash runway is 4.7 months | D | 67.6 | $3.0B |
| Denali Therapeutics Inc. (DNLI) Denali Therapeutics Inc. (DNLI) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $3.0B; last close $18.66 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 5.6 months | none | n/a | $3.0B |
| ChronoScale Holdings Corp. (CHRN) ChronoScale Holdings Corp. (CHRN) noneno letter; percentile n/a Nasdaq · General Industrial Machinery & Equipment, NEC market equity $2.8B; last close $18.59 Warnings: short runway, thin data, fortress balance sheet; 3 of 14 inputs | cash runway is 4.0 months | none | n/a | $2.8B |
| Precigen, Inc. (PGEN) Precigen, Inc. (PGEN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.7B; last close $7.58 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 1.7 months | none | n/a | $2.7B |
| Resideo Technologies, Inc. (REZI) Resideo Technologies, Inc. (REZI) C/Don the C/D boundary; percentile 59.9 NYSE · Wholesale-Hardware market equity $2.6B; last close $17.19 Warnings: short runway; 9 of 14 inputs | cash runway is 5.2 months | C/D | 59.9 | $2.6B |
| Plug Power Inc. (PLUG) Plug Power Inc. (PLUG) Eweakest fifth; percentile 96.9 Nasdaq · Electrical Industrial Apparatus market equity $2.4B; last close $1.73 Warnings: short runway, fortress balance sheet; 8 of 14 inputs | cash runway is 4.0 months | E | 96.9 | $2.4B |
| Disc Medicine, Inc. (IRON) Disc Medicine, Inc. (IRON) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $60.77 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 6.0 months | none | n/a | $2.3B |
| Nurix Therapeutics, Inc. (NRIX) Nurix Therapeutics, Inc. (NRIX) Cmiddle fifth; percentile 50.0 Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $22.20 Warnings: dilution, short runway; 7 of 14 inputs | cash runway is 2.8 months | C | 50.0 | $2.3B |
| Celldex Therapeutics, Inc. (CLDX) Celldex Therapeutics, Inc. (CLDX) B/Con the B/C boundary; percentile 39.7 Nasdaq · In Vitro & In Vivo Diagnostic Substances market equity $2.3B; last close $29.29 Warnings: short runway; 9 of 14 inputs | cash runway is 2.4 months | B/C | 39.7 | $2.3B |
| Vera Therapeutics, Inc. (VERA) Vera Therapeutics, Inc. (VERA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.1B; last close $29.74 Warnings: short runway, thin data, fortress balance sheet; 4 of 14 inputs | cash runway is 1.7 months | none | n/a | $2.1B |
| Agios Pharmaceuticals, Inc. (AGIO) Agios Pharmaceuticals, Inc. (AGIO) Bsecond fifth; percentile 28.1 Nasdaq · Pharmaceutical Preparations market equity $1.9B; last close $31.92 Warnings: short runway; 8 of 14 inputs | cash runway is 3.3 months | B | 28.1 | $1.9B |
| Xencor Inc. (XNCR) Xencor Inc. (XNCR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.8B; last close $24.48 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 2.6 months | none | n/a | $1.8B |
| UroGen Pharma Ltd. (URGN) UroGen Pharma Ltd. (URGN) B/Con the B/C boundary; percentile 39.2 Nasdaq · Pharmaceutical Preparations market equity $1.8B; last close $36.96 Warnings: short runway; 9 of 14 inputs | cash runway is 6.0 months | B/C | 39.2 | $1.8B |
| Biohaven Ltd. (BHVN) Biohaven Ltd. (BHVN) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $1.8B; last close $11.94 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 5.6 months | none | n/a | $1.8B |
| NextDecade Corp. (NEXT) NextDecade Corp. (NEXT) noneno letter; percentile n/a Nasdaq · Natural Gas Transmisison & Distribution market equity $1.8B; last close $6.74 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 4.5 months | none | n/a | $1.8B |
| Intellia Therapeutics, Inc. (NTLA) Intellia Therapeutics, Inc. (NTLA) Eweakest fifth; percentile 87.0 Nasdaq · In Vitro & In Vivo Diagnostic Substances market equity $1.8B; last close $12.59 Warnings: short runway; 7 of 14 inputs | cash runway is 3.7 months | E | 87.0 | $1.8B |
| Ultragenyx Pharmaceutical Inc. (RARE) Ultragenyx Pharmaceutical Inc. (RARE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.5B; last close $15.27 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 3.1 months | none | n/a | $1.5B |
| Lucid Group, Inc. (LCID) Lucid Group, Inc. (LCID) Eweakest fifth; percentile 97.4 Nasdaq · Motor Vehicles & Passenger Car Bodies market equity $1.5B; last close $3.82 Warnings: short runway, distress; 9 of 14 inputs | cash runway is 2.2 months | E | 97.4 | $1.5B |
| Nektar Therapeutics (NKTR) Nektar Therapeutics (NKTR) Eweakest fifth; percentile 97.6 Nasdaq · Pharmaceutical Preparations market equity $1.4B; last close $40.77 Warnings: dilution, short runway; 8 of 14 inputs | cash runway is 2.0 months | E | 97.6 | $1.4B |
| Omeros Corp. (OMER) Omeros Corp. (OMER) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.4B; last close $19.12 Warnings: short runway, thin data; 4 of 14 inputs | cash runway is 0.3 months | none | n/a | $1.4B |
| Oric Pharmaceuticals, Inc. (ORIC) Oric Pharmaceuticals, Inc. (ORIC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.2B; last close $12.02 Warnings: dilution, short runway, thin data, fortress balance sheet; 5 of 14 inputs | cash runway is 4.0 months | none | n/a | $1.2B |
| Cullinan Therapeutics, Inc. (CGEM) Cullinan Therapeutics, Inc. (CGEM) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $994.9M; last close $15.46 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 5.9 months | none | n/a | $994.9M |
| Savara Inc. (SVRA) Savara Inc. (SVRA) Cmiddle fifth; percentile 48.9 Nasdaq · Pharmaceutical Preparations market equity $992.4M; last close $4.84 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 4.5 months | C | 48.9 | $992.4M |
| Aeva Technologies, Inc. (AEVA) Aeva Technologies, Inc. (AEVA) Eweakest fifth; percentile 82.6 Nasdaq · Motor Vehicle Parts & Accessories market equity $954.3M; last close $13.67 Warnings: short runway; 9 of 14 inputs | cash runway is 4.7 months | E | 82.6 | $954.3M |
| Corvus Pharmaceuticals, Inc. (CRVS) Corvus Pharmaceuticals, Inc. (CRVS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $858.9M; last close $10.21 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 5.1 months | none | n/a | $858.9M |
| Sana Biotechnology, Inc. (SANA) Sana Biotechnology, Inc. (SANA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $835.2M; last close $2.79 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 5.2 months | none | n/a | $835.2M |
| Sable Offshore Corp. (SOC) Sable Offshore Corp. (SOC) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $740.6M; last close $3.89 Warnings: dilution, short runway, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | cash runway is 0.9 months | none | n/a | $740.6M |
| Ginkgo Bioworks Holdings, Inc. (DNA) Ginkgo Bioworks Holdings, Inc. (DNA) noneno letter; percentile n/a NYSE · Biological Products, (No Diagnostic Substances) market equity $722.5M; last close $11.35 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 6.0 months | none | n/a | $722.5M |
| Design Therapeutics, Inc. (DSGN) Design Therapeutics, Inc. (DSGN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $719.1M; last close $11.47 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 2.8 months | none | n/a | $719.1M |
| 4D Molecular Therapeutics, Inc. (FDMT) 4D Molecular Therapeutics, Inc. (FDMT) A/Bon the A/B boundary; percentile 22.2 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $701.2M; last close $12.71 Warnings: dilution, short runway; 7 of 14 inputs | cash runway is 5.4 months | A/B | 22.2 | $701.2M |
| Olema Pharmaceuticals, Inc. (OLMA) Olema Pharmaceuticals, Inc. (OLMA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $684.2M; last close $7.82 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 3.5 months | none | n/a | $684.2M |
| Hyliion Holdings Corp. (HYLN) Hyliion Holdings Corp. (HYLN) Cmiddle fifth; percentile 49.2 NYSE · Truck & Bus Bodies market equity $673.3M; last close $3.75 Warnings: short runway, fortress balance sheet; 8 of 14 inputs | cash runway is 3.7 months | C | 49.2 | $673.3M |
| Prime Medicine, Inc. (PRME) Prime Medicine, Inc. (PRME) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $649.3M; last close $3.58 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 3.6 months | none | n/a | $649.3M |
| Fulgent Genetics, Inc. (FLGT) Fulgent Genetics, Inc. (FLGT) Dfourth fifth; percentile 65.1 Nasdaq · Services-Medical Laboratories market equity $572.9M; last close $20.87 Warnings: short runway; 8 of 14 inputs | cash runway is 3.8 months | D | 65.1 | $572.9M |
| Aclaris Therapeutics, Inc. (ACRS) Aclaris Therapeutics, Inc. (ACRS) Eweakest fifth; percentile 89.5 Nasdaq · Pharmaceutical Preparations market equity $557.9M; last close $3.79 Warnings: short runway, fortress balance sheet; 9 of 14 inputs | cash runway is 3.7 months | E | 89.5 | $557.9M |
| Enovix Corp. (ENVX) Enovix Corp. (ENVX) Dfourth fifth; percentile 65.5 Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $548.6M; last close $2.50 Warnings: short runway; 9 of 14 inputs | cash runway is 3.8 months | D | 65.5 | $548.6M |
| CytomX Therapeutics, Inc. (CTMX) CytomX Therapeutics, Inc. (CTMX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $538.2M; last close $2.46 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 2.5 months | none | n/a | $538.2M |
| Regenxbio Inc. (RGNX) Regenxbio Inc. (RGNX) Cmiddle fifth; percentile 55.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $534.0M; last close $8.08 Warnings: short runway; 7 of 14 inputs | cash runway is 1.8 months | C | 55.4 | $534.0M |
| Arvinas, Inc. (ARVN) Arvinas, Inc. (ARVN) Dfourth fifth; percentile 64.6 Nasdaq · Pharmaceutical Preparations market equity $491.1M; last close $7.51 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 5.5 months | D | 64.6 | $491.1M |
| Allogene Therapeutics, Inc. (ALLO) Allogene Therapeutics, Inc. (ALLO) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $483.7M; last close $1.40 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 4.5 months | none | n/a | $483.7M |
| Senseonics Holdings, Inc. (SENS) Senseonics Holdings, Inc. (SENS) Eweakest fifth; percentile 89.9 Nasdaq · Industrial Instruments For Measurement, Display, and Control market equity $476.9M; last close $9.02 Warnings: dilution, short runway, fortress balance sheet; 9 of 14 inputs | cash runway is 5.6 months | E | 89.9 | $476.9M |
| Capricor Therapeutics, Inc. (CAPR) Capricor Therapeutics, Inc. (CAPR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $465.7M; last close $8.01 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 2.4 months | none | n/a | $465.7M |
| Ovid Therapeutics Inc. (OVID) Ovid Therapeutics Inc. (OVID) Dfourth fifth; percentile 70.5 Nasdaq · Pharmaceutical Preparations market equity $457.0M; last close $2.33 Warnings: dilution, short runway; 7 of 14 inputs | cash runway is 2.5 months | D | 70.5 | $457.0M |
| ARS Pharmaceuticals, Inc. (SPRY) ARS Pharmaceuticals, Inc. (SPRY) C/Don the C/D boundary; percentile 60.5 Nasdaq · Pharmaceutical Preparations market equity $453.5M; last close $4.57 Warnings: short runway; 7 of 14 inputs | cash runway is 0.5 months | C/D | 60.5 | $453.5M |
| Rezolute, Inc. (RZLT) Rezolute, Inc. (RZLT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $448.8M; last close $4.63 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 2.0 months | none | n/a | $448.8M |
| DiaMedica Therapeutics Inc. (DMAC) DiaMedica Therapeutics Inc. (DMAC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $431.9M; last close $8.00 Warnings: dilution, short runway, thin data; 4 of 14 inputs | cash runway is 2.0 months | none | n/a | $431.9M |
| Strata Critical Medical, Inc. (SRTA) Strata Critical Medical, Inc. (SRTA) C/Don the C/D boundary; percentile 62.2 Nasdaq · Services-Health Services market equity $395.4M; last close $4.46 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 5.4 months | C/D | 62.2 | $395.4M |
| Kyverna Therapeutics, Inc. (KYTX) Kyverna Therapeutics, Inc. (KYTX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $382.2M; last close $6.17 Warnings: dilution, short runway, thin data; 5 of 14 inputs | cash runway is 2.4 months | none | n/a | $382.2M |
| Orchestra BioMed Holdings, Inc. (OBIO) Orchestra BioMed Holdings, Inc. (OBIO) Dfourth fifth; percentile 68.4 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $344.4M; last close $5.72 Warnings: dilution, short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 4.2 months | D | 68.4 | $344.4M |
| Agenus Inc. (AGEN) Agenus Inc. (AGEN) Eweakest fifth; percentile 97.3 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $339.5M; last close $7.53 Warnings: dilution, short runway; 7 of 14 inputs | cash runway is 2.3 months | E | 97.3 | $339.5M |
| Relmada Therapeutics, Inc. (RLMD) Relmada Therapeutics, Inc. (RLMD) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $338.1M; last close $3.15 Warnings: dilution, short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 3.0 months | none | n/a | $338.1M |
| Quoin Pharmaceuticals Ltd. (QNRX) Quoin Pharmaceuticals Ltd. (QNRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $319.8M; last close $4.59 Warnings: dilution, short runway, thin data; 5 of 14 inputs | cash runway is 3.0 months | none | n/a | $319.8M |
| Lands' END, Inc. (LE) Lands' END, Inc. (LE) Dfourth fifth; percentile 69.6 Nasdaq · Retail-Family Clothing Stores market equity $307.0M; last close $10.49 Warnings: short runway; 9 of 14 inputs | cash runway is 5.2 months | D | 69.6 | $307.0M |
| Contineum Therapeutics, Inc. (CTNM) Contineum Therapeutics, Inc. (CTNM) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $304.4M; last close $13.21 Warnings: short runway, thin data, degenerate inputs; 3 of 14 inputs | cash runway is 3.3 months | none | n/a | $304.4M |
| Cypherpunk Technologies Inc. (CYPH) Cypherpunk Technologies Inc. (CYPH) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $302.8M; last close $2.81 Warnings: dilution, short runway, thin data; 5 of 14 inputs | cash runway is 4.3 months | none | n/a | $302.8M |
| EyePoint, Inc. (EYPT) EyePoint, Inc. (EYPT) Eweakest fifth; percentile 92.7 Nasdaq · Laboratory Analytical Instruments market equity $298.3M; last close $3.47 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 5.0 months | E | 92.7 | $298.3M |
| TrueBlue, Inc. (TBI) TrueBlue, Inc. (TBI) C/Don the C/D boundary; percentile 59.4 NYSE · Services-Help Supply Services market equity $278.9M; last close $9.17 Warnings: short runway, fortress balance sheet; 8 of 14 inputs | cash runway is 5.1 months | C/D | 59.4 | $278.9M |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) BridgeBio Oncology Therapeutics, Inc. (BBOT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $274.2M; last close $3.41 Warnings: short runway, thin data; 4 of 14 inputs | cash runway is 4.3 months | none | n/a | $274.2M |
| Vanda Pharmaceuticals Inc. (VNDA) Vanda Pharmaceuticals Inc. (VNDA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $273.9M; last close $4.51 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 4.7 months | none | n/a | $273.9M |
| Silvaco Group, Inc. (SVCO) Silvaco Group, Inc. (SVCO) noneno letter; percentile n/a Nasdaq · Services-Prepackaged Software market equity $270.7M; last close $7.99 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 4.6 months | none | n/a | $270.7M |
| GT Biopharma, Inc. (GTBP) GT Biopharma, Inc. (GTBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $268.9M; last close $6.22 Warnings: dilution, short runway, thin data, degenerate inputs; 2 of 14 inputs | cash runway is 4.1 months | none | n/a | $268.9M |
| AerSale Corp. (ASLE) AerSale Corp. (ASLE) Dfourth fifth; percentile 65.8 Nasdaq · Wholesale-Machinery, Equipment & Supplies market equity $260.7M; last close $4.92 Warnings: short runway, fortress balance sheet; 10 of 14 inputs | cash runway is 0.9 months | D | 65.8 | $260.7M |
| Fate Therapeutics Inc. (FATE) Fate Therapeutics Inc. (FATE) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $255.2M; last close $2.13 Warnings: short runway, thin data, fortress balance sheet; 5 of 14 inputs | cash runway is 3.8 months | none | n/a | $255.2M |
| Sutro Biopharma, Inc. (STRO) Sutro Biopharma, Inc. (STRO) Eweakest fifth; percentile 93.0 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $254.0M; last close $15.34 Warnings: dilution, short runway, distress, fortress balance sheet; 7 of 14 inputs | cash runway is 4.5 months | E | 93.0 | $254.0M |
| Cytosorbents Corp. (CTSO) Cytosorbents Corp. (CTSO) Dfourth fifth; percentile 76.2 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $234.4M; last close $3.80 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 5.8 months | D | 76.2 | $234.4M |
| Nautilus Biotechnology, Inc. (NAUT) Nautilus Biotechnology, Inc. (NAUT) noneno letter; percentile n/a Nasdaq · Laboratory Analytical Instruments market equity $231.6M; last close $1.83 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 3.1 months | none | n/a | $231.6M |
| Alector, Inc. (ALEC) Alector, Inc. (ALEC) Eweakest fifth; percentile 98.6 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $225.5M; last close $2.02 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 4.5 months | E | 98.6 | $225.5M |
| Eledon Pharmaceuticals, Inc. (ELDN) Eledon Pharmaceuticals, Inc. (ELDN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $196.7M; last close $2.41 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | cash runway is 1.1 months | none | n/a | $196.7M |
| enCore Energy Corp. (EU) enCore Energy Corp. (EU) noneno letter; percentile n/a Nasdaq · Miscellaneous Metal Ores market equity $196.2M; last close $1.03 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 5.2 months | none | n/a | $196.2M |
| Zentalis Pharmaceuticals, Inc. (ZNTL) Zentalis Pharmaceuticals, Inc. (ZNTL) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $179.9M; last close $2.50 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 2.3 months | none | n/a | $179.9M |
| Pyxis Oncology, Inc. (PYXS) Pyxis Oncology, Inc. (PYXS) Eweakest fifth; percentile 83.8 Nasdaq · Pharmaceutical Preparations market equity $166.0M; last close $1.99 Warnings: short runway, distress; 7 of 14 inputs | cash runway is 3.3 months | E | 83.8 | $166.0M |
| Coherus Oncology, Inc. (CHRS) Coherus Oncology, Inc. (CHRS) Eweakest fifth; percentile 98.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $165.3M; last close $1.06 Warnings: dilution, short runway; 10 of 14 inputs | cash runway is 5.3 months | E | 98.4 | $165.3M |
| PepGen Inc. (PEPG) PepGen Inc. (PEPG) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $164.8M; last close $2.38 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 3.9 months | none | n/a | $164.8M |
| ALX Oncology Holdings Inc. (ALXO) ALX Oncology Holdings Inc. (ALXO) Eweakest fifth; percentile 95.4 Nasdaq · Pharmaceutical Preparations market equity $163.2M; last close $1.18 Warnings: dilution, short runway, degenerate inputs, fortress balance sheet; 8 of 14 inputs | cash runway is 3.8 months | E | 95.4 | $163.2M |
| Cue Biopharma, Inc. (CUE) Cue Biopharma, Inc. (CUE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $162.2M; last close $22.16 Warnings: dilution, short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 4.2 months | none | n/a | $162.2M |
| Nkarta, Inc. (NKTX) Nkarta, Inc. (NKTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $159.0M; last close $2.21 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 3.2 months | none | n/a | $159.0M |
| Protara Therapeutics, Inc. (TARA) Protara Therapeutics, Inc. (TARA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $156.6M; last close $2.65 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 3.1 months | none | n/a | $156.6M |
| Korro Bio, Inc. (KRRO) Korro Bio, Inc. (KRRO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $155.8M; last close $10.59 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 4.4 months | none | n/a | $155.8M |
| Voyager Therapeutics, Inc. (VYGR) Voyager Therapeutics, Inc. (VYGR) D/Eon the D/E boundary; percentile 80.3 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $146.0M; last close $2.36 Warnings: short runway; 7 of 14 inputs | cash runway is 3.6 months | D/E | 80.3 | $146.0M |
| Wheels Up Experience Inc. (UP) Wheels Up Experience Inc. (UP) Eweakest fifth; percentile 98.8 NYSE · Air Transportation, Nonscheduled market equity $141.1M; last close $3.89 Warnings: short runway; 7 of 14 inputs | cash runway is 4.2 months | E | 98.8 | $141.1M |
| Outlook Therapeutics, Inc. (OTLK) Outlook Therapeutics, Inc. (OTLK) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $137.3M; last close $0.56 Warnings: dilution, short runway, late filer, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 2.4 months | none | n/a | $137.3M |
| Datavault AI Inc. (DVLT) Datavault AI Inc. (DVLT) Bsecond fifth; percentile 33.1 Nasdaq · Services-Business Services, NEC market equity $137.0M; last close $0.14 Warnings: dilution, short runway, late filer, fortress balance sheet; 9 of 14 inputs | cash runway is 0.2 months | B | 33.1 | $137.0M |
| XCF Global, Inc. (SAFX) XCF Global, Inc. (SAFX) noneno letter; percentile n/a Nasdaq · Industrial Organic Chemicals market equity $131.3M; last close $0.32 Warnings: short runway, late filer, thin data; 3 of 14 inputs | cash runway is 0.2 months | none | n/a | $131.3M |
| Shimmick Corp. (SHIM) Shimmick Corp. (SHIM) noneno letter; percentile n/a Nasdaq · Heavy Construction Other Than Bldg Const - Contractors market equity $127.3M; last close $3.06 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 4.2 months | none | n/a | $127.3M |
| Aemetis, Inc. (AMTX) Aemetis, Inc. (AMTX) Eweakest fifth; percentile 91.8 Nasdaq · Industrial Organic Chemicals market equity $124.9M; last close $1.73 Warnings: short runway; 8 of 14 inputs | cash runway is 3.2 months | E | 91.8 | $124.9M |
| TuHURA Biosciences, Inc./NV (HURA) TuHURA Biosciences, Inc./NV (HURA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $123.0M; last close $1.95 Warnings: short runway, thin data, degenerate inputs, fortress balance sheet; 2 of 14 inputs | cash runway is 0.4 months | none | n/a | $123.0M |
| RTB Digital, Inc. (RTB) RTB Digital, Inc. (RTB) Eweakest fifth; percentile 99.1 Nasdaq · Services-Management Consulting Services market equity $117.1M; last close $8.38 Warnings: dilution, short runway, late filer; 8 of 14 inputs | cash runway is 0.2 months | E | 99.1 | $117.1M |
| Kulr Technology Group, Inc. (KULR) Kulr Technology Group, Inc. (KULR) noneno letter; percentile n/a NYSE · Electronic Components & Accessories market equity $113.8M; last close $2.47 Warnings: dilution, short runway, late filer, thin data; 6 of 14 inputs | cash runway is 3.7 months | none | n/a | $113.8M |
| Genelux Corp. (GNLX) Genelux Corp. (GNLX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $113.1M; last close $2.49 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 4.4 months | none | n/a | $113.1M |
| Inovio Pharmaceuticals, Inc. (INO) Inovio Pharmaceuticals, Inc. (INO) Eweakest fifth; percentile 99.5 Nasdaq · Pharmaceutical Preparations market equity $112.7M; last close $1.08 Warnings: dilution, short runway, degenerate inputs; 7 of 14 inputs | cash runway is 4.7 months | E | 99.5 | $112.7M |
| Lenz Therapeutics, Inc. (LENZ) Lenz Therapeutics, Inc. (LENZ) Dfourth fifth; percentile 63.0 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $110.9M; last close $3.52 Warnings: short runway; 7 of 14 inputs | cash runway is 2.6 months | D | 63.0 | $110.9M |
| Surf AIR Mobility Inc. (SRFM) Surf AIR Mobility Inc. (SRFM) noneno letter; percentile n/a NYSE · Air Transportation, Nonscheduled market equity $110.7M; last close $0.93 Warnings: short runway, thin data; 3 of 14 inputs | cash runway is 4.3 months | none | n/a | $110.7M |
| Future FinTech Group Inc. (FTFT) Future FinTech Group Inc. (FTFT) Eweakest fifth; percentile 98.5 Nasdaq · Services-Business Services, NEC market equity $108.5M; last close $3.33 Warnings: dilution, short runway, late filer; 8 of 14 inputs | cash runway is 1.4 months | E | 98.5 | $108.5M |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) Corbus Pharmaceuticals Holdings, Inc. (CRBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $101.9M; last close $5.25 Warnings: dilution, short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 3.2 months | none | n/a | $101.9M |
| Anixa Biosciences Inc. (ANIX) Anixa Biosciences Inc. (ANIX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $101.2M; last close $2.90 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 2.3 months | none | n/a | $101.2M |
| Atara Biotherapeutics, Inc. (ATRA) Atara Biotherapeutics, Inc. (ATRA) Eweakest fifth; percentile 98.9 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $92.6M; last close $9.05 Warnings: dilution, short runway; 8 of 14 inputs | cash runway is 1.8 months | E | 98.9 | $92.6M |
| Nexalin Technology, Inc. (NXL) Nexalin Technology, Inc. (NXL) noneno letter; percentile n/a Nasdaq · Electromedical & Electrotherapeutic Apparatus market equity $90.6M; last close $4.06 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 2.0 months | none | n/a | $90.6M |
| Cibus, Inc. (CBUS) Cibus, Inc. (CBUS) noneno letter; percentile n/a Nasdaq · Agricultural Chemicals market equity $86.3M; last close $1.59 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash runway is 5.3 months | none | n/a | $86.3M |
| Cardiff Oncology, Inc. (CRDF) Cardiff Oncology, Inc. (CRDF) Dfourth fifth; percentile 67.3 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $82.5M; last close $1.07 Warnings: short runway, fortress balance sheet; 7 of 14 inputs | cash runway is 2.7 months | D | 67.3 | $82.5M |
| PMV Pharmaceuticals, Inc. (PMVP) PMV Pharmaceuticals, Inc. (PMVP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $79.7M; last close $1.49 Warnings: short runway, thin data; 6 of 14 inputs | cash runway is 2.1 months | none | n/a | $79.7M |
| Inseego Corp. (INSG) Inseego Corp. (INSG) Eweakest fifth; percentile 93.3 Nasdaq · Communications Equipment, NEC market equity $73.2M; last close $4.46 Warnings: short runway; 9 of 14 inputs | cash runway is 3.3 months | E | 93.3 | $73.2M |
| Microbot Medical Inc. (MBOT) Microbot Medical Inc. (MBOT) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $71.9M; last close $1.07 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 2.1 months | none | n/a | $71.9M |
| Eva Live Inc. (GOAI) Eva Live Inc. (GOAI) noneno letter; percentile n/a Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $67.9M; last close $1.76 Warnings: short runway, late filer, thin data; 3 of 14 inputs | cash runway is 4.0 months | none | n/a | $67.9M |
| Rein Therapeutics, Inc. (RNTX) Rein Therapeutics, Inc. (RNTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $66.4M; last close $0.77 Warnings: dilution, short runway, late filer, thin data, degenerate inputs, distress; 6 of 14 inputs | cash runway is 5.4 months | none | n/a | $66.4M |
| CitroTech Inc. (CITR) CitroTech Inc. (CITR) noneno letter; percentile n/a NYSE · Chemicals & Allied Products market equity $66.1M; last close $2.97 Warnings: short runway, late filer, thin data; 6 of 14 inputs | cash runway is 3.9 months | none | n/a | $66.1M |
| Neonc Technologies Holdings, Inc. (NTHI) Neonc Technologies Holdings, Inc. (NTHI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $65.6M; last close $2.53 Warnings: short runway, late filer, thin data, degenerate inputs; 3 of 14 inputs | cash runway is 1.1 months | none | n/a | $65.6M |
| Pliant Therapeutics, Inc. (PLRX) Pliant Therapeutics, Inc. (PLRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $61.9M; last close $1.00 Warnings: short runway, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | cash runway is 4.2 months | none | n/a | $61.9M |
| NexMetals Mining Corp. (NEXM) NexMetals Mining Corp. (NEXM) noneno letter; percentile n/a Nasdaq · Metal Mining market equity $60.2M; last close $1.70 Warnings: short runway, late filer, thin data; 2 of 14 inputs | cash runway is 4.3 months | none | n/a | $60.2M |
| Geospace Technologies Corp. (GEOS) Geospace Technologies Corp. (GEOS) Dfourth fifth; percentile 73.6 Nasdaq · Measuring & Controlling Devices, NEC market equity $59.8M; last close $4.62 Warnings: short runway, late filer, fortress balance sheet; 9 of 14 inputs | cash runway is 1.1 months | D | 73.6 | $59.8M |
| Skye Bioscience, Inc. (SKYE) Skye Bioscience, Inc. (SKYE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $59.5M; last close $1.67 Warnings: short runway, thin data, distress; 6 of 14 inputs | cash runway is 2.5 months | none | n/a | $59.5M |
| Sera Prognostics, Inc. (SERA) Sera Prognostics, Inc. (SERA) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories market equity $59.2M; last close $2.02 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 1.9 months | none | n/a | $59.2M |
| Veritone, Inc. (VERI) Veritone, Inc. (VERI) noneno letter; percentile n/a Nasdaq · Services-Computer Processing & Data Preparation market equity $58.8M; last close $0.59 Warnings: short runway, late filer, thin data; 3 of 14 inputs | cash runway is 3.0 months | none | n/a | $58.8M |
| Boundless Bio, Inc. (BOLD) Boundless Bio, Inc. (BOLD) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $58.7M; last close $2.61 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 4.3 months | none | n/a | $58.7M |
| PDS Biotechnology Corp. (PDSB) PDS Biotechnology Corp. (PDSB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $57.1M; last close $1.03 Warnings: short runway, thin data, fortress balance sheet; 5 of 14 inputs | cash runway is 4.0 months | none | n/a | $57.1M |
| Talphera, Inc. (TLPH) Talphera, Inc. (TLPH) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $56.1M; last close $1.07 Warnings: dilution, short runway, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | cash runway is 0.7 months | none | n/a | $56.1M |
| Connect Biopharma Holdings Ltd. (CNTB) Connect Biopharma Holdings Ltd. (CNTB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $55.5M; last close $0.91 Warnings: short runway, thin data, degenerate inputs, distress; 5 of 14 inputs | cash runway is 5.4 months | none | n/a | $55.5M |
| Adicet Bio, Inc. (ACET) Adicet Bio, Inc. (ACET) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $53.7M; last close $5.71 Warnings: short runway, thin data; 4 of 14 inputs | cash runway is 4.7 months | none | n/a | $53.7M |
| DarioHealth Corp. (DRIO) DarioHealth Corp. (DRIO) Eweakest fifth; percentile 86.8 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $53.2M; last close $5.61 Warnings: dilution, short runway; 7 of 14 inputs | cash runway is 3.1 months | E | 86.8 | $53.2M |
| Solitario Resources Corp. (XPL) Solitario Resources Corp. (XPL) noneno letter; percentile n/a NYSE · Gold and Silver Ores market equity $52.5M; last close $0.55 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | cash runway is 1.5 months | none | n/a | $52.5M |
| Caribou Biosciences, Inc. (CRBU) Caribou Biosciences, Inc. (CRBU) Dfourth fifth; percentile 63.5 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $51.6M; last close $0.48 Warnings: short runway; 7 of 14 inputs | cash runway is 3.3 months | D | 63.5 | $51.6M |
| Annovis Bio, Inc. (ANVS) Annovis Bio, Inc. (ANVS) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $49.8M; last close $1.18 Warnings: dilution, short runway, thin data, degenerate inputs; 3 of 14 inputs | cash runway is 5.2 months | none | n/a | $49.8M |
| Valion Bio, Inc. (VBIO) Valion Bio, Inc. (VBIO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $49.0M; last close $2.25 Warnings: dilution, short runway, thin data; 5 of 14 inputs | cash runway is 1.7 months | none | n/a | $49.0M |
| AEye, Inc. (LIDR) AEye, Inc. (LIDR) Eweakest fifth; percentile 96.5 Nasdaq · Motor Vehicle Parts & Accessories market equity $48.6M; last close $1.05 Warnings: dilution, short runway, fortress balance sheet; 9 of 14 inputs | cash runway is 4.6 months | E | 96.5 | $48.6M |
| BioRestorative Therapies, Inc. (BRTX) BioRestorative Therapies, Inc. (BRTX) noneno letter; percentile n/a Nasdaq · Services-Misc Health & Allied Services, NEC market equity $48.2M; last close $1.92 Warnings: dilution, short runway, late filer, thin data; 6 of 14 inputs | cash runway is 3.2 months | none | n/a | $48.2M |
| Celularity Inc. (CELU) Celularity Inc. (CELU) Eweakest fifth; percentile 94.6 Nasdaq · Pharmaceutical Preparations market equity $47.4M; last close $1.48 Warnings: short runway, late filer; 8 of 14 inputs | cash runway is 0.5 months | E | 94.6 | $47.4M |
| Cineverse Corp. (CNVS) Cineverse Corp. (CNVS) noneno letter; percentile n/a Nasdaq · Services-Video Tape Rental market equity $45.9M; last close $1.93 Warnings: dilution, short runway, thin data; 6 of 14 inputs | cash runway is 3.9 months | none | n/a | $45.9M |
| Instil Bio, Inc. (TIL) Instil Bio, Inc. (TIL) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $44.5M; last close $6.51 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 2.8 months | none | n/a | $44.5M |
| Matinas BioPharma Holdings, Inc. (MTNB) Matinas BioPharma Holdings, Inc. (MTNB) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $41.6M; last close $2.66 Warnings: dilution, short runway, late filer, thin data; 5 of 14 inputs | cash runway is 1.4 months | none | n/a | $41.6M |
| Odyssey Marine Exploration Inc. (OMEX) Odyssey Marine Exploration Inc. (OMEX) noneno letter; percentile n/a Nasdaq · Water Transportation market equity $38.5M; last close $0.69 Warnings: short runway, late filer, thin data; 4 of 14 inputs | cash runway is 2.1 months | none | n/a | $38.5M |
| Metagenomi Therapeutics, Inc. (MGX) Metagenomi Therapeutics, Inc. (MGX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $37.5M; last close $0.99 Warnings: short runway, thin data; 5 of 14 inputs | cash runway is 5.5 months | none | n/a | $37.5M |
| Aether Holdings, Inc. (ATHR) Aether Holdings, Inc. (ATHR) noneno letter; percentile n/a Nasdaq · Services-Prepackaged Software market equity $35.5M; last close $3.67 Warnings: short runway, late filer, thin data; 2 of 14 inputs | cash runway is 0.7 months | none | n/a | $35.5M |
| GridAI Technologies Corp. (GRDX) GridAI Technologies Corp. (GRDX) noneno letter; percentile n/a Nasdaq · Electric & Other Services Combined market equity $34.2M; last close $4.80 Warnings: dilution, short runway, late filer, thin data, degenerate inputs; 6 of 14 inputs | cash runway is 2.0 months | none | n/a | $34.2M |
| Accendra Health (ACH) Accendra Health (ACH) Eweakest fifth; percentile 92.2 NYSE · Wholesale-Medical, Dental & Hospital Equipment & Supplies market equity $34.1M; last close $0.45 Warnings: short runway; 10 of 14 inputs | cash runway is 0.5 months | E | 92.2 | $34.1M |
| Nanoviricides, Inc. (NNVC) Nanoviricides, Inc. (NNVC) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $33.4M; last close $1.31 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | cash runway is 4.4 months | none | n/a | $33.4M |
| Aligos Therapeutics, Inc. (ALGS) Aligos Therapeutics, Inc. (ALGS) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $33.1M; last close $5.46 Warnings: short runway, thin data, distress; 5 of 14 inputs | cash runway is 3.9 months | none | n/a | $33.1M |
| Vivakor, Inc. (VIVK) Vivakor, Inc. (VIVK) Cmiddle fifth; percentile 56.7 Nasdaq · Refuse Systems market equity $32.8M; last close $4.43 Warnings: short runway, late filer; 7 of 14 inputs | cash runway is 0.2 months | C | 56.7 | $32.8M |
| Workhorse Group Inc. (WKHS) Workhorse Group Inc. (WKHS) noneno letter; percentile n/a Nasdaq · Motor Vehicles & Passenger Car Bodies market equity $31.9M; last close $2.93 Warnings: short runway, late filer, thin data; 6 of 14 inputs | cash runway is 2.1 months | none | n/a | $31.9M |
Rule: any NT 10-K or NT 10-Q in the last 730 days. 493 triggered; among the 198 with a letter: A 19, B 34, C 22, D 46, E 77. The largest 150 by market equity are listed.
| Company | Measured | Letter | Percentile | Market equity |
|---|---|---|---|---|
| Akari Therapeutics plc (AKTX) Akari Therapeutics plc (AKTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.3T; last close $8.57 Warnings: dilution, late filer, thin data; 4 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | none | n/a | $1.3T |
| Archer-Daniels-Midland Co. (ADM) Archer-Daniels-Midland Co. (ADM) Eweakest fifth; percentile 92.7 NYSE · Fats & Oils market equity $39.7B; last close $82.45 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 92.7 | $39.7B |
| Qnity Electronics, Inc. (Q) Qnity Electronics, Inc. (Q) noneno letter; percentile n/a NYSE · Semiconductors & Related Devices market equity $26.5B; last close $126.57 Warnings: late filer, thin data; 2 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $26.5B |
| Symbotic Inc. (SYM) Symbotic Inc. (SYM) Cmiddle fifth; percentile 46.9 Nasdaq · General Industrial Machinery & Equipment, NEC market equity $25.4B; last close $42.04 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 46.9 | $25.4B |
| Trimble Inc. (TRMB) Trimble Inc. (TRMB) D/Eon the D/E boundary; percentile 80.0 Nasdaq · Measuring & Controlling Devices, NEC market equity $14.0B; last close $59.87 Warnings: late filer; 11 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | D/E | 80.0 | $14.0B |
| Hasbro, Inc. (HAS) Hasbro, Inc. (HAS) Cmiddle fifth; percentile 55.3 Nasdaq · Games, Toys & Children's Vehicles (No Dolls & Bicycles) market equity $13.0B; last close $92.50 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 55.3 | $13.0B |
| Littelfuse Inc. (LFUS) Littelfuse Inc. (LFUS) Bsecond fifth; percentile 37.0 Nasdaq · Switchgear & Switchboard Apparatus market equity $10.8B; last close $425.22 Warnings: late filer; 11 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 37.0 | $10.8B |
| AES Corp. (AES) AES Corp. (AES) noneno letter; percentile n/a NYSE · Cogeneration Services & Small Power Producers market equity $10.7B; last close $14.93 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $10.7B |
| Repligen Corp. (RGEN) Repligen Corp. (RGEN) B/Con the B/C boundary; percentile 41.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $9.2B; last close $163.99 Warnings: late filer, fortress balance sheet; 12 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | B/C | 41.4 | $9.2B |
| Pacs Group, Inc. (PACS) Pacs Group, Inc. (PACS) noneno letter; percentile n/a NYSE · Services-Skilled Nursing Care Facilities market equity $6.9B; last close $43.72 Warnings: late filer, thin data; 4 of 14 inputs | found 5 NT 10-K/Q filings in the last eight quarters | none | n/a | $6.9B |
| Landstar System Inc. (LSTR) Landstar System Inc. (LSTR) Bsecond fifth; percentile 28.4 Nasdaq · Trucking (No Local) market equity $5.7B; last close $169.41 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 28.4 | $5.7B |
| Karman Holdings Inc. (KRMN) Karman Holdings Inc. (KRMN) noneno letter; percentile n/a NYSE · Aircraft Parts & Auxiliary Equipment, NEC market equity $4.2B; last close $31.73 Warnings: late filer, thin data; 6 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $4.2B |
| Century Aluminum Co. (CENX) Century Aluminum Co. (CENX) noneno letter; percentile n/a Nasdaq · Primary Production of Aluminum market equity $3.6B; last close $36.38 Warnings: late filer, thin data; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $3.6B |
| Interparfums Inc. (IPAR) Interparfums Inc. (IPAR) Astrongest fifth; percentile 1.8 Nasdaq · Perfumes, Cosmetics & Other Toilet Preparations market equity $3.6B; last close $111.65 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | A | 1.8 | $3.6B |
| Dana Inc. (DAN) Dana Inc. (DAN) Dfourth fifth; percentile 72.5 NYSE · Motor Vehicle Parts & Accessories market equity $3.1B; last close $29.02 Warnings: late filer; 11 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 72.5 | $3.1B |
| Kyndryl Holdings, Inc. (KD) Kyndryl Holdings, Inc. (KD) noneno letter; percentile n/a NYSE · Services-Computer Integrated Systems Design market equity $2.6B; last close $11.90 Warnings: late filer, thin data, fortress balance sheet; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $2.6B |
| Neogen Corp. (NEOG) Neogen Corp. (NEOG) Cmiddle fifth; percentile 49.7 Nasdaq · In Vitro & In Vivo Diagnostic Substances market equity $2.6B; last close $11.71 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 49.7 | $2.6B |
| Adma Biologics, Inc. (ADMA) Adma Biologics, Inc. (ADMA) A/Bon the A/B boundary; percentile 18.9 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $2.3B; last close $10.32 Warnings: late filer, fortress balance sheet; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | A/B | 18.9 | $2.3B |
| Astrana Health, Inc. (ASTH) Astrana Health, Inc. (ASTH) Bsecond fifth; percentile 34.9 Nasdaq · Services-Management Consulting Services market equity $2.0B; last close $35.85 Warnings: late filer; 8 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | B | 34.9 | $2.0B |
| Driven Brands Holdings Inc. (DRVN) Driven Brands Holdings Inc. (DRVN) noneno letter; percentile n/a Nasdaq · Services-Automotive Repair, Services & Parking market equity $1.9B; last close $11.77 Warnings: late filer, thin data; 4 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $1.9B |
| Target Hospitality Corp. (TH) Target Hospitality Corp. (TH) Eweakest fifth; percentile 85.1 Nasdaq · Hotels, Rooming Houses, Camps & Other Lodging Places market equity $1.8B; last close $18.34 Warnings: late filer, fortress balance sheet; 10 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | E | 85.1 | $1.8B |
| Weis Markets Inc. (WMK) Weis Markets Inc. (WMK) Astrongest fifth; percentile 6.2 NYSE · Retail-Grocery Stores market equity $1.8B; last close $73.00 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | A | 6.2 | $1.8B |
| Surgery Partners, Inc. (SGRY) Surgery Partners, Inc. (SGRY) D/Eon the D/E boundary; percentile 81.6 Nasdaq · Services-General Medical & Surgical Hospitals, NEC market equity $1.8B; last close $13.62 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D/E | 81.6 | $1.8B |
| Azenta, Inc. (AZTA) Azenta, Inc. (AZTA) B/Con the B/C boundary; percentile 42.1 Nasdaq · Special Industry Machinery, NEC market equity $1.6B; last close $36.00 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B/C | 42.1 | $1.6B |
| TMC the metals Co. Inc. (TMC) TMC the metals Co. Inc. (TMC) noneno letter; percentile n/a Nasdaq · Metal Mining market equity $1.5B; last close $3.44 Warnings: late filer, thin data; 4 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $1.5B |
| United Parks & Resorts Inc. (PRKS) United Parks & Resorts Inc. (PRKS) Cmiddle fifth; percentile 46.3 NYSE · Services-Miscellaneous Amusement & Recreation market equity $1.5B; last close $32.11 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 46.3 | $1.5B |
| Nutex Health Inc. (NUTX) Nutex Health Inc. (NUTX) Astrongest fifth; percentile 2.4 Nasdaq · Services-Business Services, NEC market equity $1.4B; last close $205.57 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | A | 2.4 | $1.4B |
| Harmonic Inc. (HLIT) Harmonic Inc. (HLIT) C/Don the C/D boundary; percentile 62.1 Nasdaq · Radio & Tv Broadcasting & Communications Equipment market equity $1.2B; last close $11.08 Warnings: late filer, fortress balance sheet; 11 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C/D | 62.1 | $1.2B |
| Intuitive Machines, Inc. (LUNR) Intuitive Machines, Inc. (LUNR) noneno letter; percentile n/a Nasdaq · Search, Detection, Navigation, Guidance, Aeronautical Sys market equity $1.2B; last close $13.70 Warnings: late filer, thin data, fortress balance sheet; 4 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $1.2B |
| Quantum Corp. (QMCO) Quantum Corp. (QMCO) Eweakest fifth; percentile 92.5 Nasdaq · Computer Storage Devices market equity $1.1B; last close $29.15 Warnings: dilution, late filer; 7 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | E | 92.5 | $1.1B |
| Harrow, Inc. (HROW) Harrow, Inc. (HROW) Astrongest fifth; percentile 14.9 Nasdaq · Pharmaceutical Preparations market equity $1.1B; last close $30.59 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | A | 14.9 | $1.1B |
| Universal Corp. (UVV) Universal Corp. (UVV) Cmiddle fifth; percentile 47.1 NYSE · Wholesale-Farm Product Raw Materials market equity $1.1B; last close $43.08 Warnings: late filer; 10 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | C | 47.1 | $1.1B |
| McEwen Inc. (MUX) McEwen Inc. (MUX) D/Eon the D/E boundary; percentile 80.3 NYSE · Gold and Silver Ores market equity $1.1B; last close $17.32 Warnings: late filer; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D/E | 80.3 | $1.1B |
| Evolution Metals & Technologies Corp. (EMAT) Evolution Metals & Technologies Corp. (EMAT) noneno letter; percentile n/a Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $1.1B; last close $1.70 Warnings: late filer, thin data; 3 of 14 inputs | found 5 NT 10-K/Q filings in the last eight quarters | none | n/a | $1.1B |
| T1 Energy Inc. (TE) T1 Energy Inc. (TE) noneno letter; percentile n/a NYSE · Semiconductors & Related Devices market equity $1.0B; last close $3.43 Warnings: late filer, thin data; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $1.0B |
| Rackspace Technology, Inc. (RXT) Rackspace Technology, Inc. (RXT) Eweakest fifth; percentile 98.4 Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $922.6M; last close $3.63 Warnings: late filer; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 98.4 | $922.6M |
| Daily Journal Corp. (DJCO) Daily Journal Corp. (DJCO) A/Bon the A/B boundary; percentile 17.9 Nasdaq · Newspapers: Publishing or Publishing & Printing market equity $884.0M; last close $632.61 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | A/B | 17.9 | $884.0M |
| Cryoport, Inc. (CYRX) Cryoport, Inc. (CYRX) C/Don the C/D boundary; percentile 59.2 Nasdaq · Pharmaceutical Preparations market equity $856.0M; last close $16.91 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C/D | 59.2 | $856.0M |
| N-able, Inc. (NABL) N-able, Inc. (NABL) Dfourth fifth; percentile 64.9 NYSE · Services-Prepackaged Software market equity $850.1M; last close $4.50 Warnings: late filer; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 64.9 | $850.1M |
| Evolv Technologies Holdings, Inc. (EVLV) Evolv Technologies Holdings, Inc. (EVLV) Dfourth fifth; percentile 71.0 Nasdaq · Computer Peripheral Equipment, NEC market equity $829.6M; last close $4.58 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | D | 71.0 | $829.6M |
| Republic Airways Holdings Inc. (RJET) Republic Airways Holdings Inc. (RJET) Bsecond fifth; percentile 26.3 Nasdaq · Air Transportation, Scheduled market equity $810.4M; last close $17.34 Warnings: late filer; 7 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | B | 26.3 | $810.4M |
| Kopin Corp. (KOPN) Kopin Corp. (KOPN) noneno letter; percentile n/a Nasdaq · Semiconductors & Related Devices market equity $780.7M; last close $4.19 Warnings: late filer, thin data; 6 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $780.7M |
| Angel Studios, Inc. (ANGX) Angel Studios, Inc. (ANGX) noneno letter; percentile n/a NYSE · Services-Motion Picture & Video Tape Production market equity $759.1M; last close $4.05 Warnings: late filer, thin data; 5 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $759.1M |
| Bally's Corp. (BALY) Bally's Corp. (BALY) Dfourth fifth; percentile 65.7 NYSE · Hotels & Motels market equity $705.1M; last close $14.02 Warnings: late filer; 7 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | D | 65.7 | $705.1M |
| Lightpath Technologies Inc. (LPTH) Lightpath Technologies Inc. (LPTH) Bsecond fifth; percentile 29.2 Nasdaq · Semiconductors & Related Devices market equity $682.2M; last close $9.75 Warnings: dilution, late filer, fortress balance sheet; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 29.2 | $682.2M |
| Park Aerospace Corp. (PKE) Park Aerospace Corp. (PKE) Astrongest fifth; percentile 14.6 NYSE · Aircraft Parts & Auxiliary Equipment, NEC market equity $645.1M; last close $29.74 Warnings: late filer, fortress balance sheet; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | A | 14.6 | $645.1M |
| Ironwood Pharmaceuticals Inc. (IRWD) Ironwood Pharmaceuticals Inc. (IRWD) D/Eon the D/E boundary; percentile 79.7 Nasdaq · Pharmaceutical Preparations market equity $639.5M; last close $3.87 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D/E | 79.7 | $639.5M |
| Adtran Holdings, Inc. (ADTN) Adtran Holdings, Inc. (ADTN) Dfourth fifth; percentile 71.4 Nasdaq · Telephone & Telegraph Apparatus market equity $610.3M; last close $7.50 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 71.4 | $610.3M |
| Energy Vault Holdings, Inc. (NRGV) Energy Vault Holdings, Inc. (NRGV) Eweakest fifth; percentile 86.9 NYSE · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $601.9M; last close $3.31 Warnings: late filer; 8 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | E | 86.9 | $601.9M |
| XMax Inc. (XMAX) XMax Inc. (XMAX) Cmiddle fifth; percentile 42.7 Nasdaq · Household Furniture market equity $569.1M; last close $8.83 Warnings: dilution, late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 42.7 | $569.1M |
| Pangaea Logistics Solutions Ltd. (PANL) Pangaea Logistics Solutions Ltd. (PANL) noneno letter; percentile n/a Nasdaq · Deep Sea Foreign Transportation of Freight market equity $563.1M; last close $8.60 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $563.1M |
| 3D Systems Corp. (DDD) 3D Systems Corp. (DDD) Eweakest fifth; percentile 93.5 NYSE · Services-Prepackaged Software market equity $556.6M; last close $3.34 Warnings: late filer; 8 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | E | 93.5 | $556.6M |
| Forward AIR Corp. (FWRD) Forward AIR Corp. (FWRD) Eweakest fifth; percentile 86.0 Nasdaq · Arrangement of Transportation of Freight & Cargo market equity $551.3M; last close $16.33 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 86.0 | $551.3M |
| Playstudios, Inc. (MYPS) Playstudios, Inc. (MYPS) noneno letter; percentile n/a Nasdaq · Services-Prepackaged Software market equity $531.9M; last close $4.19 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $531.9M |
| Neurogene Inc. (NGNE) Neurogene Inc. (NGNE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $530.3M; last close $26.39 Warnings: late filer, thin data, degenerate inputs; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $530.3M |
| SS Innovations International, Inc. (SSII) SS Innovations International, Inc. (SSII) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $527.0M; last close $2.69 Warnings: late filer, thin data, fortress balance sheet; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $527.0M |
| Realloys Inc. (ALOY) Realloys Inc. (ALOY) Eweakest fifth; percentile 97.0 Nasdaq · Metal Mining market equity $522.9M; last close $7.57 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 97.0 | $522.9M |
| Core Laboratories Inc. (CLB) Core Laboratories Inc. (CLB) A/Bon the A/B boundary; percentile 23.1 NYSE · Oil & Gas Field Services, NEC market equity $466.2M; last close $10.16 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | A/B | 23.1 | $466.2M |
| ASP Isotopes Inc. (ASPI) ASP Isotopes Inc. (ASPI) Cmiddle fifth; percentile 44.5 Nasdaq · Miscellaneous Chemical Products market equity $433.9M; last close $2.82 Warnings: dilution, late filer, fortress balance sheet; 7 of 14 inputs | found 5 NT 10-K/Q filings in the last eight quarters | C | 44.5 | $433.9M |
| Barnes & Noble Education, Inc. (BNED) Barnes & Noble Education, Inc. (BNED) Cmiddle fifth; percentile 55.3 NYSE · Retail-Miscellaneous Shopping Goods Stores market equity $413.9M; last close $11.92 Warnings: late filer; 10 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | C | 55.3 | $413.9M |
| Ur-Energy Inc. (URG) Ur-Energy Inc. (URG) noneno letter; percentile n/a NYSE · Gold and Silver Ores market equity $401.8M; last close $1.00 Warnings: late filer, thin data; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $401.8M |
| Arcturus Therapeutics Holdings Inc. (ARCT) Arcturus Therapeutics Holdings Inc. (ARCT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $365.8M; last close $12.85 Warnings: late filer, thin data, fortress balance sheet; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $365.8M |
| Terra Innovatum Global N.V. (NKLR) Terra Innovatum Global N.V. (NKLR) noneno letter; percentile n/a Nasdaq · Fabricated Plate Work (Boiler Shops) market equity $361.3M; last close $3.28 Warnings: late filer, thin data; 2 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $361.3M |
| Powerfleet, Inc. (AIOT) Powerfleet, Inc. (AIOT) noneno letter; percentile n/a Nasdaq · Communications Equipment, NEC market equity $354.4M; last close $2.65 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $354.4M |
| Primeenergy Resources Corp. (PNRG) Primeenergy Resources Corp. (PNRG) noneno letter; percentile n/a Nasdaq · Crude Petroleum & Natural Gas market equity $334.7M; last close $207.52 Warnings: late filer, thin data; 6 of 14 inputs | found 6 NT 10-K/Q filings in the last eight quarters | none | n/a | $334.7M |
| Nano Dimension Ltd. (NNDM) Nano Dimension Ltd. (NNDM) noneno letter; percentile n/a Nasdaq · Printed Circuit Boards market equity $328.9M; last close $1.55 Warnings: late filer, thin data; 2 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $328.9M |
| GameSquare Holdings, Inc. (GAME) GameSquare Holdings, Inc. (GAME) noneno letter; percentile n/a Nasdaq · Services-Amusement & Recreation Services market equity $326.0M; last close $3.07 Warnings: dilution, late filer, thin data; 5 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $326.0M |
| Embecta Corp. (EMBC) Embecta Corp. (EMBC) C/Don the C/D boundary; percentile 62.4 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $325.8M; last close $5.76 Warnings: late filer; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C/D | 62.4 | $325.8M |
| Ftai Infrastructure Inc. (FIP) Ftai Infrastructure Inc. (FIP) noneno letter; percentile n/a Nasdaq · Railroads, Line-Haul Operating market equity $314.4M; last close $2.66 Warnings: late filer, thin data; 5 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | none | n/a | $314.4M |
| Gogo Inc. (GOGO) Gogo Inc. (GOGO) Cmiddle fifth; percentile 44.5 Nasdaq · Communications Services, NEC market equity $306.2M; last close $2.27 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 44.5 | $306.2M |
| RCM Technologies, Inc. (RCMT) RCM Technologies, Inc. (RCMT) A/Bon the A/B boundary; percentile 18.8 Nasdaq · Services-Help Supply Services market equity $297.6M; last close $42.00 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | A/B | 18.8 | $297.6M |
| TechTarget, Inc. (TTGT) TechTarget, Inc. (TTGT) noneno letter; percentile n/a Nasdaq · Telegraph & Other Message Communications market equity $296.6M; last close $4.10 Warnings: late filer, thin data; 4 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $296.6M |
| Velo3D, Inc. (VELO) Velo3D, Inc. (VELO) noneno letter; percentile n/a Nasdaq · Special Industry Machinery, NEC market equity $288.7M; last close $8.98 Warnings: late filer, thin data, fortress balance sheet; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $288.7M |
| TSS, Inc. (TSSI) TSS, Inc. (TSSI) Cmiddle fifth; percentile 44.2 Nasdaq · Services-Management Consulting Services market equity $281.3M; last close $9.98 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 44.2 | $281.3M |
| Deep Fission, Inc. (FISN) Deep Fission, Inc. (FISN) noneno letter; percentile n/a Nasdaq · Electric Services market equity $274.5M; last close $4.66 Warnings: late filer, thin data; 2 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $274.5M |
| Corvex, Inc. (MOVE) Corvex, Inc. (MOVE) noneno letter; percentile n/a Nasdaq · Services-Computer Processing & Data Preparation market equity $271.2M; last close $9.88 Warnings: late filer, thin data; 5 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | none | n/a | $271.2M |
| Standard Biotools Inc. (LAB) Standard Biotools Inc. (LAB) Dfourth fifth; percentile 75.7 Nasdaq · Pharmaceutical Preparations market equity $263.1M; last close $0.67 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 75.7 | $263.1M |
| Perma-Pipe International Holdings, Inc. (PPIH) Perma-Pipe International Holdings, Inc. (PPIH) Bsecond fifth; percentile 35.8 Nasdaq · Industrial & Commercial Fans & Blowers & Air Purifing Equip market equity $255.4M; last close $31.15 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 35.8 | $255.4M |
| Duos Technologies Group, Inc. (DUOT) Duos Technologies Group, Inc. (DUOT) Dfourth fifth; percentile 77.4 Nasdaq · Services-Prepackaged Software market equity $245.5M; last close $7.82 Warnings: dilution, late filer, fortress balance sheet; 8 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | D | 77.4 | $245.5M |
| Immersion Corp. (IMMR) Immersion Corp. (IMMR) D/Eon the D/E boundary; percentile 78.8 Nasdaq · Computer Peripheral Equipment, NEC market equity $237.1M; last close $7.13 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | D/E | 78.8 | $237.1M |
| FutureFuel Corp. (FF) FutureFuel Corp. (FF) Dfourth fifth; percentile 73.6 NYSE · Industrial Organic Chemicals market equity $227.2M; last close $5.17 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 73.6 | $227.2M |
| Microvast Holdings, Inc. (MVST) Microvast Holdings, Inc. (MVST) Eweakest fifth; percentile 87.1 Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $224.5M; last close $0.58 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 87.1 | $224.5M |
| Firy Inc. (FIRY) Firy Inc. (FIRY) Eweakest fifth; percentile 98.2 NYSE · Services-Computer Processing & Data Preparation market equity $222.2M; last close $11.98 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 5 NT 10-K/Q filings in the last eight quarters | E | 98.2 | $222.2M |
| Greenwich LifeSciences, Inc. (GLSI) Greenwich LifeSciences, Inc. (GLSI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $222.2M; last close $14.95 Warnings: late filer, thin data; 5 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | none | n/a | $222.2M |
| RCI Hospitality Holdings, Inc. (RICK) RCI Hospitality Holdings, Inc. (RICK) D/Eon the D/E boundary; percentile 80.2 Nasdaq · Retail-Eating Places market equity $204.0M; last close $26.59 Warnings: late filer; 9 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | D/E | 80.2 | $204.0M |
| Energy Services of America Corp. (ESOA) Energy Services of America Corp. (ESOA) B/Con the B/C boundary; percentile 40.3 Nasdaq · Water, Sewer, Pipeline, Comm & Power Line Construction market equity $195.2M; last close $10.46 Warnings: late filer; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B/C | 40.3 | $195.2M |
| Stoneridge Inc. (SRI) Stoneridge Inc. (SRI) Bsecond fifth; percentile 30.7 NYSE · Motor Vehicle Parts & Accessories market equity $185.1M; last close $6.48 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 30.7 | $185.1M |
| American Resources Corp. (AREC) American Resources Corp. (AREC) noneno letter; percentile n/a Nasdaq · Silver Ores market equity $176.5M; last close $1.65 Warnings: late filer, thin data, degenerate inputs; 4 of 14 inputs | found 6 NT 10-K/Q filings in the last eight quarters | none | n/a | $176.5M |
| Oramed Pharmaceuticals Inc. (ORMP) Oramed Pharmaceuticals Inc. (ORMP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $174.7M; last close $4.21 Warnings: late filer, thin data; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $174.7M |
| Quanterix Corp. (QTRX) Quanterix Corp. (QTRX) D/Eon the D/E boundary; percentile 80.2 Nasdaq · Laboratory Analytical Instruments market equity $151.8M; last close $3.20 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D/E | 80.2 | $151.8M |
| Anavex Life Sciences Corp. (AVXL) Anavex Life Sciences Corp. (AVXL) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $142.8M; last close $1.52 Warnings: late filer, thin data; 3 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $142.8M |
| Outlook Therapeutics, Inc. (OTLK) Outlook Therapeutics, Inc. (OTLK) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $137.3M; last close $0.56 Warnings: dilution, short runway, late filer, thin data, fortress balance sheet; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $137.3M |
| Datavault AI Inc. (DVLT) Datavault AI Inc. (DVLT) Bsecond fifth; percentile 33.1 Nasdaq · Services-Business Services, NEC market equity $137.0M; last close $0.14 Warnings: dilution, short runway, late filer, fortress balance sheet; 9 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | B | 33.1 | $137.0M |
| Beyond Meat, Inc. (BYND) Beyond Meat, Inc. (BYND) Eweakest fifth; percentile 91.9 Nasdaq · Food and Kindred Products market equity $132.9M; last close $7.73 Warnings: dilution, late filer; 8 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | E | 91.9 | $132.9M |
| XCF Global, Inc. (SAFX) XCF Global, Inc. (SAFX) noneno letter; percentile n/a Nasdaq · Industrial Organic Chemicals market equity $131.3M; last close $0.32 Warnings: short runway, late filer, thin data; 3 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | none | n/a | $131.3M |
| Spruce Biosciences, Inc. (SPRB) Spruce Biosciences, Inc. (SPRB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $130.9M; last close $45.26 Warnings: late filer, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $130.9M |
| NRX Pharmaceuticals, Inc. (NRXP) NRX Pharmaceuticals, Inc. (NRXP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $125.1M; last close $2.88 Warnings: dilution, late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $125.1M |
| Airsculpt Technologies, Inc. (AIRS) Airsculpt Technologies, Inc. (AIRS) Eweakest fifth; percentile 92.7 Nasdaq · Services-Offices & Clinics of Doctors of Medicine market equity $119.3M; last close $1.66 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 92.7 | $119.3M |
| Smith Midland Corp. (SMID) Smith Midland Corp. (SMID) Astrongest fifth; percentile 3.1 Nasdaq · Concrete Products, Except Block & Brick market equity $117.8M; last close $22.52 Warnings: late filer; 10 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | A | 3.1 | $117.8M |
| RTB Digital, Inc. (RTB) RTB Digital, Inc. (RTB) Eweakest fifth; percentile 99.1 Nasdaq · Services-Management Consulting Services market equity $117.1M; last close $8.38 Warnings: dilution, short runway, late filer; 8 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | E | 99.1 | $117.1M |
| Kulr Technology Group, Inc. (KULR) Kulr Technology Group, Inc. (KULR) noneno letter; percentile n/a NYSE · Electronic Components & Accessories market equity $113.8M; last close $2.47 Warnings: dilution, short runway, late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $113.8M |
| Future FinTech Group Inc. (FTFT) Future FinTech Group Inc. (FTFT) Eweakest fifth; percentile 98.5 Nasdaq · Services-Business Services, NEC market equity $108.5M; last close $3.33 Warnings: dilution, short runway, late filer; 8 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | E | 98.5 | $108.5M |
| Nextnrg, Inc. (NXXT) Nextnrg, Inc. (NXXT) Dfourth fifth; percentile 76.7 Nasdaq · Retail-Auto Dealers & Gasoline Stations market equity $104.1M; last close $0.61 Warnings: dilution, late filer; 9 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | D | 76.7 | $104.1M |
| Ultralife Corp. (ULBI) Ultralife Corp. (ULBI) Bsecond fifth; percentile 29.0 Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $103.5M; last close $6.22 Warnings: late filer; 8 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | B | 29.0 | $103.5M |
| Lakeland Industries Inc. (LAKE) Lakeland Industries Inc. (LAKE) B/Con the B/C boundary; percentile 38.6 Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies market equity $100.2M; last close $10.10 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B/C | 38.6 | $100.2M |
| Inspired Entertainment, Inc. (INSE) Inspired Entertainment, Inc. (INSE) Bsecond fifth; percentile 27.0 Nasdaq · Services-Prepackaged Software market equity $92.8M; last close $3.51 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 27.0 | $92.8M |
| Starfighters Space, Inc. (FJET) Starfighters Space, Inc. (FJET) noneno letter; percentile n/a NYSE · Air Transportation, Scheduled market equity $92.4M; last close $1.68 Warnings: late filer, thin data, degenerate inputs; 1 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | none | n/a | $92.4M |
| Quantum X Labs Inc. (QXL) Quantum X Labs Inc. (QXL) noneno letter; percentile n/a Nasdaq · Services-Prepackaged Software market equity $89.5M; last close $4.07 Warnings: late filer, thin data; 4 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $89.5M |
| Fluent, Inc. (FLNT) Fluent, Inc. (FLNT) Eweakest fifth; percentile 96.4 Nasdaq · Services-Advertising market equity $89.1M; last close $2.79 Warnings: dilution, late filer; 8 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | E | 96.4 | $89.1M |
| Flanigans Enterprises Inc. (BDL) Flanigans Enterprises Inc. (BDL) Bsecond fifth; percentile 34.2 NYSE · Retail-Eating Places market equity $86.2M; last close $46.52 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 34.2 | $86.2M |
| Dawson Geophysical Co. (DWSN) Dawson Geophysical Co. (DWSN) Cmiddle fifth; percentile 53.1 Nasdaq · Oil & Gas Field Exploration Services market equity $80.4M; last close $2.60 Warnings: late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 53.1 | $80.4M |
| Flexible Solutions International Inc. (FSI) Flexible Solutions International Inc. (FSI) Bsecond fifth; percentile 27.0 NYSE · Miscellaneous Chemical Products market equity $77.3M; last close $6.22 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 27.0 | $77.3M |
| OS Therapies Inc. (OSTX) OS Therapies Inc. (OSTX) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $74.7M; last close $1.62 Warnings: dilution, late filer, thin data; 4 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | none | n/a | $74.7M |
| Momentus Inc. (MNTS) Momentus Inc. (MNTS) Eweakest fifth; percentile 97.2 Nasdaq · Guided Missiles & Space Vehicles & Parts market equity $74.2M; last close $3.38 Warnings: dilution, late filer; 8 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | E | 97.2 | $74.2M |
| Widepoint Corp. (WYY) Widepoint Corp. (WYY) Dfourth fifth; percentile 68.3 NYSE · Services-Computer Integrated Systems Design market equity $71.7M; last close $7.19 Warnings: late filer, fortress balance sheet; 10 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 68.3 | $71.7M |
| Datacentrex, Inc. (DTCX) Datacentrex, Inc. (DTCX) noneno letter; percentile n/a Nasdaq · Services-Computer Processing & Data Preparation market equity $71.1M; last close $1.77 Warnings: late filer, thin data; 4 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $71.1M |
| Blink Charging Co. (BLNK) Blink Charging Co. (BLNK) D/Eon the D/E boundary; percentile 81.9 Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $69.2M; last close $0.48 Warnings: late filer, fortress balance sheet; 7 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | D/E | 81.9 | $69.2M |
| Eva Live Inc. (GOAI) Eva Live Inc. (GOAI) noneno letter; percentile n/a Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $67.9M; last close $1.76 Warnings: short runway, late filer, thin data; 3 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $67.9M |
| CPI Aerostructures Inc. (CVU) CPI Aerostructures Inc. (CVU) Eweakest fifth; percentile 88.6 NYSE · Aircraft Parts & Auxiliary Equipment, NEC market equity $67.6M; last close $5.08 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 88.6 | $67.6M |
| Rein Therapeutics, Inc. (RNTX) Rein Therapeutics, Inc. (RNTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $66.4M; last close $0.77 Warnings: dilution, short runway, late filer, thin data, degenerate inputs, distress; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $66.4M |
| PodcastOne, Inc. (PODC) PodcastOne, Inc. (PODC) noneno letter; percentile n/a Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $66.3M; last close $2.17 Warnings: late filer, thin data; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $66.3M |
| CitroTech Inc. (CITR) CitroTech Inc. (CITR) noneno letter; percentile n/a NYSE · Chemicals & Allied Products market equity $66.1M; last close $2.97 Warnings: short runway, late filer, thin data; 6 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $66.1M |
| Neonc Technologies Holdings, Inc. (NTHI) Neonc Technologies Holdings, Inc. (NTHI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $65.6M; last close $2.53 Warnings: short runway, late filer, thin data, degenerate inputs; 3 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $65.6M |
| AMC Robotics Corp. (AMCI) AMC Robotics Corp. (AMCI) noneno letter; percentile n/a Nasdaq · Retail-Home Furniture, Furnishings & Equipment Stores market equity $63.3M; last close $2.80 Warnings: dilution, late filer, thin data; 6 of 14 inputs | found 6 NT 10-K/Q filings in the last eight quarters | none | n/a | $63.3M |
| Eloxx Pharmaceuticals, Inc. (ELOX) Eloxx Pharmaceuticals, Inc. (ELOX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $61.3M; last close $14.64 Warnings: late filer, thin data, degenerate inputs, fortress balance sheet; 2 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | none | n/a | $61.3M |
| NexMetals Mining Corp. (NEXM) NexMetals Mining Corp. (NEXM) noneno letter; percentile n/a Nasdaq · Metal Mining market equity $60.2M; last close $1.70 Warnings: short runway, late filer, thin data; 2 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $60.2M |
| RenovoRx, Inc. (RNXT) RenovoRx, Inc. (RNXT) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $60.0M; last close $1.33 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $60.0M |
| Geospace Technologies Corp. (GEOS) Geospace Technologies Corp. (GEOS) Dfourth fifth; percentile 73.6 Nasdaq · Measuring & Controlling Devices, NEC market equity $59.8M; last close $4.62 Warnings: short runway, late filer, fortress balance sheet; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | D | 73.6 | $59.8M |
| Solesence, Inc. (SLSN) Solesence, Inc. (SLSN) noneno letter; percentile n/a Nasdaq · Perfumes, Cosmetics & Other Toilet Preparations market equity $59.1M; last close $0.81 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $59.1M |
| Techprecision Corp. (TPCS) Techprecision Corp. (TPCS) Eweakest fifth; percentile 92.1 Nasdaq · Fabricated Structural Metal Products market equity $58.8M; last close $5.80 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | E | 92.1 | $58.8M |
| Veritone, Inc. (VERI) Veritone, Inc. (VERI) noneno letter; percentile n/a Nasdaq · Services-Computer Processing & Data Preparation market equity $58.8M; last close $0.59 Warnings: short runway, late filer, thin data; 3 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $58.8M |
| Paradium.AI, Inc. (PAAI) Paradium.AI, Inc. (PAAI) Cmiddle fifth; percentile 57.3 NYSE · Cable & Other Pay Television Services market equity $54.3M; last close $1.15 Warnings: late filer; 12 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | C | 57.3 | $54.3M |
| BranchOut Food Inc. (BOF) BranchOut Food Inc. (BOF) noneno letter; percentile n/a Nasdaq · Food and Kindred Products market equity $54.2M; last close $3.93 Warnings: dilution, late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $54.2M |
| Saga Communications Inc. (SGA) Saga Communications Inc. (SGA) D/Eon the D/E boundary; percentile 80.1 Nasdaq · Radio Broadcasting Stations market equity $53.4M; last close $8.38 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | D/E | 80.1 | $53.4M |
| AgEagle Aerial Systems Inc. (UAVS) AgEagle Aerial Systems Inc. (UAVS) Eweakest fifth; percentile 98.4 NYSE · Aircraft market equity $52.2M; last close $0.83 Warnings: dilution, late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 98.4 | $52.2M |
| Circle8 Group Inc. (CIRC) Circle8 Group Inc. (CIRC) noneno letter; percentile n/a Nasdaq · Services-Help Supply Services market equity $51.0M; last close $0.44 Warnings: dilution, late filer, thin data; 6 of 14 inputs | found 3 NT 10-K/Q filings in the last eight quarters | none | n/a | $51.0M |
| Bgsf, Inc. (BGSF) Bgsf, Inc. (BGSF) Bsecond fifth; percentile 36.1 NYSE · Services-Help Supply Services market equity $50.9M; last close $4.65 Warnings: late filer; 9 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 36.1 | $50.9M |
| American Vanguard Corp. (AVD) American Vanguard Corp. (AVD) D/Eon the D/E boundary; percentile 80.6 NYSE · Agricultural Chemicals market equity $50.4M; last close $1.71 Warnings: late filer; 9 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | D/E | 80.6 | $50.4M |
| Solidion Technology Inc. (STI) Solidion Technology Inc. (STI) noneno letter; percentile n/a Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $49.2M; last close $5.67 Warnings: dilution, late filer, thin data, degenerate inputs; 3 of 14 inputs | found 7 NT 10-K/Q filings in the last eight quarters | none | n/a | $49.2M |
| ONE Group Hospitality, Inc. (STKS) ONE Group Hospitality, Inc. (STKS) Bsecond fifth; percentile 26.1 Nasdaq · Retail-Eating Places market equity $48.2M; last close $1.51 Warnings: late filer; 7 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | B | 26.1 | $48.2M |
| BioRestorative Therapies, Inc. (BRTX) BioRestorative Therapies, Inc. (BRTX) noneno letter; percentile n/a Nasdaq · Services-Misc Health & Allied Services, NEC market equity $48.2M; last close $1.92 Warnings: dilution, short runway, late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $48.2M |
| Celularity Inc. (CELU) Celularity Inc. (CELU) Eweakest fifth; percentile 94.6 Nasdaq · Pharmaceutical Preparations market equity $47.4M; last close $1.48 Warnings: short runway, late filer; 8 of 14 inputs | found 5 NT 10-K/Q filings in the last eight quarters | E | 94.6 | $47.4M |
| Sow Good Inc. (SOWG) Sow Good Inc. (SOWG) noneno letter; percentile n/a Nasdaq · Food and Kindred Products market equity $44.2M; last close $2.33 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $44.2M |
| Opal Fuels Inc. (OPAL) Opal Fuels Inc. (OPAL) noneno letter; percentile n/a Nasdaq · Gas & Other Services Combined market equity $42.3M; last close $1.68 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $42.3M |
| Matinas BioPharma Holdings, Inc. (MTNB) Matinas BioPharma Holdings, Inc. (MTNB) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $41.6M; last close $2.66 Warnings: dilution, short runway, late filer, thin data; 5 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $41.6M |
| Abundia Global Impact Group, Inc. (AGIG) Abundia Global Impact Group, Inc. (AGIG) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $41.5M; last close $0.93 Warnings: late filer, thin data; 6 of 14 inputs | found 2 NT 10-K/Q filings in the last eight quarters | none | n/a | $41.5M |
| China Pharma Holdings, Inc. (CPHI) China Pharma Holdings, Inc. (CPHI) Eweakest fifth; percentile 93.2 NYSE · Pharmaceutical Preparations market equity $41.3M; last close $0.97 Warnings: dilution, late filer; 8 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | E | 93.2 | $41.3M |
| All In FutureTech Alliance, Inc. (AIFA) All In FutureTech Alliance, Inc. (AIFA) Cmiddle fifth; percentile 47.5 Nasdaq · Services-Amusement & Recreation Services market equity $40.6M; last close $6.30 Warnings: late filer; 7 of 14 inputs | found 4 NT 10-K/Q filings in the last eight quarters | C | 47.5 | $40.6M |
| Massimo Group (MAMO) Massimo Group (MAMO) noneno letter; percentile n/a Nasdaq · Miscellaneous Transportation Equipment market equity $40.2M; last close $0.94 Warnings: late filer, thin data; 6 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $40.2M |
| Elauwit Connection, Inc. (ELWT) Elauwit Connection, Inc. (ELWT) noneno letter; percentile n/a Nasdaq · Communications Services, NEC market equity $39.7M; last close $6.80 Warnings: late filer, thin data, fortress balance sheet; 3 of 14 inputs | found 1 NT 10-K/Q filings in the last eight quarters | none | n/a | $39.7M |
Rule: failure probability in the top decile of the filers where it resolves. 49 triggered; among the 28 with a letter: A 0, B 0, C 0, D 5, E 23.
| Company | Measured | Letter | Percentile | Market equity |
|---|---|---|---|---|
| Lucid Group, Inc. (LCID) Lucid Group, Inc. (LCID) Eweakest fifth; percentile 97.4 Nasdaq · Motor Vehicles & Passenger Car Bodies market equity $1.5B; last close $3.82 Warnings: short runway, distress; 9 of 14 inputs | CHS probability 19.382527%; universe top-decile threshold 1.068854% | E | 97.4 | $1.5B |
| Sutro Biopharma, Inc. (STRO) Sutro Biopharma, Inc. (STRO) Eweakest fifth; percentile 93.0 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $254.0M; last close $15.34 Warnings: dilution, short runway, distress, fortress balance sheet; 7 of 14 inputs | CHS probability 1.321634%; universe top-decile threshold 1.068854% | E | 93.0 | $254.0M |
| NU Skin Enterprises, Inc. (NUS) NU Skin Enterprises, Inc. (NUS) Dfourth fifth; percentile 64.6 NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries market equity $232.2M; last close $4.76 Warnings: distress, fortress balance sheet; 11 of 14 inputs | CHS probability 2.240619%; universe top-decile threshold 1.068854% | D | 64.6 | $232.2M |
| Pyxis Oncology, Inc. (PYXS) Pyxis Oncology, Inc. (PYXS) Eweakest fifth; percentile 83.8 Nasdaq · Pharmaceutical Preparations market equity $166.0M; last close $1.99 Warnings: short runway, distress; 7 of 14 inputs | CHS probability 2.507714%; universe top-decile threshold 1.068854% | E | 83.8 | $166.0M |
| Minerva Neurosciences, Inc. (NERV) Minerva Neurosciences, Inc. (NERV) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $153.7M; last close $3.23 Warnings: dilution, thin data, degenerate inputs, distress; 6 of 14 inputs | CHS probability 10.968507%; universe top-decile threshold 1.068854% | none | n/a | $153.7M |
| Health Catalyst, Inc. (HCAT) Health Catalyst, Inc. (HCAT) noneno letter; percentile n/a Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $131.7M; last close $1.75 Warnings: thin data, distress; 6 of 14 inputs | CHS probability 2.553133%; universe top-decile threshold 1.068854% | none | n/a | $131.7M |
| Heron Therapeutics, Inc. (HRTX) Heron Therapeutics, Inc. (HRTX) Eweakest fifth; percentile 87.3 Nasdaq · Pharmaceutical Preparations market equity $68.0M; last close $0.36 Warnings: distress; 9 of 14 inputs | CHS probability 1.171951%; universe top-decile threshold 1.068854% | E | 87.3 | $68.0M |
| Rein Therapeutics, Inc. (RNTX) Rein Therapeutics, Inc. (RNTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $66.4M; last close $0.77 Warnings: dilution, short runway, late filer, thin data, degenerate inputs, distress; 6 of 14 inputs | CHS probability 1.334985%; universe top-decile threshold 1.068854% | none | n/a | $66.4M |
| Skye Bioscience, Inc. (SKYE) Skye Bioscience, Inc. (SKYE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $59.5M; last close $1.67 Warnings: short runway, thin data, distress; 6 of 14 inputs | CHS probability 7.304380%; universe top-decile threshold 1.068854% | none | n/a | $59.5M |
| Connect Biopharma Holdings Ltd. (CNTB) Connect Biopharma Holdings Ltd. (CNTB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $55.5M; last close $0.91 Warnings: short runway, thin data, degenerate inputs, distress; 5 of 14 inputs | CHS probability 2.011420%; universe top-decile threshold 1.068854% | none | n/a | $55.5M |
| LeonaBio, Inc. (LONA) LeonaBio, Inc. (LONA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $54.2M; last close $5.74 Warnings: thin data, distress; 6 of 14 inputs | CHS probability 8.021477%; universe top-decile threshold 1.068854% | none | n/a | $54.2M |
| Teads Holding Co. (TEAD) Teads Holding Co. (TEAD) Dfourth fifth; percentile 66.1 Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $53.9M; last close $0.56 Warnings: distress; 9 of 14 inputs | CHS probability 2.277029%; universe top-decile threshold 1.068854% | D | 66.1 | $53.9M |
| Clene Inc. (CLNN) Clene Inc. (CLNN) Eweakest fifth; percentile 97.0 Nasdaq · Pharmaceutical Preparations market equity $49.9M; last close $3.88 Warnings: dilution, distress; 8 of 14 inputs | CHS probability 5.228627%; universe top-decile threshold 1.068854% | E | 97.0 | $49.9M |
| Lite Strategy, Inc. (LITS) Lite Strategy, Inc. (LITS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $37.1M; last close $1.23 Warnings: thin data, degenerate inputs, distress; 6 of 14 inputs | CHS probability 2.542619%; universe top-decile threshold 1.068854% | none | n/a | $37.1M |
| Aligos Therapeutics, Inc. (ALGS) Aligos Therapeutics, Inc. (ALGS) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $33.1M; last close $5.46 Warnings: short runway, thin data, distress; 5 of 14 inputs | CHS probability 1.467351%; universe top-decile threshold 1.068854% | none | n/a | $33.1M |
| Cosmos Health Inc. (COSM) Cosmos Health Inc. (COSM) Eweakest fifth; percentile 89.1 Nasdaq · Wholesale-Drugs, Proprietaries & Druggists' Sundries market equity $31.6M; last close $0.31 Warnings: dilution, short runway, late filer, distress; 10 of 14 inputs | CHS probability 1.516980%; universe top-decile threshold 1.068854% | E | 89.1 | $31.6M |
| Quince Therapeutics, Inc. (QNCX) Quince Therapeutics, Inc. (QNCX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $29.9M; last close $29.29 Warnings: dilution, late filer, thin data, distress, fortress balance sheet; 6 of 14 inputs | CHS probability 4.759935%; universe top-decile threshold 1.068854% | none | n/a | $29.9M |
| SRX Global Inc. (SRXH) SRX Global Inc. (SRXH) noneno letter; percentile n/a NYSE · Beverages market equity $28.4M; last close $1.39 Warnings: late filer, thin data, distress, fortress balance sheet; 5 of 14 inputs | CHS probability 6.028179%; universe top-decile threshold 1.068854% | none | n/a | $28.4M |
| BeyondSpring Inc. (BYSI) BeyondSpring Inc. (BYSI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $25.0M; last close $0.63 Warnings: short runway, thin data, degenerate inputs, distress; 5 of 14 inputs | CHS probability 3.649101%; universe top-decile threshold 1.068854% | none | n/a | $25.0M |
| InspireMD, Inc. (NSPR) InspireMD, Inc. (NSPR) Dfourth fifth; percentile 65.9 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $22.3M; last close $0.47 Warnings: dilution, short runway, distress; 9 of 14 inputs | CHS probability 2.091412%; universe top-decile threshold 1.068854% | D | 65.9 | $22.3M |
| SolarMax Technology, Inc. (SMXT) SolarMax Technology, Inc. (SMXT) Eweakest fifth; percentile 96.1 Nasdaq · Construction - Special Trade Contractors market equity $22.1M; last close $4.66 Warnings: late filer, distress; 7 of 14 inputs | CHS probability 4.338298%; universe top-decile threshold 1.068854% | E | 96.1 | $22.1M |
| Dyadic International Inc. (DYAI) Dyadic International Inc. (DYAI) Eweakest fifth; percentile 91.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $16.2M; last close $0.49 Warnings: short runway, distress; 9 of 14 inputs | CHS probability 3.469403%; universe top-decile threshold 1.068854% | E | 91.4 | $16.2M |
| Fabric.AI, Inc. (FABC) Fabric.AI, Inc. (FABC) Eweakest fifth; percentile 94.4 Nasdaq · Communications Services, NEC market equity $15.7M; last close $2.20 Warnings: dilution, short runway, degenerate inputs, distress, fortress balance sheet; 7 of 14 inputs | CHS probability 3.283692%; universe top-decile threshold 1.068854% | E | 94.4 | $15.7M |
| Astrotech Corp. (ASTC) Astrotech Corp. (ASTC) Eweakest fifth; percentile 97.2 Nasdaq · Laboratory Analytical Instruments market equity $13.7M; last close $6.89 Warnings: distress, fortress balance sheet; 9 of 14 inputs | CHS probability 1.524448%; universe top-decile threshold 1.068854% | E | 97.2 | $13.7M |
| Karyopharm Therapeutics Inc. (KPTI) Karyopharm Therapeutics Inc. (KPTI) Eweakest fifth; percentile 83.2 Nasdaq · Pharmaceutical Preparations market equity $13.6M; last close $0.60 Warnings: dilution, distress, fortress balance sheet; 7 of 14 inputs | CHS probability 22.949430%; universe top-decile threshold 1.068854% | E | 83.2 | $13.6M |
| Cerenome, Inc. (CNSY) Cerenome, Inc. (CNSY) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $13.6M; last close $1.80 Warnings: dilution, short runway, late filer, thin data, distress, fortress balance sheet; 6 of 14 inputs | CHS probability 10.402784%; universe top-decile threshold 1.068854% | none | n/a | $13.6M |
| Intensity Therapeutics, Inc. (INTS) Intensity Therapeutics, Inc. (INTS) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $12.0M; last close $3.61 Warnings: dilution, thin data, distress; 5 of 14 inputs | CHS probability 1.766360%; universe top-decile threshold 1.068854% | none | n/a | $12.0M |
| Cardlytics, Inc. (CDLX) Cardlytics, Inc. (CDLX) Eweakest fifth; percentile 94.8 Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $11.5M; last close $1.95 Warnings: distress; 8 of 14 inputs | CHS probability 6.983924%; universe top-decile threshold 1.068854% | E | 94.8 | $11.5M |
| Lantern Pharma Inc. (LTRN) Lantern Pharma Inc. (LTRN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $10.6M; last close $0.84 Warnings: short runway, thin data, distress; 5 of 14 inputs | CHS probability 14.353906%; universe top-decile threshold 1.068854% | none | n/a | $10.6M |
| Arrive AI Inc. (ARAI) Arrive AI Inc. (ARAI) noneno letter; percentile n/a Nasdaq · Services-To Dwellings & Other Buildings market equity $9.2M; last close $0.17 Warnings: short runway, late filer, thin data, distress; 2 of 14 inputs | CHS probability 13.892993%; universe top-decile threshold 1.068854% | none | n/a | $9.2M |
| Myseum.AI, Inc. (MYSE) Myseum.AI, Inc. (MYSE) noneno letter; percentile n/a Nasdaq · Telegraph & Other Message Communications market equity $9.1M; last close $1.81 Warnings: short runway, thin data, degenerate inputs, distress; 6 of 14 inputs | CHS probability 3.721868%; universe top-decile threshold 1.068854% | none | n/a | $9.1M |
| Super League Enterprise, Inc. (SLE) Super League Enterprise, Inc. (SLE) Eweakest fifth; percentile 89.3 Nasdaq · Services-Computer Integrated Systems Design market equity $8.1M; last close $4.75 Warnings: short runway, distress; 7 of 14 inputs | CHS probability 3.717346%; universe top-decile threshold 1.068854% | E | 89.3 | $8.1M |
| Cyngn Inc. (CYN) Cyngn Inc. (CYN) Eweakest fifth; percentile 96.2 Nasdaq · Services-Computer Programming Services market equity $8.0M; last close $0.58 Warnings: dilution, short runway, late filer, distress; 8 of 14 inputs | CHS probability 3.424122%; universe top-decile threshold 1.068854% | E | 96.2 | $8.0M |
| InMed Pharmaceuticals Inc. (INM) InMed Pharmaceuticals Inc. (INM) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $7.3M; last close $1.33 Warnings: dilution, thin data, distress; 5 of 14 inputs | CHS probability 3.127131%; universe top-decile threshold 1.068854% | none | n/a | $7.3M |
| Bolt Biotherapeutics, Inc. (BOLT) Bolt Biotherapeutics, Inc. (BOLT) Eweakest fifth; percentile 95.9 Nasdaq · Pharmaceutical Preparations market equity $7.0M; last close $3.61 Warnings: short runway, distress; 7 of 14 inputs | CHS probability 4.401891%; universe top-decile threshold 1.068854% | E | 95.9 | $7.0M |
| DSS, Inc. (DSS) DSS, Inc. (DSS) Eweakest fifth; percentile 92.5 NYSE · Paperboard Containers & Boxes market equity $6.1M; last close $0.64 Warnings: short runway, distress; 8 of 14 inputs | CHS probability 9.245359%; universe top-decile threshold 1.068854% | E | 92.5 | $6.1M |
| Imunon, Inc. (IMNN) Imunon, Inc. (IMNN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $6.0M; last close $1.14 Warnings: dilution, short runway, thin data, distress, fortress balance sheet; 6 of 14 inputs | CHS probability 6.404641%; universe top-decile threshold 1.068854% | none | n/a | $6.0M |
| enVVeno Medical Corp. (NVNO) enVVeno Medical Corp. (NVNO) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $5.6M; last close $8.27 Warnings: dilution, short runway, thin data, degenerate inputs, distress; 6 of 14 inputs | CHS probability 1.178085%; universe top-decile threshold 1.068854% | none | n/a | $5.6M |
| AIM ImmunoTech Inc. (AIM) AIM ImmunoTech Inc. (AIM) Dfourth fifth; percentile 66.5 NYSE · Biological Products, (No Diagnostic Substances) market equity $5.5M; last close $0.18 Warnings: late filer, degenerate inputs, distress; 8 of 14 inputs | CHS probability 3.371634%; universe top-decile threshold 1.068854% | D | 66.5 | $5.5M |
| Lexaria Bioscience Corp. (LEXX) Lexaria Bioscience Corp. (LEXX) Eweakest fifth; percentile 87.6 Nasdaq · Pharmaceutical Preparations market equity $5.3M; last close $3.37 Warnings: dilution, short runway, distress; 9 of 14 inputs | CHS probability 1.126547%; universe top-decile threshold 1.068854% | E | 87.6 | $5.3M |
| Q/C Technologies, Inc. (QCLS) Q/C Technologies, Inc. (QCLS) noneno letter; percentile n/a Nasdaq · In Vitro & In Vivo Diagnostic Substances market equity $5.2M; last close $0.64 Warnings: short runway, late filer, thin data, distress; 5 of 14 inputs | CHS probability 1.440744%; universe top-decile threshold 1.068854% | none | n/a | $5.2M |
| SenesTech, Inc. (SNES) SenesTech, Inc. (SNES) Dfourth fifth; percentile 67.3 Nasdaq · Agricultural Chemicals market equity $3.9M; last close $0.72 Warnings: dilution, distress, fortress balance sheet; 9 of 14 inputs | CHS probability 2.480835%; universe top-decile threshold 1.068854% | D | 67.3 | $3.9M |
| Focus Universal Inc. (FCUV) Focus Universal Inc. (FCUV) Eweakest fifth; percentile 98.6 Nasdaq · Industrial Instruments For Measurement, Display, and Control market equity $3.1M; last close $4.60 Warnings: dilution, distress; 8 of 14 inputs | CHS probability 35.551552%; universe top-decile threshold 1.068854% | E | 98.6 | $3.1M |
| Silo Pharma, Inc. (SILO) Silo Pharma, Inc. (SILO) Eweakest fifth; percentile 94.9 Nasdaq · Pharmaceutical Preparations market equity $2.3M; last close $1.41 Warnings: dilution, degenerate inputs, distress; 7 of 14 inputs | CHS probability 3.315400%; universe top-decile threshold 1.068854% | E | 94.9 | $2.3M |
| Beyond Air, Inc. (XAIR) Beyond Air, Inc. (XAIR) Eweakest fifth; percentile 91.9 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $2.2M; last close $2.36 Warnings: dilution, short runway, distress; 7 of 14 inputs | CHS probability 5.369254%; universe top-decile threshold 1.068854% | E | 91.9 | $2.2M |
| Curis Inc. (CRIS) Curis Inc. (CRIS) Eweakest fifth; percentile 100.0 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $1.5M; last close $0.78 Warnings: dilution, short runway, distress; 7 of 14 inputs | CHS probability 24.008539%; universe top-decile threshold 1.068854% | E | 100.0 | $1.5M |
| Nexentis Technologies Inc. (NXTS) Nexentis Technologies Inc. (NXTS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $1.3M; last close $0.90 Warnings: dilution, thin data, distress, fortress balance sheet; 6 of 14 inputs | CHS probability 17.392299%; universe top-decile threshold 1.068854% | none | n/a | $1.3M |
| Arcadia Biosciences, Inc. (RKDA) Arcadia Biosciences, Inc. (RKDA) Eweakest fifth; percentile 100.0 Nasdaq · Crude Petroleum & Natural Gas market equity $659,160; last close $0.27 Warnings: distress, fortress balance sheet; 8 of 14 inputs | CHS probability 11.601161%; universe top-decile threshold 1.068854% | E | 100.0 | $659,160 |
| Ocean Power Technologies, Inc. (OPTT) Ocean Power Technologies, Inc. (OPTT) Eweakest fifth; percentile 98.6 NYSE · Electric Services market equity $270,169; last close $0.91 Warnings: short runway, late filer, distress; 10 of 14 inputs | CHS probability 7.646349%; universe top-decile threshold 1.068854% | E | 98.6 | $270,169 |
Rule: latest revenue or total assets at or below $100,000. 154 triggered; among the 15 with a letter: A 0, B 1, C 1, D 4, E 9. The largest 150 by market equity are listed.
| Company | Measured | Letter | Percentile | Market equity |
|---|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) Summit Therapeutics Inc. (SMMT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $13.7B; last close $17.17 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $13.7B |
| Praxis Precision Medicines, Inc. (PRAX) Praxis Precision Medicines, Inc. (PRAX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $7.4B; last close $263.40 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $7.4B |
| Spyre Therapeutics, Inc. (SYRE) Spyre Therapeutics, Inc. (SYRE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $7.0B; last close $80.00 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $7.0B |
| Scholar Rock Holding Corp. (SRRK) Scholar Rock Holding Corp. (SRRK) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $5.1B; last close $42.17 Warnings: thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.1B |
| Oruka Therapeutics, Inc. (ORKA) Oruka Therapeutics, Inc. (ORKA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.1B; last close $77.25 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.1B |
| Viking Therapeutics, Inc. (VKTX) Viking Therapeutics, Inc. (VKTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.2B; last close $27.74 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $3.2B |
| Amylyx Pharmaceuticals, Inc. (AMLX) Amylyx Pharmaceuticals, Inc. (AMLX) Dfourth fifth; percentile 67.6 Nasdaq · Pharmaceutical Preparations market equity $3.0B; last close $27.22 Warnings: short runway, degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | D | 67.6 | $3.0B |
| Denali Therapeutics Inc. (DNLI) Denali Therapeutics Inc. (DNLI) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $3.0B; last close $18.66 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $3.0B |
| Novagold Resources Inc. (NG) Novagold Resources Inc. (NG) noneno letter; percentile n/a NYSE · Gold and Silver Ores market equity $2.8B; last close $6.26 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.8B |
| Sellas Life Sciences Group, Inc. (SLS) Sellas Life Sciences Group, Inc. (SLS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $11.26 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.3B |
| NextDecade Corp. (NEXT) NextDecade Corp. (NEXT) noneno letter; percentile n/a Nasdaq · Natural Gas Transmisison & Distribution market equity $1.8B; last close $6.74 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $1.8B |
| Cullinan Therapeutics, Inc. (CGEM) Cullinan Therapeutics, Inc. (CGEM) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $994.9M; last close $15.46 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $994.9M |
| Sable Offshore Corp. (SOC) Sable Offshore Corp. (SOC) noneno letter; percentile n/a NYSE · Crude Petroleum & Natural Gas market equity $740.6M; last close $3.89 Warnings: dilution, short runway, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $740.6M |
| Achieve Life Sciences, Inc. (ACHV) Achieve Life Sciences, Inc. (ACHV) noneno letter; percentile n/a Nasdaq · In Vitro & In Vivo Diagnostic Substances market equity $739.9M; last close $7.18 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $739.9M |
| Avalo Therapeutics, Inc. (AVTX) Avalo Therapeutics, Inc. (AVTX) Bsecond fifth; percentile 23.8 Nasdaq · Pharmaceutical Preparations market equity $720.3M; last close $13.43 Warnings: dilution, degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | B | 23.8 | $720.3M |
| Design Therapeutics, Inc. (DSGN) Design Therapeutics, Inc. (DSGN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $719.1M; last close $11.47 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $719.1M |
| Fractyl Health, Inc. (GUTS) Fractyl Health, Inc. (GUTS) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $673.3M; last close $4.24 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $673.3M |
| Monopar Therapeutics (MNPR) Monopar Therapeutics (MNPR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $563.7M; last close $84.74 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $563.7M |
| Neurogene Inc. (NGNE) Neurogene Inc. (NGNE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $530.3M; last close $26.39 Warnings: late filer, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $530.3M |
| Altimmune, Inc. (ALT) Altimmune, Inc. (ALT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $505.7M; last close $2.60 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $505.7M |
| Allogene Therapeutics, Inc. (ALLO) Allogene Therapeutics, Inc. (ALLO) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $483.7M; last close $1.40 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $483.7M |
| Capricor Therapeutics, Inc. (CAPR) Capricor Therapeutics, Inc. (CAPR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $465.7M; last close $8.01 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $465.7M |
| International Tower Hill Mines Ltd. (THM) International Tower Hill Mines Ltd. (THM) noneno letter; percentile n/a NYSE · Metal Mining market equity $456.4M; last close $2.33 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $456.4M |
| Impact Biomedical Inc. (IBO) Impact Biomedical Inc. (IBO) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $443.1M; last close $4.23 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $443.1M |
| Entera Bio Ltd. (ENTX) Entera Bio Ltd. (ENTX) Dfourth fifth; percentile 65.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $432.9M; last close $2.51 Warnings: degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | D | 65.4 | $432.9M |
| Vista Gold Corp. (VGZ) Vista Gold Corp. (VGZ) noneno letter; percentile n/a NYSE · Gold and Silver Ores market equity $389.7M; last close $2.68 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $389.7M |
| Relmada Therapeutics, Inc. (RLMD) Relmada Therapeutics, Inc. (RLMD) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $338.1M; last close $3.15 Warnings: dilution, short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $338.1M |
| Artiva Biotherapeutics, Inc. (ARTV) Artiva Biotherapeutics, Inc. (ARTV) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $332.5M; last close $6.80 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $332.5M |
| Benitec Biopharma Inc. (BNTC) Benitec Biopharma Inc. (BNTC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $305.2M; last close $8.76 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $305.2M |
| Contineum Therapeutics, Inc. (CTNM) Contineum Therapeutics, Inc. (CTNM) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $304.4M; last close $13.21 Warnings: short runway, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $304.4M |
| Rocket Pharmaceuticals, Inc. (RCKT) Rocket Pharmaceuticals, Inc. (RCKT) C/Don the C/D boundary; percentile 58.1 Nasdaq · Pharmaceutical Preparations market equity $288.7M; last close $2.62 Warnings: degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | C/D | 58.1 | $288.7M |
| Fulcrum Therapeutics, Inc. (FULC) Fulcrum Therapeutics, Inc. (FULC) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $286.1M; last close $3.76 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $286.1M |
| Larimar Therapeutics, Inc. (LRMR) Larimar Therapeutics, Inc. (LRMR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $280.5M; last close $2.69 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $280.5M |
| GT Biopharma, Inc. (GTBP) GT Biopharma, Inc. (GTBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $268.9M; last close $6.22 Warnings: dilution, short runway, thin data, degenerate inputs; 2 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $268.9M |
| Inhibikase Therapeutics, Inc. (IKT) Inhibikase Therapeutics, Inc. (IKT) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $266.5M; last close $1.91 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $266.5M |
| Palisade BIO, Inc. (PALI) Palisade BIO, Inc. (PALI) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $252.7M; last close $1.46 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $252.7M |
| Lightbridge Corp. (LTBR) Lightbridge Corp. (LTBR) noneno letter; percentile n/a Nasdaq · Industrial Inorganic Chemicals market equity $225.1M; last close $6.01 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $225.1M |
| Lyell Immunopharma, Inc. (LYEL) Lyell Immunopharma, Inc. (LYEL) Dfourth fifth; percentile 69.2 Nasdaq · Pharmaceutical Preparations market equity $215.4M; last close $8.76 Warnings: dilution, degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | D | 69.2 | $215.4M |
| Eledon Pharmaceuticals, Inc. (ELDN) Eledon Pharmaceuticals, Inc. (ELDN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $196.7M; last close $2.41 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $196.7M |
| Zentalis Pharmaceuticals, Inc. (ZNTL) Zentalis Pharmaceuticals, Inc. (ZNTL) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $179.9M; last close $2.50 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $179.9M |
| Compass Therapeutics, Inc. (CMPX) Compass Therapeutics, Inc. (CMPX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $177.1M; last close $0.99 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $177.1M |
| American Resources Corp. (AREC) American Resources Corp. (AREC) noneno letter; percentile n/a Nasdaq · Silver Ores market equity $176.5M; last close $1.65 Warnings: late filer, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $176.5M |
| ALX Oncology Holdings Inc. (ALXO) ALX Oncology Holdings Inc. (ALXO) Eweakest fifth; percentile 95.4 Nasdaq · Pharmaceutical Preparations market equity $163.2M; last close $1.18 Warnings: dilution, short runway, degenerate inputs, fortress balance sheet; 8 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 95.4 | $163.2M |
| Atomera Inc. (ATOM) Atomera Inc. (ATOM) Eweakest fifth; percentile 92.1 Nasdaq · Semiconductors & Related Devices market equity $161.2M; last close $4.13 Warnings: dilution, degenerate inputs; 8 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 92.1 | $161.2M |
| Nkarta, Inc. (NKTX) Nkarta, Inc. (NKTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $159.0M; last close $2.21 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $159.0M |
| Minerva Neurosciences, Inc. (NERV) Minerva Neurosciences, Inc. (NERV) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $153.7M; last close $3.23 Warnings: dilution, thin data, degenerate inputs, distress; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $153.7M |
| Spruce Biosciences, Inc. (SPRB) Spruce Biosciences, Inc. (SPRB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $130.9M; last close $45.26 Warnings: late filer, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $130.9M |
| TuHURA Biosciences, Inc./NV (HURA) TuHURA Biosciences, Inc./NV (HURA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $123.0M; last close $1.95 Warnings: short runway, thin data, degenerate inputs, fortress balance sheet; 2 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $123.0M |
| Genelux Corp. (GNLX) Genelux Corp. (GNLX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $113.1M; last close $2.49 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $113.1M |
| Inovio Pharmaceuticals, Inc. (INO) Inovio Pharmaceuticals, Inc. (INO) Eweakest fifth; percentile 99.5 Nasdaq · Pharmaceutical Preparations market equity $112.7M; last close $1.08 Warnings: dilution, short runway, degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 99.5 | $112.7M |
| Vivani Medical, Inc. (VANI) Vivani Medical, Inc. (VANI) noneno letter; percentile n/a Nasdaq · Electromedical & Electrotherapeutic Apparatus market equity $111.0M; last close $1.22 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $111.0M |
| Aardvark Therapeutics, Inc. (AARD) Aardvark Therapeutics, Inc. (AARD) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $103.1M; last close $4.68 Warnings: thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $103.1M |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) Corbus Pharmaceuticals Holdings, Inc. (CRBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $101.9M; last close $5.25 Warnings: dilution, short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $101.9M |
| Immuneering Corp. (IMRX) Immuneering Corp. (IMRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $97.0M; last close $3.72 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $97.0M |
| OnKure Therapeutics, Inc. (OKUR) OnKure Therapeutics, Inc. (OKUR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $93.1M; last close $2.29 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $93.1M |
| Starfighters Space, Inc. (FJET) Starfighters Space, Inc. (FJET) noneno letter; percentile n/a NYSE · Air Transportation, Scheduled market equity $92.4M; last close $1.68 Warnings: late filer, thin data, degenerate inputs; 1 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $92.4M |
| Gain Therapeutics, Inc. (GANX) Gain Therapeutics, Inc. (GANX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $70.5M; last close $1.61 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $70.5M |
| Maia Biotechnology, Inc. (MAIA) Maia Biotechnology, Inc. (MAIA) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $69.9M; last close $1.16 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $69.9M |
| Tenax Therapeutics, Inc. (TENX) Tenax Therapeutics, Inc. (TENX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $69.6M; last close $1.87 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $69.6M |
| XBiotech Inc. (XBIT) XBiotech Inc. (XBIT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $67.1M; last close $2.18 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $67.1M |
| Rein Therapeutics, Inc. (RNTX) Rein Therapeutics, Inc. (RNTX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $66.4M; last close $0.77 Warnings: dilution, short runway, late filer, thin data, degenerate inputs, distress; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $66.4M |
| Neonc Technologies Holdings, Inc. (NTHI) Neonc Technologies Holdings, Inc. (NTHI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $65.6M; last close $2.53 Warnings: short runway, late filer, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $65.6M |
| Pliant Therapeutics, Inc. (PLRX) Pliant Therapeutics, Inc. (PLRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $61.9M; last close $1.00 Warnings: short runway, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $61.9M |
| Eloxx Pharmaceuticals, Inc. (ELOX) Eloxx Pharmaceuticals, Inc. (ELOX) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $61.3M; last close $14.64 Warnings: late filer, thin data, degenerate inputs, fortress balance sheet; 2 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $61.3M |
| Ideal Power Inc. (IPWR) Ideal Power Inc. (IPWR) Eweakest fifth; percentile 96.6 Nasdaq · Semiconductors & Related Devices market equity $60.6M; last close $3.69 Warnings: dilution, degenerate inputs, fortress balance sheet; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 96.6 | $60.6M |
| Sera Prognostics, Inc. (SERA) Sera Prognostics, Inc. (SERA) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories market equity $59.2M; last close $2.02 Warnings: short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $59.2M |
| iBio, Inc. (IBIO) iBio, Inc. (IBIO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $59.2M; last close $0.91 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $59.2M |
| Westwater Resources, Inc. (WWR) Westwater Resources, Inc. (WWR) noneno letter; percentile n/a NYSE · Metal Mining market equity $58.4M; last close $0.45 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $58.4M |
| Talphera, Inc. (TLPH) Talphera, Inc. (TLPH) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $56.1M; last close $1.07 Warnings: dilution, short runway, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $56.1M |
| Connect Biopharma Holdings Ltd. (CNTB) Connect Biopharma Holdings Ltd. (CNTB) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $55.5M; last close $0.91 Warnings: short runway, thin data, degenerate inputs, distress; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $55.5M |
| Solitario Resources Corp. (XPL) Solitario Resources Corp. (XPL) noneno letter; percentile n/a NYSE · Gold and Silver Ores market equity $52.5M; last close $0.55 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $52.5M |
| Inmune Bio, Inc. (INMB) Inmune Bio, Inc. (INMB) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $50.8M; last close $1.84 Warnings: thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $50.8M |
| Annovis Bio, Inc. (ANVS) Annovis Bio, Inc. (ANVS) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $49.8M; last close $1.18 Warnings: dilution, short runway, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $49.8M |
| Solidion Technology Inc. (STI) Solidion Technology Inc. (STI) noneno letter; percentile n/a Nasdaq · Miscellaneous Electrical Machinery, Equipment & Supplies market equity $49.2M; last close $5.67 Warnings: dilution, late filer, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $49.2M |
| Instil Bio, Inc. (TIL) Instil Bio, Inc. (TIL) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $44.5M; last close $6.51 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $44.5M |
| Sow Good Inc. (SOWG) Sow Good Inc. (SOWG) noneno letter; percentile n/a Nasdaq · Food and Kindred Products market equity $44.2M; last close $2.33 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $44.2M |
| Grace Therapeutics, Inc. (GRCE) Grace Therapeutics, Inc. (GRCE) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $42.9M; last close $2.02 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $42.9M |
| Incannex Healthcare Inc. (IXHL) Incannex Healthcare Inc. (IXHL) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $40.1M; last close $3.21 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $40.1M |
| Lite Strategy, Inc. (LITS) Lite Strategy, Inc. (LITS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $37.1M; last close $1.23 Warnings: thin data, degenerate inputs, distress; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $37.1M |
| Edesa Biotech, Inc. (EDSA) Edesa Biotech, Inc. (EDSA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $35.3M; last close $3.70 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $35.3M |
| GridAI Technologies Corp. (GRDX) GridAI Technologies Corp. (GRDX) noneno letter; percentile n/a Nasdaq · Electric & Other Services Combined market equity $34.2M; last close $4.80 Warnings: dilution, short runway, late filer, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $34.2M |
| Actinium Pharmaceuticals, Inc. (ATNM) Actinium Pharmaceuticals, Inc. (ATNM) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $34.0M; last close $1.08 Warnings: thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $34.0M |
| Nanoviricides, Inc. (NNVC) Nanoviricides, Inc. (NNVC) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $33.4M; last close $1.31 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $33.4M |
| BeyondSpring Inc. (BYSI) BeyondSpring Inc. (BYSI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $25.0M; last close $0.63 Warnings: short runway, thin data, degenerate inputs, distress; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $25.0M |
| Atossa Therapeutics, Inc. (ATOS) Atossa Therapeutics, Inc. (ATOS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $24.1M; last close $2.42 Warnings: thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $24.1M |
| Ascent Solar Technologies, Inc. (ASTI) Ascent Solar Technologies, Inc. (ASTI) noneno letter; percentile n/a Nasdaq · Semiconductors & Related Devices market equity $22.0M; last close $2.24 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $22.0M |
| Modular Medical, Inc. (MODD) Modular Medical, Inc. (MODD) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $21.7M; last close $2.61 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $21.7M |
| PAVmed Inc. (PAVM) PAVmed Inc. (PAVM) Eweakest fifth; percentile 99.7 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $21.5M; last close $2.67 Warnings: dilution, short runway, degenerate inputs; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 99.7 | $21.5M |
| BioCardia, Inc. (BCDA) BioCardia, Inc. (BCDA) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $16.0M; last close $1.05 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $16.0M |
| Fabric.AI, Inc. (FABC) Fabric.AI, Inc. (FABC) Eweakest fifth; percentile 94.4 Nasdaq · Communications Services, NEC market equity $15.7M; last close $2.20 Warnings: dilution, short runway, degenerate inputs, distress, fortress balance sheet; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 94.4 | $15.7M |
| Citius Pharmaceuticals, Inc. (CTXR) Citius Pharmaceuticals, Inc. (CTXR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $13.4M; last close $0.51 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $13.4M |
| Caring Brands, Inc. (CABR) Caring Brands, Inc. (CABR) noneno letter; percentile n/a Nasdaq · Perfumes, Cosmetics & Other Toilet Preparations market equity $12.0M; last close $1.20 Warnings: thin data, degenerate inputs, fortress balance sheet; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $12.0M |
| Phio Pharmaceuticals Corp. (PHIO) Phio Pharmaceuticals Corp. (PHIO) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $11.3M; last close $0.98 Warnings: dilution, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $11.3M |
| Clearone Inc. (CLRO) Clearone Inc. (CLRO) noneno letter; percentile n/a Nasdaq · Telephone & Telegraph Apparatus market equity $11.0M; last close $4.03 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $11.0M |
| Theriva Biologics, Inc. (TOVX) Theriva Biologics, Inc. (TOVX) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $10.4M; last close $0.23 Warnings: dilution, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $10.4M |
| Senti Biosciences Holdings, Inc. (SNTI) Senti Biosciences Holdings, Inc. (SNTI) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $10.0M; last close $0.31 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $10.0M |
| Myseum.AI, Inc. (MYSE) Myseum.AI, Inc. (MYSE) noneno letter; percentile n/a Nasdaq · Telegraph & Other Message Communications market equity $9.1M; last close $1.81 Warnings: short runway, thin data, degenerate inputs, distress; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $9.1M |
| Endra Life Sciences Inc. (NDRA) Endra Life Sciences Inc. (NDRA) noneno letter; percentile n/a Nasdaq · Electromedical & Electrotherapeutic Apparatus market equity $8.9M; last close $6.27 Warnings: dilution, short runway, late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $8.9M |
| Moleculin Biotech, Inc. (MBRX) Moleculin Biotech, Inc. (MBRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $8.3M; last close $0.43 Warnings: dilution, short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $8.3M |
| Azitra, Inc. (AZTR) Azitra, Inc. (AZTR) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $8.0M; last close $0.13 Warnings: dilution, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $8.0M |
| Aqua Metals, Inc. (AQMS) Aqua Metals, Inc. (AQMS) noneno letter; percentile n/a Nasdaq · Secondary Smelting & Refining of Nonferrous Metals market equity $7.4M; last close $2.04 Warnings: dilution, short runway, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $7.4M |
| Global Interactive Technologies, Inc. (GITS) Global Interactive Technologies, Inc. (GITS) noneno letter; percentile n/a Nasdaq · Services-Computer Programming, Data Processing, Etc. market equity $6.7M; last close $1.73 Warnings: dilution, late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $6.7M |
| Exicure, Inc. (XCUR) Exicure, Inc. (XCUR) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $6.5M; last close $1.25 Warnings: late filer, thin data, degenerate inputs, fortress balance sheet; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $6.5M |
| Kala BIO, Inc. (KALA) Kala BIO, Inc. (KALA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.7M; last close $0.30 Warnings: dilution, short runway, late filer, thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.7M |
| Creative Medical Technology Holdings, Inc. (CELZ) Creative Medical Technology Holdings, Inc. (CELZ) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $5.7M; last close $0.90 Warnings: dilution, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.7M |
| enVVeno Medical Corp. (NVNO) enVVeno Medical Corp. (NVNO) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $5.6M; last close $8.27 Warnings: dilution, short runway, thin data, degenerate inputs, distress; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.6M |
| Auddia Inc. (AUUD) Auddia Inc. (AUUD) noneno letter; percentile n/a Nasdaq · Services-Computer Processing & Data Preparation market equity $5.6M; last close $0.96 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.6M |
| AIM ImmunoTech Inc. (AIM) AIM ImmunoTech Inc. (AIM) Dfourth fifth; percentile 66.5 NYSE · Biological Products, (No Diagnostic Substances) market equity $5.5M; last close $0.18 Warnings: late filer, degenerate inputs, distress; 8 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | D | 66.5 | $5.5M |
| Lunai Bioworks Inc. (LNAI) Lunai Bioworks Inc. (LNAI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.1M; last close $1.14 Warnings: dilution, late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $5.1M |
| Aethlon Medical Inc. (AEMD) Aethlon Medical Inc. (AEMD) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $4.3M; last close $6.05 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $4.3M |
| PharmaCyte Biotech, Inc. (PMCB) PharmaCyte Biotech, Inc. (PMCB) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $4.3M; last close $0.40 Warnings: dilution, late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $4.3M |
| Processa Pharmaceuticals, Inc. (PCSA) Processa Pharmaceuticals, Inc. (PCSA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.8M; last close $1.73 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $3.8M |
| GRI Bio, Inc. (GRI) GRI Bio, Inc. (GRI) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.7M; last close $1.88 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $3.7M |
| Autonomix Medical, Inc. (AMIX) Autonomix Medical, Inc. (AMIX) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $3.0M; last close $3.10 Warnings: short runway, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $3.0M |
| Adagio Medical Holdings, Inc. (ADGM) Adagio Medical Holdings, Inc. (ADGM) noneno letter; percentile n/a Nasdaq · Surgical & Medical Instruments & Apparatus market equity $2.9M; last close $0.13 Warnings: dilution, short runway, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.9M |
| HCW Biologics Inc. (HCWB) HCW Biologics Inc. (HCWB) Eweakest fifth; percentile 99.2 Nasdaq · Pharmaceutical Preparations market equity $2.8M; last close $1.62 Warnings: dilution, short runway, late filer, degenerate inputs, fortress balance sheet; 8 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 99.2 | $2.8M |
| Silo Pharma, Inc. (SILO) Silo Pharma, Inc. (SILO) Eweakest fifth; percentile 94.9 Nasdaq · Pharmaceutical Preparations market equity $2.3M; last close $1.41 Warnings: dilution, degenerate inputs, distress; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 94.9 | $2.3M |
| Genprex, Inc. (GNPX) Genprex, Inc. (GNPX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.3M; last close $2.75 Warnings: dilution, late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.3M |
| Jupiter Neurosciences, Inc. (JUNS) Jupiter Neurosciences, Inc. (JUNS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.1M; last close $2.81 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.1M |
| Oragenics Inc. (OGEN) Oragenics Inc. (OGEN) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $2.1M; last close $0.48 Warnings: dilution, short runway, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.1M |
| Alaunos Therapeutics, Inc. (TCRT) Alaunos Therapeutics, Inc. (TCRT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.0M; last close $0.79 Warnings: short runway, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $2.0M |
| Endovia Health Sciences, Inc. (EDVA) Endovia Health Sciences, Inc. (EDVA) Eweakest fifth; percentile 98.4 NYSE · Beverages market equity $1.0M; last close $0.15 Warnings: short runway, late filer, degenerate inputs, fortress balance sheet; 7 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | E | 98.4 | $1.0M |
| Decoy Therapeutics Inc. (DCOY) Decoy Therapeutics Inc. (DCOY) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $995,881; last close $1.52 Warnings: dilution, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | $995,881 |
| Aclarion, Inc. (ACON) Aclarion, Inc. (ACON) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories last close $2.35 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Aclarion, Inc. (ACONW) Aclarion, Inc. (ACONW) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories last close $0.03 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Aedis Energy Inc. (ALCE) Aedis Energy Inc. (ALCE) noneno letter; percentile n/a None · Electric & Other Services Combined last close $0.21 Warnings: short runway, late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Aspire-Lakewood Holdings, Inc. (ASBP) Aspire-Lakewood Holdings, Inc. (ASBP) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations last close $8.38 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Aspire-Lakewood Holdings, Inc. (ASBPW) Aspire-Lakewood Holdings, Inc. (ASBPW) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations last close $0.02 Warnings: late filer, thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Bimergen Energy Corp. (BESS) Bimergen Energy Corp. (BESS) noneno letter; percentile n/a NYSE · Electric Services last close $2.23 Warnings: late filer, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Bimergen Energy Corp. (BESS-WT) Bimergen Energy Corp. (BESS-WT) noneno letter; percentile n/a NYSE · Electric Services Warnings: late filer, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Bio Green Med Solution, Inc. (BGMS) Bio Green Med Solution, Inc. (BGMS) noneno letter; percentile n/a Nasdaq · Wholesale-Durable Goods, NEC last close $0.88 Warnings: late filer, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Nuburu, Inc. (BURU) Nuburu, Inc. (BURU) noneno letter; percentile n/a NYSE · Miscellaneous Electrical Machinery, Equipment & Supplies last close $0.95 Warnings: short runway, late filer, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Cardio Diagnostics Holdings, Inc. (CDIO) Cardio Diagnostics Holdings, Inc. (CDIO) noneno letter; percentile n/a Nasdaq · In Vitro & In Vivo Diagnostic Substances last close $1.86 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Cardio Diagnostics Holdings, Inc. (CDIOW) Cardio Diagnostics Holdings, Inc. (CDIOW) noneno letter; percentile n/a Nasdaq · In Vitro & In Vivo Diagnostic Substances last close $0.01 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Hadron Energy, Inc. (HDRN) Hadron Energy, Inc. (HDRN) noneno letter; percentile n/a Nasdaq · Electric Services last close $1.06 Warnings: thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Hadron Energy, Inc. (HDRNW) Hadron Energy, Inc. (HDRNW) noneno letter; percentile n/a Nasdaq · Electric Services last close $0.13 Warnings: thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Hycroft Mining Holding Corp. (HYMC) Hycroft Mining Holding Corp. (HYMC) noneno letter; percentile n/a Nasdaq · Gold and Silver Ores last close $18.20 Warnings: thin data, degenerate inputs, fortress balance sheet; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Jubilant Flame International, Ltd. (JFIL) Jubilant Flame International, Ltd. (JFIL) noneno letter; percentile n/a None · Services-Computer Programming Services Warnings: thin data, degenerate inputs; 1 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Jocom Holdings Corp. (JOCM) Jocom Holdings Corp. (JOCM) noneno letter; percentile n/a None · Services-Miscellaneous Business Services Warnings: late filer, thin data, degenerate inputs; 1 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Kiora Pharmaceuticals Inc. (KPRX) Kiora Pharmaceuticals Inc. (KPRX) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations last close $2.54 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Net Power Inc. (NPWR) Net Power Inc. (NPWR) noneno letter; percentile n/a NYSE · Electrical Industrial Apparatus last close $1.25 Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Net Power Inc. (NPWR-WT) Net Power Inc. (NPWR-WT) noneno letter; percentile n/a NYSE · Electrical Industrial Apparatus Warnings: thin data, degenerate inputs; 5 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| One World Products, Inc. (OWPC) One World Products, Inc. (OWPC) noneno letter; percentile n/a None · Pharmaceutical Preparations Warnings: late filer, thin data, degenerate inputs; 3 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| ProtoKinetix, Inc. (PKTX) ProtoKinetix, Inc. (PKTX) noneno letter; percentile n/a None · Pharmaceutical Preparations Warnings: late filer, thin data, degenerate inputs; 2 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Rafael Holdings, Inc. (RFL) Rafael Holdings, Inc. (RFL) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations last close $1.49 Warnings: late filer, thin data, degenerate inputs; 6 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Revolution Medicines, Inc. (RVMD) Revolution Medicines, Inc. (RVMD) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) last close $188.00 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Revolution Medicines, Inc. (RVMDW) Revolution Medicines, Inc. (RVMDW) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) last close $11.53 Warnings: thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| SAB Biotherapeutics, Inc. (SABS) SAB Biotherapeutics, Inc. (SABS) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) last close $2.90 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| SAB Biotherapeutics, Inc. (SABSW) SAB Biotherapeutics, Inc. (SABSW) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) last close $0.03 Warnings: short runway, thin data, degenerate inputs; 4 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a | |
| Starguide Group, Inc. (STRG) Starguide Group, Inc. (STRG) noneno letter; percentile n/a None · Wholesale-Miscellaneous Nondurable Goods Warnings: late filer, thin data, degenerate inputs; 1 of 14 inputs | latest revenue or assets are at or below the $100,000 validity floor | none | n/a |
Rule: cash above total debt; informational, never a warning. 663 triggered; among the 466 with a letter: A 151, B 93, C 79, D 67, E 76. The largest 150 by market equity are listed.
| Company | Measured | Letter | Percentile | Market equity |
|---|---|---|---|---|
| Nvidia Corp. (NVDA) Nvidia Corp. (NVDA) Astrongest fifth; percentile 3.0 Nasdaq · Semiconductors & Related Devices market equity $5.6T; last close $230.70 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 2,137,000,000 USD; Altman Z is not used | A | 3.0 | $5.6T |
| Amazon COM Inc. (AMZN) Amazon COM Inc. (AMZN) A/Bon the A/B boundary; percentile 20.2 Nasdaq · Retail-Catalog & Mail-Order Houses market equity $2.7T; last close $254.10 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 17,974,000,000 USD; Altman Z is not used | A/B | 20.2 | $2.7T |
| Tesla, Inc. (TSLA) Tesla, Inc. (TSLA) B/Con the B/C boundary; percentile 38.3 Nasdaq · Motor Vehicles & Passenger Car Bodies market equity $1.5T; last close $375.06 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 9,929,000,000 USD; Altman Z is not used | B/C | 38.3 | $1.5T |
| Advanced Micro Devices Inc. (AMD) Advanced Micro Devices Inc. (AMD) A/Bon the A/B boundary; percentile 20.2 Nasdaq · Semiconductors & Related Devices market equity $1.0T; last close $620.83 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 2,534,000,000 USD; Altman Z is not used | A/B | 20.2 | $1.0T |
| Costco Wholesale Corp. (COST) Costco Wholesale Corp. (COST) Astrongest fifth; percentile 4.7 Nasdaq · Retail-Variety Stores market equity $420.1B; last close $947.68 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 3,727,000,000 USD; Altman Z is not used | A | 4.7 | $420.1B |
| LAM Research Corp. (LRCX) LAM Research Corp. (LRCX) Astrongest fifth; percentile 8.3 Nasdaq · Special Industry Machinery, NEC market equity $401.2B; last close $320.67 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 1,848,681,000 USD; Altman Z is not used | A | 8.3 | $401.2B |
| Sandisk Corp. (SNDK) Sandisk Corp. (SNDK) Astrongest fifth; percentile 10.3 Nasdaq · Computer Storage Devices market equity $235.7B; last close $1,610.84 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 4,762,000,000 USD; Altman Z is not used | A | 10.3 | $235.7B |
| Western Digital Corp. (WDC) Western Digital Corp. (WDC) Cmiddle fifth; percentile 44.6 Nasdaq · Computer Storage Devices market equity $141.8B; last close $393.28 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 527,000,000 USD; Altman Z is not used | C | 44.6 | $141.8B |
| Automatic Data Processing Inc. (ADP) Automatic Data Processing Inc. (ADP) C/Don the C/D boundary; percentile 58.9 Nasdaq · Services-Computer Processing & Data Preparation market equity $107.6B; last close $270.13 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 1,352,400,000 USD; Altman Z is not used | C/D | 58.9 | $107.6B |
| Monster Beverage Corp. (MNST) Monster Beverage Corp. (MNST) Astrongest fifth; percentile 6.5 Nasdaq · Bottled & Canned Soft Drinks & Carbonated Waters market equity $85.5B; last close $43.66 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 1,159,336,000 USD; Altman Z is not used | A | 6.5 | $85.5B |
| Motorola Solutions, Inc. (MSI) Motorola Solutions, Inc. (MSI) Cmiddle fifth; percentile 57.1 NYSE · Radio & Tv Broadcasting & Communications Equipment market equity $74.0B; last close $447.00 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 381,000,000 USD; Altman Z is not used | C | 57.1 | $74.0B |
| Ross Stores, Inc. (ROST) Ross Stores, Inc. (ROST) Astrongest fifth; percentile 3.5 Nasdaq · Retail-Family Clothing Stores market equity $71.9B; last close $225.18 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 3,076,786,000 USD; Altman Z is not used | A | 3.5 | $71.9B |
| Teradyne, Inc. (TER) Teradyne, Inc. (TER) A/Bon the A/B boundary; percentile 18.1 Nasdaq · Instruments For Meas & Testing of Electricity & Elec Signals market equity $62.3B; last close $398.81 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 294,256,000 USD; Altman Z is not used | A/B | 18.1 | $62.3B |
| Ciena Corp. (CIEN) Ciena Corp. (CIEN) B/Con the B/C boundary; percentile 39.5 NYSE · Telephone & Telegraph Apparatus market equity $60.4B; last close $425.94 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 247,541,000 USD; Altman Z is not used | B/C | 39.5 | $60.4B |
| Comfort Systems USA Inc. (FIX) Comfort Systems USA Inc. (FIX) Astrongest fifth; percentile 2.7 NYSE · Electrical Work market equity $60.1B; last close $1,708.11 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 836,672,000 USD; Altman Z is not used | A | 2.7 | $60.1B |
| Fastenal Co. (FAST) Fastenal Co. (FAST) Astrongest fifth; percentile 2.7 Nasdaq · Retail-Building Materials, Hardware, Garden Supply market equity $57.9B; last close $50.50 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 151,800,000 USD; Altman Z is not used | A | 2.7 | $57.9B |
| Natera, Inc. (NTRA) Natera, Inc. (NTRA) Astrongest fifth; percentile 12.7 Nasdaq · Services-Medical Laboratories market equity $56.3B; last close $390.68 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 184,352,000 USD; Altman Z is not used | A | 12.7 | $56.3B |
| Baker Hughes Co. (BKR) Baker Hughes Co. (BKR) noneno letter; percentile n/a Nasdaq · Oil & Gas Field Machinery & Equipment market equity $55.9B; last close $56.31 Warnings: thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 711,000,000 USD; Altman Z is not used | none | n/a | $55.9B |
| Chipotle Mexican Grill Inc. (CMG) Chipotle Mexican Grill Inc. (CMG) Astrongest fifth; percentile 5.4 NYSE · Retail-Eating Places market equity $41.4B; last close $32.65 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 350,545,000 USD; Altman Z is not used | A | 5.4 | $41.4B |
| Rocket Lab Corp. (RKLB) Rocket Lab Corp. (RKLB) C/Don the C/D boundary; percentile 62.6 Nasdaq · Guided Missiles & Space Vehicles & Parts market equity $40.9B; last close $68.40 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 676,265,000 USD; Altman Z is not used | C/D | 62.6 | $40.9B |
| OLD Dominion Freight Line, Inc. (ODFL) OLD Dominion Freight Line, Inc. (ODFL) Astrongest fifth; percentile 12.2 Nasdaq · Trucking (No Local) market equity $37.7B; last close $181.66 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 100,096,000 USD; Altman Z is not used | A | 12.2 | $37.7B |
| Zscaler, Inc. (ZS) Zscaler, Inc. (ZS) Astrongest fifth; percentile 12.7 Nasdaq · Services-Computer Programming Services market equity $35.4B; last close $216.88 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 280,805,000 USD; Altman Z is not used | A | 12.7 | $35.4B |
| Emcor Group, Inc. (EME) Emcor Group, Inc. (EME) Astrongest fifth; percentile 14.9 NYSE · Electrical Work market equity $34.3B; last close $777.80 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 786,912,000 USD; Altman Z is not used | A | 14.9 | $34.3B |
| Roblox Corp. (RBLX) Roblox Corp. (RBLX) Bsecond fifth; percentile 36.9 NYSE · Services-Prepackaged Software market equity $32.5B; last close $45.54 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 30,949,000 USD; Altman Z is not used | B | 36.9 | $32.5B |
| Dexcom Inc. (DXCM) Dexcom Inc. (DXCM) A/Bon the A/B boundary; percentile 18.4 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $31.9B; last close $84.44 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 67,200,000 USD; Altman Z is not used | A/B | 18.4 | $31.9B |
| Cognizant Technology Solutions Corp. (CTSH) Cognizant Technology Solutions Corp. (CTSH) Cmiddle fifth; percentile 52.2 Nasdaq · Services-Computer Programming Services market equity $28.4B; last close $60.02 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 411,000,000 USD; Altman Z is not used | C | 52.2 | $28.4B |
| Williams Sonoma Inc. (WSM) Williams Sonoma Inc. (WSM) Bsecond fifth; percentile 29.2 NYSE · Retail-Home Furniture, Furnishings & Equipment Stores market equity $28.1B; last close $238.79 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 222,927,000 USD; Altman Z is not used | B | 29.2 | $28.1B |
| TechnipFMC plc (FTI) TechnipFMC plc (FTI) Astrongest fifth; percentile 11.0 NYSE · Oil & Gas Field Machinery & Equipment market equity $27.3B; last close $69.60 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 601,900,000 USD; Altman Z is not used | A | 11.0 | $27.3B |
| Verisign Inc/Ca (VRSN) Verisign Inc/Ca (VRSN) Bsecond fifth; percentile 34.9 Nasdaq · Services-Computer Programming Services market equity $26.9B; last close $297.70 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 339,223,000 USD; Altman Z is not used | B | 34.9 | $26.9B |
| West Pharmaceutical Services Inc. (WST) West Pharmaceutical Services Inc. (WST) A/Bon the A/B boundary; percentile 20.8 NYSE · Surgical & Medical Instruments & Apparatus market equity $25.6B; last close $363.17 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 588,500,000 USD; Altman Z is not used | A/B | 20.8 | $25.6B |
| Roivant Sciences Ltd. (ROIV) Roivant Sciences Ltd. (ROIV) Cmiddle fifth; percentile 54.1 Nasdaq · Pharmaceutical Preparations market equity $24.7B; last close $34.22 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 6,064,362,000 USD; Altman Z is not used | C | 54.1 | $24.7B |
| Roku, Inc. (ROKU) Roku, Inc. (ROKU) A/Bon the A/B boundary; percentile 19.9 Nasdaq · Cable & Other Pay Television Services market equity $22.7B; last close $153.81 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 155,564,000 USD; Altman Z is not used | A/B | 19.9 | $22.7B |
| Pultegroup (PHM) Pultegroup (PHM) noneno letter; percentile n/a NYSE · Operative Builders market equity $21.3B; last close $113.52 Warnings: thin data, fortress balance sheet; 5 of 14 inputs | cash minus debt is 1,936,969,000 USD; Altman Z is not used | none | n/a | $21.3B |
| Rivian Automotive, Inc. DE (RIVN) Rivian Automotive, Inc. DE (RIVN) Dfourth fifth; percentile 76.7 Nasdaq · Motor Vehicles & Passenger Car Bodies market equity $19.5B; last close $14.33 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 3,426,000,000 USD; Altman Z is not used | D | 76.7 | $19.5B |
| First Solar, Inc. (FSLR) First Solar, Inc. (FSLR) Bsecond fifth; percentile 29.6 Nasdaq · Semiconductors & Related Devices market equity $19.2B; last close $178.87 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 1,296,269,000 USD; Altman Z is not used | B | 29.6 | $19.2B |
| Snap-on Inc. (SNA) Snap-on Inc. (SNA) Bsecond fifth; percentile 31.1 NYSE · Cutlery, Handtools & General Hardware market equity $18.6B; last close $358.99 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 421,900,000 USD; Altman Z is not used | B | 31.1 | $18.6B |
| Best BUY Co. Inc. (BBY) Best BUY Co. Inc. (BBY) Astrongest fifth; percentile 7.8 NYSE · Retail-Radio, Tv & Consumer Electronics Stores market equity $18.5B; last close $88.37 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 573,000,000 USD; Altman Z is not used | A | 7.8 | $18.5B |
| ITT Inc. (ITT) ITT Inc. (ITT) Astrongest fifth; percentile 2.8 NYSE · Pumps & Pumping Equipment market equity $17.8B; last close $198.73 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 1,221,400,000 USD; Altman Z is not used | A | 2.8 | $17.8B |
| Dynatrace, Inc. (DT) Dynatrace, Inc. (DT) Astrongest fifth; percentile 5.2 NYSE · Services-Prepackaged Software market equity $17.7B; last close $61.15 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 189,049,000 USD; Altman Z is not used | A | 5.2 | $17.7B |
| Fabrinet (FN) Fabrinet (FN) Bsecond fifth; percentile 35.3 NYSE · Telephone & Telegraph Apparatus market equity $17.5B; last close $487.65 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 120,805,000 USD; Altman Z is not used | B | 35.3 | $17.5B |
| Tractor Supply Co. (TSCO) Tractor Supply Co. (TSCO) Astrongest fifth; percentile 5.1 Nasdaq · Retail-Building Materials, Hardware, Garden Supply market equity $17.4B; last close $33.48 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 44,109,000 USD; Altman Z is not used | A | 5.1 | $17.4B |
| NVR Inc. (NVR) NVR Inc. (NVR) noneno letter; percentile n/a NYSE · Operative Builders market equity $16.0B; last close $6,005.39 Warnings: thin data, fortress balance sheet; 5 of 14 inputs | cash minus debt is 266,138,000 USD; Altman Z is not used | none | n/a | $16.0B |
| Exelixis, Inc. (EXEL) Exelixis, Inc. (EXEL) Astrongest fifth; percentile 2.2 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $14.6B; last close $59.01 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 183,164,000 USD; Altman Z is not used | A | 2.2 | $14.6B |
| Onto Innovation Inc. (ONTO) Onto Innovation Inc. (ONTO) Astrongest fifth; percentile 15.1 NYSE · Measuring & Controlling Devices, NEC market equity $14.4B; last close $292.94 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 44,765,000 USD; Altman Z is not used | A | 15.1 | $14.4B |
| Tyler Technologies Inc. (TYL) Tyler Technologies Inc. (TYL) Bsecond fifth; percentile 36.7 NYSE · Services-Prepackaged Software market equity $13.6B; last close $331.24 Warnings: fortress balance sheet; 14 of 14 inputs | cash minus debt is 415,737,000 USD; Altman Z is not used | B | 36.7 | $13.6B |
| Guidewire Software, Inc. (GWRE) Guidewire Software, Inc. (GWRE) Bsecond fifth; percentile 37.7 NYSE · Services-Prepackaged Software market equity $13.5B; last close $164.66 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 149,089,000 USD; Altman Z is not used | B | 37.7 | $13.5B |
| Mueller Industries Inc. (MLI) Mueller Industries Inc. (MLI) Bsecond fifth; percentile 29.9 NYSE · Rolling Drawing & Extruding of Nonferrous Metals market equity $13.4B; last close $60.52 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 458,281,000 USD; Altman Z is not used | B | 29.9 | $13.4B |
| Hasbro, Inc. (HAS) Hasbro, Inc. (HAS) Cmiddle fifth; percentile 55.3 Nasdaq · Games, Toys & Children's Vehicles (No Dolls & Bicycles) market equity $13.0B; last close $92.50 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | cash minus debt is 533,912,000 USD; Altman Z is not used | C | 55.3 | $13.0B |
| Corcept Therapeutics Inc. (CORT) Corcept Therapeutics Inc. (CORT) Astrongest fifth; percentile 3.5 Nasdaq · Pharmaceutical Preparations market equity $12.8B; last close $118.66 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 48,032,000 USD; Altman Z is not used | A | 3.5 | $12.8B |
| Skyworks Solutions, Inc. (SWKS) Skyworks Solutions, Inc. (SWKS) Cmiddle fifth; percentile 54.8 Nasdaq · Semiconductors & Related Devices market equity $12.2B; last close $80.75 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 664,900,000 USD; Altman Z is not used | C | 54.8 | $12.2B |
| Costar Group, Inc. (CSGP) Costar Group, Inc. (CSGP) Bsecond fifth; percentile 26.6 Nasdaq · Services-Business Services, NEC market equity $12.1B; last close $29.82 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 1,493,000,000 USD; Altman Z is not used | B | 26.6 | $12.1B |
| SailPoint, Inc. (SAIL) SailPoint, Inc. (SAIL) noneno letter; percentile n/a Nasdaq · Services-Prepackaged Software market equity $11.4B; last close $20.01 Warnings: thin data, fortress balance sheet; 3 of 14 inputs | cash minus debt is 358,144,000 USD; Altman Z is not used | none | n/a | $11.4B |
| Advanced Energy Industries Inc. (AEIS) Advanced Energy Industries Inc. (AEIS) B/Con the B/C boundary; percentile 40.7 Nasdaq · Electronic Components, NEC market equity $11.4B; last close $284.31 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 223,700,000 USD; Altman Z is not used | B/C | 40.7 | $11.4B |
| Bio-Techne Corp. (TECH) Bio-Techne Corp. (TECH) Bsecond fifth; percentile 31.1 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $11.4B; last close $72.46 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 64,712,000 USD; Altman Z is not used | B | 31.1 | $11.4B |
| Sanmina Corp. (SANM) Sanmina Corp. (SANM) Cmiddle fifth; percentile 52.8 Nasdaq · Printed Circuit Boards market equity $11.3B; last close $210.35 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 132,527,000 USD; Altman Z is not used | C | 52.8 | $11.3B |
| Viavi Solutions Inc. (VIAV) Viavi Solutions Inc. (VIAV) C/Don the C/D boundary; percentile 57.9 Nasdaq · Semiconductors & Related Devices market equity $10.9B; last close $44.09 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 281,000,000 USD; Altman Z is not used | C/D | 57.9 | $10.9B |
| Formfactor Inc. (FORM) Formfactor Inc. (FORM) Bsecond fifth; percentile 25.6 Nasdaq · Semiconductors & Related Devices market equity $10.7B; last close $137.08 Warnings: fortress balance sheet; 14 of 14 inputs | cash minus debt is 91,122,000 USD; Altman Z is not used | B | 25.6 | $10.7B |
| Texas Roadhouse, Inc. (TXRH) Texas Roadhouse, Inc. (TXRH) Bsecond fifth; percentile 28.0 Nasdaq · Retail-Eating Places market equity $10.7B; last close $162.69 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 208,044,000 USD; Altman Z is not used | B | 28.0 | $10.7B |
| Paycom Software, Inc. (PAYC) Paycom Software, Inc. (PAYC) A/Bon the A/B boundary; percentile 18.8 NYSE · Services-Prepackaged Software market equity $10.4B; last close $230.33 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 371,700,000 USD; Altman Z is not used | A/B | 18.8 | $10.4B |
| Elastic N.V. (ESTC) Elastic N.V. (ESTC) Bsecond fifth; percentile 24.4 NYSE · Services-Prepackaged Software market equity $10.0B; last close $95.31 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 197,830,000 USD; Altman Z is not used | B | 24.4 | $10.0B |
| Ensign Group, Inc. (ENSG) Ensign Group, Inc. (ENSG) Astrongest fifth; percentile 15.9 Nasdaq · Services-Skilled Nursing Care Facilities market equity $10.0B; last close $171.41 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 359,529,000 USD; Altman Z is not used | A | 15.9 | $10.0B |
| 10x Genomics, Inc. (TXG) 10x Genomics, Inc. (TXG) B/Con the B/C boundary; percentile 38.3 Nasdaq · Laboratory Analytical Instruments market equity $9.9B; last close $77.23 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 394,447,000 USD; Altman Z is not used | B/C | 38.3 | $9.9B |
| Leonardo DRS, Inc. (DRS) Leonardo DRS, Inc. (DRS) Bsecond fifth; percentile 30.2 Nasdaq · Search, Detection, Navigation, Guidance, Aeronautical Sys market equity $9.6B; last close $35.85 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 326,000,000 USD; Altman Z is not used | B | 30.2 | $9.6B |
| Twist Bioscience Corp. (TWST) Twist Bioscience Corp. (TWST) C/Don the C/D boundary; percentile 60.8 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $9.5B; last close $152.02 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 89,501,000 USD; Altman Z is not used | C/D | 60.8 | $9.5B |
| Glaukos Corp. (GKOS) Glaukos Corp. (GKOS) Bsecond fifth; percentile 34.9 NYSE · Surgical & Medical Instruments & Apparatus market equity $9.5B; last close $161.17 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 11,876,000 USD; Altman Z is not used | B | 34.9 | $9.5B |
| Repligen Corp. (RGEN) Repligen Corp. (RGEN) B/Con the B/C boundary; percentile 41.4 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $9.2B; last close $163.99 Warnings: late filer, fortress balance sheet; 12 of 14 inputs | cash minus debt is 23,808,000 USD; Altman Z is not used | B/C | 41.4 | $9.2B |
| Corteva, Inc. (CTVA) Corteva, Inc. (CTVA) Cmiddle fifth; percentile 52.8 NYSE · Agricultural Production-Crops market equity $9.2B; last close $13.74 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 2,835,000,000 USD; Altman Z is not used | C | 52.8 | $9.2B |
| Protagonist Therapeutics, Inc. (PTGX) Protagonist Therapeutics, Inc. (PTGX) Astrongest fifth; percentile 0.0 Nasdaq · Pharmaceutical Preparations market equity $9.1B; last close $139.91 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 23,212,000 USD; Altman Z is not used | A | 0.0 | $9.1B |
| Applied Optoelectronics, Inc. (AAOI) Applied Optoelectronics, Inc. (AAOI) Dfourth fifth; percentile 65.1 Nasdaq · Semiconductors & Related Devices market equity $9.0B; last close $106.67 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | cash minus debt is 172,165,000 USD; Altman Z is not used | D | 65.1 | $9.0B |
| MP Materials Corp. DE (MP) MP Materials Corp. DE (MP) Eweakest fifth; percentile 86.6 NYSE · Metal Mining market equity $8.2B; last close $46.17 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 167,270,000 USD; Altman Z is not used | E | 86.6 | $8.2B |
| GAP Inc. (GAP) GAP Inc. (GAP) Bsecond fifth; percentile 30.4 NYSE · Retail-Family Clothing Stores market equity $8.2B; last close $23.37 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 534,000,000 USD; Altman Z is not used | B | 30.4 | $8.2B |
| Paylocity Holding Corp. (PCTY) Paylocity Holding Corp. (PCTY) Bsecond fifth; percentile 33.7 Nasdaq · Services-Prepackaged Software market equity $8.1B; last close $152.95 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 190,667,000 USD; Altman Z is not used | B | 33.7 | $8.1B |
| Kratos Defense & Security Solutions, Inc. (KTOS) Kratos Defense & Security Solutions, Inc. (KTOS) Astrongest fifth; percentile 16.9 Nasdaq · Guided Missiles & Space Vehicles & Parts market equity $7.9B; last close $41.93 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 52,700,000 USD; Altman Z is not used | A | 16.9 | $7.9B |
| Caris Life Sciences, Inc. (CAI) Caris Life Sciences, Inc. (CAI) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories market equity $7.8B; last close $27.52 Warnings: thin data, fortress balance sheet; 3 of 14 inputs | cash minus debt is 417,824,000 USD; Altman Z is not used | none | n/a | $7.8B |
| Applied Digital Corp. (APLD) Applied Digital Corp. (APLD) Cmiddle fifth; percentile 50.4 Nasdaq · Services-Computer Processing & Data Preparation market equity $7.2B; last close $23.72 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 31,608,000 USD; Altman Z is not used | C | 50.4 | $7.2B |
| Simpson Manufacturing Co., Inc. (SSD) Simpson Manufacturing Co., Inc. (SSD) Astrongest fifth; percentile 3.9 NYSE · Cutlery, Handtools & General Hardware market equity $7.0B; last close $171.93 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 84,138,000 USD; Altman Z is not used | A | 3.9 | $7.0B |
| Plexus Corp. (PLXS) Plexus Corp. (PLXS) B/Con the B/C boundary; percentile 38.1 Nasdaq · Printed Circuit Boards market equity $7.0B; last close $261.46 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 36,483,000 USD; Altman Z is not used | B/C | 38.1 | $7.0B |
| Powell Industries Inc. (POWL) Powell Industries Inc. (POWL) Bsecond fifth; percentile 30.7 Nasdaq · Switchgear & Switchboard Apparatus market equity $6.9B; last close $189.18 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 101,954,000 USD; Altman Z is not used | B | 30.7 | $6.9B |
| Sprouts Farmers Market, Inc. (SFM) Sprouts Farmers Market, Inc. (SFM) A/Bon the A/B boundary; percentile 22.2 Nasdaq · Retail-Grocery Stores market equity $6.2B; last close $66.05 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 76,794,000 USD; Altman Z is not used | A/B | 22.2 | $6.2B |
| Dutch Bros Inc. (BROS) Dutch Bros Inc. (BROS) Astrongest fifth; percentile 11.3 NYSE · Retail-Eating & Drinking Places market equity $6.1B; last close $39.77 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 66,941,000 USD; Altman Z is not used | A | 11.3 | $6.1B |
| Lyft, Inc. (LYFT) Lyft, Inc. (LYFT) Cmiddle fifth; percentile 54.0 Nasdaq · Services-Business Services, NEC market equity $6.1B; last close $16.14 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 78,998,000 USD; Altman Z is not used | C | 54.0 | $6.1B |
| IES Holdings, Inc. (IESC) IES Holdings, Inc. (IESC) Bsecond fifth; percentile 25.4 Nasdaq · Electrical Work market equity $6.0B; last close $300.63 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 2,728,000 USD; Altman Z is not used | B | 25.4 | $6.0B |
| Epam Systems, Inc. (EPAM) Epam Systems, Inc. (EPAM) Bsecond fifth; percentile 26.6 NYSE · Services-Computer Programming Services market equity $5.9B; last close $113.86 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 1,297,105,000 USD; Altman Z is not used | B | 26.6 | $5.9B |
| Landstar System Inc. (LSTR) Landstar System Inc. (LSTR) Bsecond fifth; percentile 28.4 Nasdaq · Trucking (No Local) market equity $5.7B; last close $169.41 Warnings: late filer, fortress balance sheet; 8 of 14 inputs | cash minus debt is 396,694,000 USD; Altman Z is not used | B | 28.4 | $5.7B |
| Crocs, Inc. (CROX) Crocs, Inc. (CROX) Bsecond fifth; percentile 35.0 Nasdaq · Rubber & Plastics Footwear market equity $5.6B; last close $116.72 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 172,098,000 USD; Altman Z is not used | B | 35.0 | $5.6B |
| Laureate Education, Inc. (LAUR) Laureate Education, Inc. (LAUR) A/Bon the A/B boundary; percentile 21.2 Nasdaq · Services-Educational Services market equity $5.4B; last close $39.20 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 73,580,000 USD; Altman Z is not used | A/B | 21.2 | $5.4B |
| Cogent Biosciences, Inc. (COGT) Cogent Biosciences, Inc. (COGT) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $5.2B; last close $30.09 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | cash minus debt is 89,117,000 USD; Altman Z is not used | none | n/a | $5.2B |
| Pricesmart Inc. (PSMT) Pricesmart Inc. (PSMT) Astrongest fifth; percentile 9.7 Nasdaq · Retail-Variety Stores market equity $5.2B; last close $167.12 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 54,427,000 USD; Altman Z is not used | A | 9.7 | $5.2B |
| Ollie's Bargain Outlet Holdings, Inc. (OLLI) Ollie's Bargain Outlet Holdings, Inc. (OLLI) Astrongest fifth; percentile 12.5 Nasdaq · Retail-Variety Stores market equity $5.2B; last close $86.75 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 258,706,000 USD; Altman Z is not used | A | 12.5 | $5.2B |
| Scholar Rock Holding Corp. (SRRK) Scholar Rock Holding Corp. (SRRK) noneno letter; percentile n/a Nasdaq · Biological Products, (No Diagnostic Substances) market equity $5.1B; last close $42.17 Warnings: thin data, degenerate inputs, fortress balance sheet; 6 of 14 inputs | cash minus debt is 50,855,000 USD; Altman Z is not used | none | n/a | $5.1B |
| Blackberry Ltd. (BB) Blackberry Ltd. (BB) Cmiddle fifth; percentile 51.2 NYSE · Services-Prepackaged Software market equity $5.1B; last close $8.63 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 78,200,000 USD; Altman Z is not used | C | 51.2 | $5.1B |
| Amarin Corp. Plc\Uk (AMRN) Amarin Corp. Plc\Uk (AMRN) Eweakest fifth; percentile 84.3 Nasdaq · Pharmaceutical Preparations market equity $5.0B; last close $12.02 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 594,886,000 USD; Altman Z is not used | E | 84.3 | $5.0B |
| MYR Group Inc. (MYRG) MYR Group Inc. (MYRG) Astrongest fifth; percentile 3.6 Nasdaq · Water, Sewer, Pipeline, Comm & Power Line Construction market equity $4.8B; last close $311.43 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 91,119,000 USD; Altman Z is not used | A | 3.6 | $4.8B |
| Gossamer Bio, Inc. (GOSS) Gossamer Bio, Inc. (GOSS) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $4.8B; last close $9.72 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 106,567,000 USD; Altman Z is not used | none | n/a | $4.8B |
| Warrior MET Coal, Inc. (HCC) Warrior MET Coal, Inc. (HCC) A/Bon the A/B boundary; percentile 19.0 NYSE · Silver Ores market equity $4.7B; last close $89.87 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 145,711,000 USD; Altman Z is not used | A/B | 19.0 | $4.7B |
| Uranium Energy Corp. (UEC) Uranium Energy Corp. (UEC) D/Eon the D/E boundary; percentile 82.4 NYSE · Miscellaneous Metal Ores market equity $4.5B; last close $9.15 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 32,536,000 USD; Altman Z is not used | D/E | 82.4 | $4.5B |
| Gentex Corp. (GNTX) Gentex Corp. (GNTX) Astrongest fifth; percentile 0.9 Nasdaq · Motor Vehicle Parts & Accessories market equity $4.5B; last close $21.15 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 569,734,496 USD; Altman Z is not used | A | 0.9 | $4.5B |
| Primoris Services Corp. (PRIM) Primoris Services Corp. (PRIM) A/Bon the A/B boundary; percentile 18.2 NYSE · Water, Sewer, Pipeline, Comm & Power Line Construction market equity $4.4B; last close $82.66 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 65,600,000 USD; Altman Z is not used | A/B | 18.2 | $4.4B |
| Oceaneering International Inc. (OII) Oceaneering International Inc. (OII) Astrongest fifth; percentile 2.7 NYSE · Oil & Gas Field Services, NEC market equity $4.4B; last close $44.50 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 201,457,000 USD; Altman Z is not used | A | 2.7 | $4.4B |
| Diodes Inc. (DIOD) Diodes Inc. (DIOD) Cmiddle fifth; percentile 53.6 Nasdaq · Semiconductors & Related Devices market equity $4.4B; last close $96.33 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 341,546,000 USD; Altman Z is not used | C | 53.6 | $4.4B |
| Tutor Perini Corp. (TPC) Tutor Perini Corp. (TPC) A/Bon the A/B boundary; percentile 22.1 NYSE · General Bldg Contractors - Nonresidential Bldgs market equity $4.4B; last close $84.34 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 327,179,000 USD; Altman Z is not used | A/B | 22.1 | $4.4B |
| Champion Homes, Inc. (SKY) Champion Homes, Inc. (SKY) Astrongest fifth; percentile 14.6 NYSE · Mobile Homes market equity $4.4B; last close $81.59 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 614,480,000 USD; Altman Z is not used | A | 14.6 | $4.4B |
| Core Natural Resources, Inc. (CNR) Core Natural Resources, Inc. (CNR) Astrongest fifth; percentile 16.3 NYSE · Silver Ores market equity $4.4B; last close $88.53 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 78,014,000 USD; Altman Z is not used | A | 16.3 | $4.4B |
| UFP Industries Inc. (UFPI) UFP Industries Inc. (UFPI) A/Bon the A/B boundary; percentile 19.1 Nasdaq · Sawmills & Planting Mills, General market equity $4.2B; last close $76.46 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 684,441,000 USD; Altman Z is not used | A/B | 19.1 | $4.2B |
| LivaNova plc (LIVN) LivaNova plc (LIVN) Astrongest fifth; percentile 10.0 Nasdaq · Electromedical & Electrotherapeutic Apparatus market equity $4.2B; last close $75.93 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 259,489,000 USD; Altman Z is not used | A | 10.0 | $4.2B |
| Grand Canyon Education, Inc. (LOPE) Grand Canyon Education, Inc. (LOPE) Astrongest fifth; percentile 5.7 Nasdaq · Services-Educational Services market equity $4.2B; last close $160.38 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 137,995,000 USD; Altman Z is not used | A | 5.7 | $4.2B |
| Korn Ferry (KFY) Korn Ferry (KFY) Bsecond fifth; percentile 33.4 NYSE · Services-Employment Agencies market equity $4.0B; last close $72.97 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 380,838,000 USD; Altman Z is not used | B | 33.4 | $4.0B |
| Ondas Inc. (ONDS) Ondas Inc. (ONDS) Cmiddle fifth; percentile 45.6 Nasdaq · Radio & Tv Broadcasting & Communications Equipment market equity $3.9B; last close $6.85 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | cash minus debt is 25,394,642 USD; Altman Z is not used | C | 45.6 | $3.9B |
| FTI Consulting, Inc. (FCN) FTI Consulting, Inc. (FCN) Bsecond fifth; percentile 26.9 NYSE · Services-Management Consulting Services market equity $3.9B; last close $140.45 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 660,493,000 USD; Altman Z is not used | B | 26.9 | $3.9B |
| Archer Aviation Inc. (ACHR) Archer Aviation Inc. (ACHR) noneno letter; percentile n/a NYSE · Aircraft market equity $3.6B; last close $4.72 Warnings: thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 941,200,000 USD; Altman Z is not used | none | n/a | $3.6B |
| Interparfums Inc. (IPAR) Interparfums Inc. (IPAR) Astrongest fifth; percentile 1.8 Nasdaq · Perfumes, Cosmetics & Other Toilet Preparations market equity $3.6B; last close $111.65 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | cash minus debt is 159,464,197,000 USD; Altman Z is not used | A | 1.8 | $3.6B |
| National Healthcare Corp. (NHC) National Healthcare Corp. (NHC) B/Con the B/C boundary; percentile 40.0 NYSE · Services-Skilled Nursing Care Facilities market equity $3.5B; last close $223.10 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 52,829,000 USD; Altman Z is not used | B/C | 40.0 | $3.5B |
| Robert Half Inc. (RHI) Robert Half Inc. (RHI) Cmiddle fifth; percentile 52.8 NYSE · Services-Help Supply Services market equity $3.5B; last close $34.09 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 270,021,000 USD; Altman Z is not used | C | 52.8 | $3.5B |
| iRhythm Holdings, Inc. (IRTC) iRhythm Holdings, Inc. (IRTC) Astrongest fifth; percentile 7.3 Nasdaq · Surgical & Medical Instruments & Apparatus market equity $3.4B; last close $102.84 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 117,872,000 USD; Altman Z is not used | A | 7.3 | $3.4B |
| Stride, Inc. (LRN) Stride, Inc. (LRN) Astrongest fifth; percentile 1.2 NYSE · Services-Educational Services market equity $3.4B; last close $81.32 Warnings: fortress balance sheet; 13 of 14 inputs | cash minus debt is 336,506,000 USD; Altman Z is not used | A | 1.2 | $3.4B |
| Celcuity Inc. (CELC) Celcuity Inc. (CELC) noneno letter; percentile n/a Nasdaq · Services-Medical Laboratories market equity $3.3B; last close $67.86 Warnings: dilution, thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 28,156,000 USD; Altman Z is not used | none | n/a | $3.3B |
| IPG Photonics Corp. (IPGP) IPG Photonics Corp. (IPGP) C/Don the C/D boundary; percentile 61.9 Nasdaq · Semiconductors & Related Devices market equity $3.3B; last close $77.80 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 682,178,000 USD; Altman Z is not used | C/D | 61.9 | $3.3B |
| Tarsus Pharmaceuticals, Inc. (TARS) Tarsus Pharmaceuticals, Inc. (TARS) Astrongest fifth; percentile 4.9 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $3.2B; last close $72.26 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 111,202,000 USD; Altman Z is not used | A | 4.9 | $3.2B |
| Extreme Networks Inc. (EXTR) Extreme Networks Inc. (EXTR) Bsecond fifth; percentile 33.9 Nasdaq · Computer Communications Equipment market equity $3.2B; last close $24.17 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 46,758,000 USD; Altman Z is not used | B | 33.9 | $3.2B |
| United States Lime & Minerals Inc. (USLM) United States Lime & Minerals Inc. (USLM) Astrongest fifth; percentile 1.5 Nasdaq · Mining & Quarrying of Nonmetallic Minerals (No Fuels) market equity $3.1B; last close $109.02 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 371,124,000 USD; Altman Z is not used | A | 1.5 | $3.1B |
| Dyne Therapeutics, Inc. (DYN) Dyne Therapeutics, Inc. (DYN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $3.1B; last close $16.38 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | cash minus debt is 744,448,000 USD; Altman Z is not used | none | n/a | $3.1B |
| Peabody Energy Corp. (BTU) Peabody Energy Corp. (BTU) B/Con the B/C boundary; percentile 38.8 NYSE · Bituminous Coal & Lignite Surface Mining market equity $3.0B; last close $25.03 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 254,100,000 USD; Altman Z is not used | B/C | 38.8 | $3.0B |
| Arcus Biosciences, Inc. (RCUS) Arcus Biosciences, Inc. (RCUS) noneno letter; percentile n/a NYSE · Pharmaceutical Preparations market equity $3.0B; last close $23.82 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 123,000,000 USD; Altman Z is not used | none | n/a | $3.0B |
| Cal-Maine Foods Inc. (CALM) Cal-Maine Foods Inc. (CALM) Bsecond fifth; percentile 32.5 Nasdaq · Agricultural Prod-Livestock & Animal Specialties market equity $3.0B; last close $64.81 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 66,910,000 USD; Altman Z is not used | B | 32.5 | $3.0B |
| American Eagle Outfitters Inc. (AEO) American Eagle Outfitters Inc. (AEO) Astrongest fifth; percentile 16.3 NYSE · Retail-Family Clothing Stores market equity $3.0B; last close $17.97 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 238,923,000 USD; Altman Z is not used | A | 16.3 | $3.0B |
| Benchmark Electronics Inc. (BHE) Benchmark Electronics Inc. (BHE) Cmiddle fifth; percentile 54.4 NYSE · Printed Circuit Boards market equity $2.9B; last close $81.17 Warnings: fortress balance sheet; 12 of 14 inputs | cash minus debt is 115,238,000 USD; Altman Z is not used | C | 54.4 | $2.9B |
| Ouster, Inc. (OUST) Ouster, Inc. (OUST) Cmiddle fifth; percentile 52.8 Nasdaq · General Industrial Machinery & Equipment, NEC market equity $2.9B; last close $39.50 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 83,358,000 USD; Altman Z is not used | C | 52.8 | $2.9B |
| Aehr Test Systems (AEHR) Aehr Test Systems (AEHR) Cmiddle fifth; percentile 48.6 Nasdaq · Instruments For Meas & Testing of Electricity & Elec Signals market equity $2.8B; last close $87.21 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 16,848,000 USD; Altman Z is not used | C | 48.6 | $2.8B |
| Imax Corp. (IMAX) Imax Corp. (IMAX) noneno letter; percentile n/a NYSE · Photographic Equipment & Supplies market equity $2.8B; last close $51.38 Warnings: fortress balance sheet; 7 of 14 inputs | cash minus debt is 187,239,000 USD; Altman Z is not used | none | n/a | $2.8B |
| Harley-Davidson, Inc. (HOG) Harley-Davidson, Inc. (HOG) Cmiddle fifth; percentile 48.8 NYSE · Motorcycles, Bicycles & Parts market equity $2.8B; last close $26.73 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 622,503,000 USD; Altman Z is not used | C | 48.8 | $2.8B |
| ChronoScale Holdings Corp. (CHRN) ChronoScale Holdings Corp. (CHRN) noneno letter; percentile n/a Nasdaq · General Industrial Machinery & Equipment, NEC market equity $2.8B; last close $18.59 Warnings: short runway, thin data, fortress balance sheet; 3 of 14 inputs | cash minus debt is 38,413,000 USD; Altman Z is not used | none | n/a | $2.8B |
| Rogers Corp. (ROG) Rogers Corp. (ROG) Astrongest fifth; percentile 4.8 NYSE · Plastic Materials, Synth Resins & Nonvulcan Elastomers market equity $2.6B; last close $148.14 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 16,863,000 USD; Altman Z is not used | A | 4.8 | $2.6B |
| Kyndryl Holdings, Inc. (KD) Kyndryl Holdings, Inc. (KD) noneno letter; percentile n/a NYSE · Services-Computer Integrated Systems Design market equity $2.6B; last close $11.90 Warnings: late filer, thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 330,000,000 USD; Altman Z is not used | none | n/a | $2.6B |
| Liquidia Corp. (LQDA) Liquidia Corp. (LQDA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.5B; last close $28.02 Warnings: thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 73,404,000 USD; Altman Z is not used | none | n/a | $2.5B |
| Supernus Pharmaceuticals, Inc. (SUPN) Supernus Pharmaceuticals, Inc. (SUPN) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.4B; last close $42.15 Warnings: thin data, fortress balance sheet; 5 of 14 inputs | cash minus debt is 17,077,000 USD; Altman Z is not used | none | n/a | $2.4B |
| Kaiser Aluminum Corp. (KALU) Kaiser Aluminum Corp. (KALU) C/Don the C/D boundary; percentile 57.5 Nasdaq · Rolling Drawing & Extruding of Nonferrous Metals market equity $2.4B; last close $150.08 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 45,100,000 USD; Altman Z is not used | C/D | 57.5 | $2.4B |
| Redwire Corp. (RDW) Redwire Corp. (RDW) D/Eon the D/E boundary; percentile 79.9 NYSE · Guided Missiles & Space Vehicles & Parts market equity $2.4B; last close $9.76 Warnings: dilution, fortress balance sheet; 9 of 14 inputs | cash minus debt is 9,269,000 USD; Altman Z is not used | D/E | 79.9 | $2.4B |
| Plug Power Inc. (PLUG) Plug Power Inc. (PLUG) Eweakest fifth; percentile 96.9 Nasdaq · Electrical Industrial Apparatus market equity $2.4B; last close $1.73 Warnings: short runway, fortress balance sheet; 8 of 14 inputs | cash minus debt is 131,133,000 USD; Altman Z is not used | E | 96.9 | $2.4B |
| Innospec Inc. (IOSP) Innospec Inc. (IOSP) Astrongest fifth; percentile 14.2 Nasdaq · Chemicals & Allied Products market equity $2.4B; last close $97.81 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 105,300,000 USD; Altman Z is not used | A | 14.2 | $2.4B |
| Eplus Inc. (PLUS) Eplus Inc. (PLUS) Astrongest fifth; percentile 10.5 Nasdaq · Wholesale-Computers & Peripheral Equipment & Software market equity $2.4B; last close $91.24 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 350,602,000 USD; Altman Z is not used | A | 10.5 | $2.4B |
| Disc Medicine, Inc. (IRON) Disc Medicine, Inc. (IRON) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $60.77 Warnings: short runway, thin data, fortress balance sheet; 6 of 14 inputs | cash minus debt is 61,986,000 USD; Altman Z is not used | none | n/a | $2.3B |
| Adma Biologics, Inc. (ADMA) Adma Biologics, Inc. (ADMA) A/Bon the A/B boundary; percentile 18.9 Nasdaq · Biological Products, (No Diagnostic Substances) market equity $2.3B; last close $10.32 Warnings: late filer, fortress balance sheet; 10 of 14 inputs | cash minus debt is 15,487,000 USD; Altman Z is not used | A/B | 18.9 | $2.3B |
| Harmony Biosciences Holdings, Inc. (HRMY) Harmony Biosciences Holdings, Inc. (HRMY) Astrongest fifth; percentile 1.4 Nasdaq · Pharmaceutical Preparations market equity $2.3B; last close $39.60 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 588,839,000 USD; Altman Z is not used | A | 1.4 | $2.3B |
| LiveRamp Holdings, Inc. (RAMP) LiveRamp Holdings, Inc. (RAMP) Astrongest fifth; percentile 11.1 NYSE · Services-Computer Processing & Data Preparation market equity $2.3B; last close $37.56 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 1,061,473,000 USD; Altman Z is not used | A | 11.1 | $2.3B |
| Flywire Corp. (FLYW) Flywire Corp. (FLYW) Astrongest fifth; percentile 6.0 Nasdaq · Services-Business Services, NEC market equity $2.2B; last close $18.43 Warnings: fortress balance sheet; 9 of 14 inputs | cash minus debt is 359,421,000 USD; Altman Z is not used | A | 6.0 | $2.2B |
| Nlight, Inc. (LASR) Nlight, Inc. (LASR) C/Don the C/D boundary; percentile 60.5 Nasdaq · Semiconductors & Related Devices market equity $2.2B; last close $38.28 Warnings: fortress balance sheet; 8 of 14 inputs | cash minus debt is 149,369,000 USD; Altman Z is not used | C/D | 60.5 | $2.2B |
| Alpha Metallurgical Resources, Inc. (AMR) Alpha Metallurgical Resources, Inc. (AMR) Cmiddle fifth; percentile 49.7 NYSE · Bituminous Coal & Lignite Surface Mining market equity $2.2B; last close $173.98 Warnings: fortress balance sheet; 10 of 14 inputs | cash minus debt is 356,133,000 USD; Altman Z is not used | C | 49.7 | $2.2B |
| Proto Labs Inc. (PRLB) Proto Labs Inc. (PRLB) Astrongest fifth; percentile 2.0 NYSE · Fabricated Structural Metal Products market equity $2.2B; last close $92.31 Warnings: fortress balance sheet; 11 of 14 inputs | cash minus debt is 43,319,000 USD; Altman Z is not used | A | 2.0 | $2.2B |
| Immunome Inc. (IMNM) Immunome Inc. (IMNM) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.2B; last close $19.32 Warnings: dilution, thin data, fortress balance sheet; 5 of 14 inputs | cash minus debt is 39,266,000 USD; Altman Z is not used | none | n/a | $2.2B |
| Vera Therapeutics, Inc. (VERA) Vera Therapeutics, Inc. (VERA) noneno letter; percentile n/a Nasdaq · Pharmaceutical Preparations market equity $2.1B; last close $29.74 Warnings: short runway, thin data, fortress balance sheet; 4 of 14 inputs | cash minus debt is 279,887,000 USD; Altman Z is not used | none | n/a | $2.1B |
Rule: fewer than 7 of the 14 inputs computable; no letter is given. 1,335 triggered; among the 0 with a letter: A 0, B 0, C 0, D 0, E 0. The largest 150 by market equity are listed.